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Abstract 
 
Oxidative biocatalysts have a vast industrial and biotechnological potential in 
areas such as fine chemical and antibiotic synthesis.  They offer an 
environmentally compatible and sustainable route to catalysis, often simpler and 
more specific than chemical alternatives.  However, the routine use of 
biocatalysts in biopharmaceutical manufacture has been hindered by biocatalyst 
complexity and the experimental burden necessary for implementation.  This 
thesis aims to investigate, using automated microscale technologies, how 
oxidative biocatalytic bioprocesses can be designed and developed at a reduced 
cost and timeframe compared to conventional laboratory scale experimentation.   
 
A robotic platform was used with 96-Deep square well microtiter plates to 
develop an effective bioprocess for investigating cyclohexanone monooxygenase 
(CHMO).  E. coli cultivations for CHMO production, bioconversion, liquid-
liquid metabolite extraction and analytic techniques were conducted using the 
developed microscale automated approach.  Each step allowed rapid and 
reproducible collection of quantitative kinetic data over multiples runs achieving 
‘walk away operation’.  Whole bioprocess evaluation was achieved, whereby 
linking multiple unit operations enabled rapid assessment of process interactions.  
Factors influencing CHMO activity and bioconversion yields were investigated 
along with alternative bioconversion substrates.  From identified limitations of 
the CHMO system an optimised process was developed where the processing 
time was almost halved and CHMO activity increased 5-fold.  
 
Two novel self-sufficient cytochrome P450 systems, P450SU1 and P450SU2 
were investigated using an automated approach where factors limiting 
bioconversion were identified.  Implementation of the required improvements 
resulted in a 5-fold improvement in enzymatic expression and 5-fold and 1.5-fold 
increase in product formation from cytochrome P450SU1 and P450SU2, 
respectively. 
 
 5 
A matched oxygen transfer coefficient approach was used for predictive scale-
up.  The optimised microscale CHMO and P450 processes were scaled to 75 L 
and 7.5 L bioreactor scale, respectively.  Growth and bioconversion kinetics 
were found to be identical between scales for the CHMO system whereas 
differences were observed for the P450 systems.  
 
Results described in this thesis have demonstrated the benefits of microscale 
automated methodologies for the creation, investigation and predictive scale-up 
of oxidative biocatalytic bioprocesses.  The established strategies evaluated in 
this work contribute to meeting the current demand to decrease developmental 
costs and timelines. 
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Nomenclature 
 
Upper Case 
 
D = Oxygen diffusion coefficient, m2s-1 
HV = Vessel height, m 
KLa = Gas liquid mass transfer coefficient, s-1 
N = Shaking frequency, s-1 
W = Wetting tension, Nm-1 
X = Biomass concentration, gDCWL-1   
DOT = Dissolved oxygen tension, % 
OD = Optical density, dimensionless 
Pg = Gassed power, W 
V = Volume, m3 
OTR = Oxygen transfer rate, mmolL-1h-1 
CER = Carbon evolution rate, mmolL-1h-1 
CV = Coefficient of variance, % 
CL = Dissolved oxygen concentration in the bulk liquid, mmolL-1 
CL* = Dissolved oxygen concentration in liquid phase which is in equilibrium 
with the gas phase, mmolL-1 
E = Biological enhancement, dimensionless 
U = Units, µmolmin-1 
 
Lower Case 
 
ai = Initial specific surface area, m-1 
dV = Vessel diameter, m 
di = Impeller diameter, m 
dt = Shaking amplitude, m 
g = Gravitational acceleration, m s-2 
x = Geometry dependent coefficient, constant in Eq. (4.1), dimensionless 
y = Geometry dependent coefficient, constant in Eq. (4.1), dimensionless 
Cp = unsaturated oxygen fraction at time t, dimensionless 
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Greek 
 
µ = Specific growth rate, s-1 
! = Density, kgm-1 
"p = probe response time, s 
 
Dimensionless Groups (µ (kgm-1s-1) refers to viscosity below) 
 
Bo = Bond number, (= (!dv2g)/W), dimensionless 
Fr = Froude number, (= dt*(2*#*N)2/2 * g), dimensionless 
Re = Reynolds number, (= !Ndv2/ µ), dimensionless 
Sc = Schmidt number, (= µ/!D), dimensionless 
 
Abbreviations 
 
96-DSW = 96-Deep square well 
96-SRW = 96 standard round well 
CHMO = Cyclohexanone monooxygenase 
BVMO = Baeyer-Villiger monooxygenase 
E. coli [pQR367] = E. coli BL21 Star (DE3)pLysS [pQR367] 
E. coli [pQR368] = E. coli BL21 Star (DE3)pLysS [pQR368] 
CHO = Chinese hamster ovary 
DO = Dissolved Oxygen 
DMSO = Dimethyl sulfoxide  
IPTG = Isopropylthiogalactoside 
CO = Carbon monoxide 
CYP = Cytochrome 
FAD = Flavin adenine dinucleotide 
FMN = Flavin mononuleotide  
ALA = Alpha-aminolevulinic acid 
FeCL3 = Ferric chloride 
DTT = Dithiothreitol 
EDTA = Ethylenediaminetetraacetic acid 
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PPG = Polypropylene glycol 
BSA = Bovine serum albumin  
PMSF = Phenylmethylsulfonyl fluoride 
LB = Luria Bertani 
TB = Terrific Broth 
SOC = Super optimal broth with catabolite repression  
UV = Ultra violet 
HPLC = High pressure liquid chromatography 
GC = Gas chromatography 
TLC = Thin layer chromatography 
IPA = Isopropyl alcohol 
DMF = Dimethyl formamide 
RO = Reverse osmosis 
DNA = Deoxyribonucleic aid  
cDNA = Complementary deoxyribonucleic aid 
SDS PAGE = Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
POF = Polymer optical fibre 
LED = Light emitting diode 
LiHa = Liquid handling arm 
RoMa = Robotic movement arm 
MS = Mass spectroscopy 
NMR = Nuclear magnetic resonance 
IR = Infrared spectroscopy  
CFD = Computational fluid dynamics 
rpm = Revolutions per minute 
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Figure 4.9 GC chromatogram of mixed chemically synthesised and 
biologically produced oxocan-2-one (retention time: 10.04 minutes) from 
cycloheptanone (retention time: 8.12 minutes). Naphthalene was used as an 
internal standard (retention time: 11.23 minutes).   
162 
Figure 4.10 Growth (A) and bioconversion kinetics (B) of E. coli TOP10 
[pQR210] biocatalyst catalysing bicyclo[3.2.0]hept-2-en-6-one (unfilled 
166 
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symbols) to lactone product (filled symbols) collected from a optimised ($) 
and non-optimised run (!). Error bars indicate the range of measured values 
about the mean. 
Figure 4.11 (A) Growth and (B) bioconversion kinetics of E. coli TOP10 
[pQR210] with substrates (1R)-camphor (#), (1R)-fenchone (!), (+)-
dihydrocarvone ("), cyclooctanone (!), norcamphor (!) to 2-
oxabicyclo[3.2.1]octan-3-one (&) and cycloheptanone ($) to oxocan-2-one 
(%). Substrate addition was at the 3 h time point. Error bars indicate the 
range of measured values about the mean. 
168 
Figure 4.12 GC chromatogram of (1R)-camphor (retention time: 10.76 
minutes) bioconversion after (A) 0 hours and (B) 4 hours. Peak at a retention 
time of 9.23 minutes is a potential camphor product and peak at 6.34 
minutes is DMSO used to solubilise camphor during the bioconversion. 
170 
Figure 4.13 Percentage relative activity of CHMO in the presence of each 
substrate compared to the natural substrate cyclohexanone. 
173 
Figure 5.1 Growth kinetics of E. coli [pQR367] ($), E. coli [pQR368] (!) 
and E. coli BL21 Star (DE3)pLysS (control) (!) during a induced (closed 
symbol) and non-induced (open symbol) shake flask culture catalysing 7-
ethoxycoumarin to 7-hydroxycoumarin. Error bars indicate the range of 
measured values about the mean. 
181 
Figure 5.2 Representative CO difference spectra of (A) P450SU1 expressed 
in E. coli [pQR367] and (B) P450SU2 expressed in E. coli [pQR368]. 
Samples were from cultures where no 7-ethoxycoumarin was added. 
182 
Figure 5.3 TLC analysis showing the bioconversion of 7-ethoxycoumarin to 
7-hydroxycoumarin. (A) Shows compounds under UV light. Column S and 
P contain standards of 7-ethoxycoumarin and 7-hydroxycoumarin in ethyl 
acetate. (B) Shows compounds stained with permanganate and visualised 
under UV light. Columns 2, 4 and 5 are from induced cultures of E. coli 
[pQR368], E. coli [pQR367] and E. coli BL21 Star (DE3)pLysS (control). 
Columns 1 and 3 are from non-induced cultures of E. coli [pQR368] and E. 
coli [pQR367]. 
184 
Figure 5.4 7-hydroxycoumarin concentration after 30 hours of induced and 
non-induced culture of E. coli [pQR368], E. coli [pQR367] and induced 
184 
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culture of E. coli BL21 Star (DE3)pLysS (control). Error bars indicate the 
range of measured values about the mean. 
Figure 5.5 Cooling time required to achieve the correct induction 
temperature of 25 oC.  
188 
Figure 5.6 The effect of microwell agitation rate on growth of E. coli 
[pQR367] ($) and E. coli [pQR368] (!). 600 rpm (unfilled symbols), 800 
rpm (grey filled symbols), 1000 rpm (black filled symbols). Error bars 
indicate the range of measured values about the mean. 
191 
Figure 5.7 The effect of microwell agitation rate on 7-hydroxycoumarin 
production from E. coli [pQR367] expressing P450SU1 (grey bars) and E. 
coli [pQR368] expressing P450SU2 (white bars). Error bars indicate the 
range of measured values about the mean. 
191 
Figure 5.8 The effect of microwell fill volume on growth E. coli [pQR367]. 
1000 "L (!), 800 "L (!), 700 "L (!), 600 "L ("), 500 "L (#), 400 "L 
($). Error bars indicate the range of measured values about the mean. 
194 
Figure 5.9 The effect of microwell fill volume on 7-hydroxycoumarin 
production from E. coli [pQR367] expressing P450SU1. Error bars indicate 
the range of measured values about the mean. 
194 
Figure 5.10 The effect of well position on the amount of liquid evaporated 
from a 96-DSW plate at 25 oC and 800 rpm. Plate locations: top left (!), top 
right (!), middle left (!), middle ("), middle right (+), bottom left ($), 
bottom right (#). Error bars indicate the range of measured values about the 
mean. 
196 
Figure 5.11 The effect of covering wells with a gas permeable membrane 
(open symbols) on the culture of E. coli [pQR367] ($) and E. coli 
[pQR368] (!) compared to uncovered wells (closed symbols). Error bars 
indicate the range of measured values about the mean. 
196 
Figure 5.12 7-hydroxycoumarin production from E. coli [pQR367] (grey 
bars) and E. coli [pQR368] (white bars). Substrate addition took place after 
3 hours of culture. No product detected prior to 20 hours of culture. Error 
bars indicate the range of measured values about the mean. 
199 
Figure 5.13 The effect of substrate addition time on 7-hydroxycoumarin 
production from E. coli [pQR367] (grey bars) and E. coli [pQR368] (white 
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bars). Error bars indicate the range of measured values about the mean. 
Figure 5.14 Schematic representation of the fully automated linked process 
sequence using E. coli [pQR367] and E. coli [pQR368] expressing 
cytochrome P450SU1 and P450SU2 respectively. Coloured wells represent 
filled wells as an example (orange: media and culture, blue: RO water).   
201 
Figure 5.15 User prompt to initiate expression phase. 202 
Figure 5.16 Reproducibility of growth kinetic data collected from three 
separate runs on the culture of (A) E. coli [pQR367] in different areas of a 
96-DSW plate (!) columns 3-4, ($) columns 7-8 and (!) columns 11-12 
and (B) of E. coli [pQR368] in different areas of a 96-DSW plate (&) 
columns 1-2, (%) columns 5-6 and (") columns 9-10. Error bars indicate 
the range of measured values about the mean. 
204 
Figure 5.17 Reproducibility of bioconversion kinetic data collected on the 
culture of E. coli [pQR367] in different areas of a 96-DSW plate (&) 
columns 3-4, (%) columns 7-8 and (") columns 11-12 and the culture of E. 
coli [pQR368] (!) columns 1-2, ($) columns 5-6 and (!) columns 9-10. 
Error bars indicate the range of measured values about the mean. 
207 
Figure 5.18 Representative CO difference spectra of (A) P450SU1 
expressed in E. coli [pQR367] and (B) P450SU2 expressed in E. coli 
[pQR368] during automated process sequence. Samples were from cultures 
where no 7-ethoxycoumarin was added. 
208 
Figure 5.19 The effect of $-benzoflavone ($-B), $-benzoflavone (b-B), 
ALA, hemin, FeCl3, thiamine, and trace elements on 7-hydroxycourmarin 
production from (A) E. coli [pQR367] expressing P450SU1 and (B) E. coli 
[pQR368] expressing P450SU2. Error bars indicate the range of measured 
values about the mean. 
211 
Figure 5.20 The effect of the sugars D-fructose, D-glucose, maltose, L-
arabinose, D-ribose and glycerol on 7-hydroxycourmarin production from 
(A) E. coli [pQR367] expressing P450SU1 and (B) E. coli [pQR368] 
expressing P450SU2. Error bars indicate the range of measured values about 
the mean. 
212 
Figure 5.21 The effect of ALA concentration on the culture of (A) E. coli 
[pQR367] and (B) E. coli [pQR368]. 0 mM (!), 1 mM ("), 2 mM (#), 3 
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mM ($), 4 mM (!), 5 mM (!). Error bars indicate the range of measured 
values about the mean. 
Figure 5.22 The effect of ALA concentration on 7-hydroxycoumarin 
production from (A) E. coli [pQR367] and (B) E. coli [pQR368]. 0 mM (!), 
1 mM ("), 2 mM (#), 3 mM ($), 4 mM (!), 5 mM (!). Error bars 
indicate the range of measured values about the mean. 
217 
Figure 5.23 Representative CO difference spectra of (A) P450SU1 
expressed in E. coli [pQR367] and (B) P450SU2 expressed in E. coli 
[pQR368] cultured at varying ALA concentrations. Samples were from 
cultures where no 7-ethoxycoumarin was added. 
220 
Figure 5.24 The effect of glycerol concentration on the culture of (A) E. coli 
[pQR367] and (B) E. coli [pQR368]. 2.5 gL-1 (#), 5 gL-1 ($), 10 gL-1 (!), 
20 gL-1 (!), fed 10 gL-1 every 5 hours (!). Error bars indicate the range of 
measured values about the mean. 
222 
Figure 5.25 The effect of glycerol concentration on 7-hydroxycoumarin 
production from (A) E. coli [pQR367] and (B) E. coli [pQR368]. 2.5 gL-1 
(#), 5 gL-1 ($), 10 gL-1 (!), 20 gL-1 (!), fed 10 gL-1 every 5 hours (!). 
Error bars indicate the range of measured values about the mean. 
224 
Figure 5.26 Representative CO difference spectra of P450SU2 expressed in 
E. coli [pQR368] cultured at varying glycerol concentrations. Samples were 
from cultures where no 7-ethoxycoumarin was added. 
226 
Figure 5.27 The effect of substrate concentration on 7-hydroxycoumarin 
production from (A) E. coli [pQR367] expressing P450SU1 and (B) E. coli 
[pQR368] expressing P450SU2. Experiments were conducted as described 
in section 2.3.2.3. Error bars indicate the range of measured values about the 
mean. 
228 
Figure 5.28 The effect of 7-ethoxycoumarin concentration on the culture of 
E. coli [pQR368]. 0.5 mM (!), 0.6 mM (!), 0.7 mM ($), 0.8 mM (#), 1 
mM ("). Error bars indicate the range of measured values about the mean. 
230 
Figure 5.29 The effect of substrate concentration on 7-hydroxycoumarin 
production from E. coli [pQR368]. 0.5 mM (!), 0.6 mM (!), 0.7 mM ($), 
0.8 mM (#), 1 mM ("). Error bars indicate the range of measured values 
about the mean. 
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Figure 5.30 (A) Growth kinetics and (B) time course of 7-hydroxycoumarin 
production from E. coli [pQR367] (!) and E. coli [pQR368] ($) with 20 
gL-1 glycerol, 5 mM ALA and 1 mM 7-ethoxycoumarin (closed symbols) 
and no media supplementation with 1 mM 7-ethoxycoumarin (open 
symbols). Error bars indicate the range of measured values about the mean. 
232 
Figure 5.31 CO difference spectra of (A) P450SU1 expressed in E. coli 
[pQR367] and (B) P450SU2 expressed in E. coli [pQR368] with (blue line) 
and without (green line) the addition of 5 mM ALA and 20 gL-1 glycerol. 
Samples were from cultures where no 7-ethoxycoumarin was added. 
234 
Figure 6.1 (A) Growth kinetics at a matched KLa of 115 h-1 for E. coli 
TOP10 [pQR210] in a 75 L bioreactor (working volume 45 L) (!) and 96-
DSW plate with a 500 "L fill volume (&) and corresponding 75 L DOT 
profile (----). Error bars indicate the standard deviation of triplicate optical 
density readings for the 75 L process and the range of measured values about 
the mean for the microwell process. (B) Bioconversion kinetics of CHMO 
with 0.5 gL-1 bicyclo[3.2.0]hept-2-en-6-one (unfilled symbols) to lactone 
product (filled symbols) at a matched KLa of 115 h-1 in a 75 L bioreactor 
($) and 96-DSW plate (!). Error bars indicate the range of measured 
values about the mean. 
243 
Figure 6.2 Relationship between 96-DSW plate fill volume and KLa. Values 
were measured using the gassing out approach in an adapted 96-DSW as 
described in section 2.6.11.1. These experiments were conducted at 37 oC, in 
LB glycerol medium with 0.2 mLL-1 PPG and at 1000 rpm. Errors bars 
indicate the standard deviation of triplicate measurements. 
248 
Figure 6.3 Relationship between 75 L stirred bioreactor agitation speed and 
KLa. Values were measured using the gassing out approach as described in 
section 2.6.11.3. These experiments were conducted at 37 oC, in LB glycerol 
medium with 0.2 mLL-1 PPG, at a working volume of 45 L and an aeration 
rate of 1 vvm. Errors bars indicate the standard deviation of triplicate 
measurements.  
249 
Figure 6.4 (A) Growth kinetics of E. coli TOP10 [pQR210] at a matched 
KLa of 228 h-1 in a 75 L bioreactor (working volume 45 L) (!) and 96-DSW 
plate with a 500 "L fill volume (&) and corresponding 75 L DOT profile (--
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--). Error bars indicate the standard deviation of triplicate optical density 
readings for the 75 L process and microwell process.  (B) Bioconversion 
kinetics of E. coli TOP10 [pQR210] biocatalyst with 0.5 gL-1 
bicyclo[3.2.0]hept-2-en-6-one (unfilled symbols) to lactone product (filled 
symbols) at a matched KLa of 228 h-1 in a 75 L bioreactor (!) and 96-DSW 
plate ($). Error bars indicate the standard deviation of triplicate GC 
samples. 
Figure 6.5 The effect of agitation speed and temperature (! 37 oC, $ 25 
oC) on measured KLa values in a 7.5 L stirred bioreactor. Values were 
measured using the gassing out approach as described in section 2.6.11.2. 
These experiments were conducted in TB medium with 0.2 mLL-1 PPG, at a 
working volume of 5 L and an aeration rate of 1 vvm. Errors bars indicate 
the standard deviation of triplicate measurements. 
256 
Figure 6.6 (A) Growth kinetics of E. coli [pQR367] (!) and E. coli 
[pQR368] ($) at a matched KLa of 200 h-1 in a 7.5 L bioreactor (working 
volume 5 L) and 96-DSW plate with a 1 mL fill volume (open symbols) for 
the first 3 hours of culture and then a matched KLa of 62 h-1 for the 
remaining culture time and corresponding 7.5 L DOT profile for E. coli 
[pQR367] (light grey line) and E. coli [pQR368] (dark grey line) cultures. 
Error bars indicate the standard deviation of triplicate optical density 
readings for the 7.5 L process and the range of measured values about the 
mean for the microwell process.  
259 
Figure 6.6 (B) 7-hydroxycoumarin production from P450SU1 (!) and 
P450SU2 ($) at a matched KLa of 62 h-1 in a 7.5 L bioreactor (closed 
symbol) and 96-DSW plate (open symbol). Error bars indicate the standard 
deviation of triplicate 7.5 L HPLC samples and the range of measured values 
about the mean for 96-DSW plate HPLC samples. 
260 
Figure A.1 Dry cell weight calibration curve for E. coli TOP10 [pQR210] 
cells. Error bars indicate the range about the mean of duplicate optical 
density readings (x) and duplicate biomass concentration measurements (y). 
Measurements were conducted as described in section 2.6.1 and 2.6.2. 
308 
Figure A.2 Dry cell weight calibration curve for E. coli [pQR367] cells. 
Error bars indicate the range about the mean of duplicate optical density 
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readings (x) and duplicate biomass concentration measurements (y). 
Measurements were conducted as described in section 2.6.1 and 2.6.2. 
Figure A.3 Dry cell weight calibration curve for E. coli [pQR368] cells. 
Error bars indicate the range about the mean of duplicate optical density 
readings (x) and duplicate biomass concentration measurements (y). 
Measurements were conducted as described in section 2.6.1 and 2.6.2. 
309 
Figure A.4 Bicyclo[3.2.0]hept-2-en-6-one calibration curve. Error bars 
indicate the standard deviation of triplicate stock preparations in ethyl 
acetate. Experiments were conducted as described in section 2.6.4.2. 
310 
Figure A.5 (1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one calibration curve. 
Error bars indicate the standard deviation of triplicate stock preparations in 
ethyl acetate. Experiments were conducted as described in section 2.6.4.2. 
310 
Figure A.6 Cyclohexanone calibration curve. Error bars indicate the 
standard deviation of triplicate stock preparations in ethyl acetate. 
Experiments were conducted as described in section 2.6.4.2. 
311 
Figure A.7 #-caprolactone calibration curve. Error bars indicate the standard 
deviation of triplicate stock preparations in ethyl acetate. Experiments were 
conducted as described in section 2.6.4.2. 
311 
Figure A.8 Norcamphor calibration curve. Error bars indicate the standard 
deviation of triplicate stock preparations in ethyl acetate. Experiments were 
conducted as described in section 2.6.4.2. 
312 
Figure A.9 2-oxabicyclo[3.2.1]octan-3-one calibration curve. Error bars 
indicate the standard deviation of triplicate stock preparations in ethyl 
acetate. Experiments were conducted as described in section 2.6.4.2. 
312 
Figure A.10 Cycloheptanone calibration curve. Error bars indicate the 
standard deviation of triplicate stock preparations in ethyl acetate. 
Experiments were conducted as described in section 2.6.4.2. 
313 
Figure A.11 Oxocan-2-one calibration curve. Error bars indicate the 
standard deviation of triplicate stock preparations in ethyl acetate. 
Experiments were conducted as described in section 2.6.4.2. 
313 
Figure A.12 (1R)-(-)-fenchone calibration curve. Error bars indicate the 
standard deviation of triplicate stock preparations in ethyl acetate. 
Experiments were conducted as described in section 2.6.4.2. 
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Figure A.13 (+)-(3R,6SR)-Dihydrocarvone calibration curve. Error bars 
indicate the standard deviation of triplicate stock preparations in ethyl 
acetate. Experiments were conducted as described in section 2.6.4.2. 
314 
Figure A.14 Cyclooctanone calibration curve. Error bars indicate the 
standard deviation of triplicate stock preparations in ethyl acetate. 
Experiments were conducted as described in section 2.6.4.2. 
315 
Figure A.15 (1R)-(+)-camphor calibration curve. Error bars indicate the 
standard deviation of triplicate stock preparations in ethyl acetate. 
Experiments were conducted as described in section 2.6.4.2. 
315 
Figure A.16 7-ethoxycoumarin calibration curve. Error bars indicate the 
standard deviation of triplicate stock preparations in acetonitrile. 
Experiments were conducted as described in section 2.6.5.2. 
316 
Figure A.17 7-hydroxycoumarin calibration curve. Error bars indicate the 
standard deviation of triplicate stock preparations in acetonitrile. 
Experiments were conducted as described in section 2.6.5.2. 
316 
Figure B.1 Chromatogram of 1 gL-1 bicyclo[3.2.0]hept-2-en-6-one 
(retention time: 6.44 min) dissolved in ethyl acetate. Peak present at 11 
minutes corresponds to naphthalene which was used as an internal standard 
and added to all samples.   
317 
Figure B.2 Chromatogram of 1 gL-1 (1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-
one (retention time: 13.53 min) dissolved in ethyl acetate. Peak present at 11 
minutes corresponds to naphthalene which was used as an internal standard 
and added to all samples.   
318 
Figure B.3 Chromatogram of 1 gL-1 cyclohexanone (retention time: 5.65 
min) dissolved in ethyl acetate. Peak present at 11 minutes corresponds to 
naphthalene which was used as an internal standard and added to all 
samples. 
318 
Figure B.4 Chromatogram of 1 gL-1 #-caprolactone (retention time: 12.81 
min) dissolved in ethyl acetate. 
319 
Figure B.5 Chromatogram of 1 gL-1 norcamphor (retention time: 7.39 min) 
dissolved in ethyl acetate. Peak present at 11 minutes corresponds to 
naphthalene which was used as an internal standard and added to all 
samples. 
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Figure B.6 Chromatogram of 1 gL-1 2-oxabicyclo[3.2.1]octan-3-one 
(retention time: 14.83 min) dissolved in ethyl acetate. Peak present at 11 
minutes corresponds to naphthalene which was used as an internal standard 
and added to all samples. 
320 
Figure B.7 Chromatogram of 1 gL-1 cycloheptanone (retention time: 8.25 
min) dissolved in ethyl acetate. Peak present at 11 minutes corresponds to 
naphthalene which was used as an internal standard and added to all 
samples. 
320 
Figure B.8 Chromatogram of 0.5 gL-1 oxocan-2-one (retention time: 10.13 
min) dissolved in ethyl acetate. Peak present at 11 minutes corresponds to 
naphthalene which was used as an internal standard and added to all 
samples. 
321 
Figure B.9 Chromatogram of 1 gL-1 (1R)-(-)-fenchone (retention time: 9.19 
min) dissolved in ethyl acetate. Peak present at 11 minutes corresponds to 
naphthalene which was used as an internal standard and added to all 
samples. 
321 
Figure B.10 Chromatogram of 1 gL-1 (+)-(3R,6SR)-dihydrocarvone (isomer 
1 retention time: 11.68 min, isomer 2 retention time: 11.86 min) dissolved in 
ethyl acetate. Peak present at 11 minutes corresponds to naphthalene which 
was used as an internal standard and added to all samples. 
322 
Figure B.11 Chromatogram of 1 gL-1 cyclooctanone (retention time: 10.42 
min) dissolved in ethyl acetate. Peak present at 11 minutes corresponds to 
naphthalene which was used as an internal standard and added to all 
samples. 
322 
Figure B.12 Chromatogram of 1 gL-1 camphor (retention time: 10.81 min) 
dissolved in ethyl acetate. Peak present at 11 minutes corresponds to 
naphthalene which was used as an internal standard and added to all 
samples. 
323 
Figure B.13 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 bicyclo[3.2.0]hept-2-en-6-one (retention time: 6.57 
min) to (-)-(1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one and (-)-(1R,5S)-3-
oxabicyclo[3.3.0]oct-6-en-2-one (retention times: 13.56 min and 13.67 min) 
at (A) 0 minutes and (B) 60 minutes. Peak present at 11 minutes corresponds 
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to naphthalene which was used as an internal standard and added to all 
samples. Results are from microwell based bioconversions.   
Figure B.14 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 cyclohexanone (retention time: 5.10 min) to #-
caprolactone (retention time: 12.77 min) at (A) 0 minutes and (B) 60 
minutes. Peak present at 11 minutes corresponds to naphthalene which was 
used as an internal standard and added to all samples. Results are from 
microwell based bioconversions.   
325 
Figure B.15 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 norcamphor (retention time: 7.66 min) to 2-
oxabicyclo[3.2.1]octan-3-one (retention time: 14.79 min) at (A) 0 minutes 
and (B) 60 minutes. Peak present at 11 minutes corresponds to naphthalene 
which was used as an internal standard and added to all samples. Results are 
from microwell based bioconversions.   
326 
Figure B.16 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 cycloheptanone (retention time: 8.28 min) to 
oxocan-2-one (retention time: 10.18 min) at (A) 0 minutes and (B) 60 
minutes. Peak present at 11 minutes corresponds to naphthalene which was 
used as an internal standard and added to all samples. Results are from 
microwell based bioconversions.   
327 
Figure B.17 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 (1R)-(-)-fenchone (retention time: 9.24 min) at (A) 0 
minutes and (B) 60 minutes. Peak present at 6.34 minutes corresponds to 
DMSO used to solubilise substrate. Peak present at 11 minutes corresponds 
to naphthalene which was used as an internal standard and added to all 
samples. Results are from microwell based bioconversions.   
328 
Figure B.18 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 camphor (retention time: 10.82 min) at (A) 0 
minutes and (B) 60 minutes. Peak present at 6.37 minutes corresponds to 
DMSO used to solubilise substrate. Peak present at 11 minutes corresponds 
to naphthalene which was used as an internal standard and added to all 
samples. Results are from microwell based bioconversions.   
329 
Figure B.19 Chromatograms displaying the E. coli TOP10 [pQR210] 330 
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bioconversion of 1 gL-1 cyclooctanone (retention time: 10.44 min) at (A) 0 
minutes and (B) 60 minutes. Peak present at 11 minutes corresponds to 
naphthalene which was used as an internal standard and added to all 
samples. Results are from microwell based bioconversions.   
Figure B.20 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 (+)-(3R,6SR)-dihydrocarvone (isomer 1 retention 
time: 11.83 min, isomer 2 retention time: 12.02 min) at (A) 0 minutes and 
(B) 60 minutes. Peak present at 6.40 minutes corresponds to DMSO used to 
solubilise substrate. Peak present at 11 minutes corresponds to naphthalene 
which was used as an internal standard and added to all samples. Results are 
from microwell based bioconversions.   
331 
Figure B.21 Chromatogram of 1 gL-1 7-ethoxycoumarin (retention time: 9.7 
min) dissolved in acentonitrile.  
332 
Figure B.22 Chromatogram of 1 gL-1 7-hydroxycoumarin (retention time: 
6.26 min) dissolved in acentonitrile.  
332 
Figure B.23 Chromatograms displaying E. coli [pQR367] bioconversion of 
1 mM 7-ethoxycoumarin (retention time: 9.73 min) to 7-hydroxycoumarin 
(retention time: 6.26 min) at (A) 0 minutes and (B) 30 hours of 
bioconversion. Results are from induced shake flask based bioconversions.   
333 
Figure B.24 Chromatograms displaying E. coli [pQR368] bioconversion of 
1 mM 7-ethoxycoumarin (retention time: 9.73 min) to 7-hydroxycoumarin 
(retention time: 6.26 min) at (A) 0 minutes and (B) 30 hours of 
bioconversion. Results are from induced shake flask based bioconversions.   
334 
Figure C.1 The background absorbance change with time and the 
absorbance change with time after addition of the cyclohexanone substrate 
for a typical spectrophotometric assay for CHMO activity.  Assay performed 
as described in section 2.6.8. 
336 
Figure C.2 CO difference spectrums showing the effect of sample 
incubation time with carbon monoxide prior to wavelength scan. 
337 
Figure C.3 The effect of substrate addition on CO difference spectrum. 337 
Figure C.4 Spectrums of sample reduced with sodium hydrosulphite and the 
same sample which has been bubbled with CO. 
339 
Figure C.5 CO difference spectrum. 339 
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Figure D.1 Representative Proton NMR of purified norcamphor products 2-
oxabicyclo[3.2.1]octan-3-one and 3-oxabicyclo[3.2.1]octan-2-one. 
340 
Figure D.2 Representative C-13 NMR of purified norcamphor products 2-
oxabicyclo[3.2.1]octan-3-one and 3-oxabicyclo[3.2.1]octan-2-one. 
341 
Figure D.3 Representative mass spectrum of purified norcamphor products 
2-oxabicyclo[3.2.1]octan-3-one and 3-oxabicyclo[3.2.1]octan-2-one.   
342 
Figure D.4 Representative infra red spectrum of purified norcamphor 
products 2-oxabicyclo[3.2.1]octan-3-one and 3-oxabicyclo[3.2.1]octan-2-
one. Trough at 1730.1 cm-1 indicates a carbonyl group (C=O) and a trough at 
2949.5 cm-1 indicates a C-H group. 
343 
Figure D.5 Representative Proton NMR of chemically synthesised oxocan-
2-one from cycloheptanone. 
344 
Figure D.6 Representative mass spectrum of chemically synthesised 
oxocan-2-one from cycloheptanone. 
345 
Figure D.7 Representative Proton NMR of purified oxocan-2-one from 
CHMO catalysed cycloheptanone. 
346 
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1 Introduction 
 
1.1 The Context of the Research 
 
There is a current trend to minimise the environmental impact of pharmaceutical 
manufacturing processes.  It is well known that most of the organic chemistry 
forming the basis of such processes utilise multi-step synthetic methods with 
poor atom efficiency, where the by-product formation outweighs the final 
product recovery (Strukul, 1998).  In particular, chemical oxidations are 
highlighted as being one of the least atom efficient and green of all industrial 
reactions (Lye et al., 2002).  Biocatalytic alternatives hold many desirable traits 
such as the use of cleaner reagents and reactants, reduction in waste and 
simplification of synthetic procedures (Strukul, 1998), all of which are 
compatible with the concept of green chemistry.  However, the design and 
implementation of a biocatalytic process can be challenging and has until now 
hindered the progression to full industrial exploitation.  This is because 
biological processes involve multiple variables and individual process steps each 
requiring identification, characterisation and eventual optimisation.  The 
experimental burden required to achieve optimised large-scale bioproduction will 
be labour intensive, time consuming and characterised by high investment in 
resources.  The pharmaceutical industry is an ever competitive market with over 
600 biologics under development each year (Bareither and Pollard, 2010), thus, 
in order to achieve a commercially viable product or process, methods need to be 
put in place to decrease costs and accelerate process development. 
 
An approach is proposed where existing unit operations are miniaturised and 
linked to create small-scale process sequences within contained robotic 
platforms.  The use of miniaturisation reduces resources and simplifies operation 
while automation increases consistency, speed and cuts down operator 
requirement.  The integration of multiple operations is crucially important to 
streamline development and enable the interactions having an impact on product 
quality to be evaluated.  Furthermore, key factors influencing biological 
parameters such as cellular growth and yield can be rapidly identified and further 
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optimised (Bareither and Pollard, 2010).  In this way large-scale expensive trails 
can be minimised and conducted earlier using small-scale models.  In addition if 
routine and repetitive tasks are conducted by robotic devices process 
performance can be improved by having a reduced downtime and operators 
assigned problem solving tasks.  In order for scale down methods to be adopted 
such methods must demonstrate robustness and, more importantly, scalability to 
effectively mimic the performance of stirred tank systems for which a large-scale 
platform exists.  The thesis will examine the hypothesis that high-throughput 
automated microscale approaches can be used for the development and 
investigation of novel oxidative biocatalytic processes.  This is in line with one 
of the most challenging problems the pharmaceutical sector faces to establish 
financially viable and robust manufacturing processes (Chhatre and Titchener-
Hooker, 2009). 
 
1.2 Literature Survey 
 
1.2.1 Microscale Bioprocessing Technology 
 
1.2.1.1 Overview of Technology 
 
There is continual pressure on the pharmaceutical and biotechnology industries 
to reduce developmental timelines and costs.  Revenue reduction due to patent 
expiration, the requirement of reduced product costs from healthcare providers, 
and increased competition from generics on company pipeline portfolios are the 
main factors contributing to these pressures (Bareither and Pollard, 2010).  One 
approach to tackle this issue is to invest in microscale bioprocessing technologies 
which refer to the microlitre study of individual bioprocess unit operations 
(Micheletti and Lye, 2006).  Using microlitre volumes reduces the reagent 
requirements which can be significant when working with expensive media 
components, substrates or enzymatic cofactors (Bhambure et al., 2011).  A wide 
range of process variables can be investigated enabling an increased knowledge 
of process constraints and limitations for fast identification of optimal conditions.  
Furthermore, such studies can be used as a rational basis for scale-up of the 
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systems evaluated (Fernandes and Cabral, 2006).  Therefore microscale 
technologies have the potential to accelerate both upstream (Baboo et al., 2012) 
and downstream (Rayat et al., 2010) experimentation during early process 
design.  This would ultimately lead to a reduction in the time it takes to progress 
from the initial discovery stages to delivering a usable product to the market.  
Thus microscale technologies aim at delivering quantitative bioprocess 
information early so that the translation from bioprocess design to manufacturing 
scale can be accelerated (Micheletti and Lye, 2006).   
 
Two approaches currently being adopted are miniature stirred systems and 
miniature shaken systems.  Miniaturisation is a common feature of both where 
the primary aim is to achieve higher throughput and the ultimate challenge is to 
accurately mimic large-scale processes whilst retaining the degree of 
functionality present in conventional bioreactors (Betts and Baganz, 2006).  
Miniature stirred systems and miniature shaken systems will be discussed in the 
following sections where the key features of each system will be highlighted and 
the most promising technologies will be discussed.   
 
1.2.1.2 Miniature Stirred Systems 
 
Currently there are two types of miniature stirred systems used for small-scale 
development.  One approach is to use geometrically similar scaled down versions 
of conventional stirred tank reactors, with volumes ranging from 50 mL to 300 
mL (Kumar et al., 2006).  The second type have volumes of 10 mL and below 
and examples exist which utilise microtiter plates (Girard et al., 2001) or cuvettes 
(Kostov et al., 2001) containing stirrer bars or miniature agitation systems.  
Miniature stirred systems are used for early-stage process development and cell 
characterisation to speed up bioprocessing and reduce the labour requirement and 
material cost (Betts and Baganz, 2006).  This is achieved through increased 
throughput and parallelization.  Reducing the size of a bioreactor means that 
multiple units can be run in parallel to investigate a range of process variables.  
Gill et al. (2008) developed a novel miniature bioreactor system with the 
capacity to run 4 to 16 independently controlled fermentations.  By using an 
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agitated microwell plate Girard et al. (2001) reported a small-scale bioreactor 
system where up to 12 experiments could be run simultaneously with the 
potential for parallelization of several hundred bioreactors if multiple plates were 
used within an automated platform.  The highest throughout achievable in a 
stirred miniature system was reported by Puskeiler et al. (2005) who developed a 
“Bioreactor Block” with 48 individual bioreactors able to run simultaneously.  
The idea of multiplexing to achieve high-throughput processes has also been 
applied to microfluidic systems.  Szita et al. (2005) reported a 150 µL working 
volume microbioreactor system and demonstrated how 8 bioreactors could be 
run in parallel.  While reproducible performance was obtained across all 
bioreactors, these systems still face the challenge of providing sufficient material 
for analytical and purification studies. 
 
A disadvantage of reduced volumes can be a lack of monitoring and control.  
However, the scale at which miniature stirred systems operate means this has not 
been found to be an issue.  While standard industrial probes are bulky and cannot 
be used in volumes below 2 mL, online monitoring and control of pH, 
temperature and dissolved oxygen tension (DOT) has been demonstrated using 
miniature probes (Gill et al., 2008), fibre optics (Lamping et al., 2003) and 
sensing patches (Puskeiler et al., 2005; Harms et al., 2006).  A few years ago 
Fluorometrix developed Cellstation, a miniature bioreactor system with the 
capacity to monitor pH (Kermis et al., 2002), DOT and OD using online optical 
sensors during cultivations (Betts and Baganz, 2006).  However, the addition of 
monitoring and control capacity to small-scale bioreactors increases costs 
(Kumar et al., 2004) as miniaturised probes are expensive or, in some cases, 
detrimental to the process in cases where oxygen is actually consumed by 
particular probes (Kostov et al., 2001).  Therefore considering these drawbacks 
Kostov et al. (2001) reported a 2 mL low cost microbioreactor for high-
throughput bioprocessing equipped with pH, oxygen and OD detection systems 
based on optical sensors for monitoring the culture environment.  
 
Automation is a useful method to increase the productivity and robustness of a 
process.  Presently, this is an area of much interest and continual research where 
the incorporation of automated technology with miniature stirred systems has 
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proved promising.  Automation can be applied for the setup, preparation and 
monitoring of the culture.  Medicel Explorer is a 15 parallel unit fermentation 
system with automated sample collection and online OD measurement (Bareither 
and Pollard, 2010).  Sterilisation, probe calibration, inoculation, sampling and 
harvesting have also been automated using Biospectra for mammalian cell 
culture (Bareither and Pollard, 2010).  Gill et al. (2008) demonstrated fully 
integrated automated control of DOT and pH in each of 16 miniature reactors.  
Smaller systems can also be combined with sophisticated robotics for an 
increased level of process automation and will be discussed in section 1.2.2. 
 
During bioreactor operation effective oxygen transfer to growing cells is a 
critical parameter.  This needs to be maximised as in general higher oxygen 
transfer rates lead to higher cell densities and therefore increased product yield.  
The mechanical stirring utilised by miniature bioreactor systems provides both 
agitation of the cell suspension and the dispersion of the gas phase.  This method 
of agitation has been found to achieve oxygen transfer capacities typically 
characterised by oxygen mass transfer coefficient (KLa) values similar to 
conventional lab-scale stirred tank reactors (Kumar et al., 2004; Betts and 
Baganz, 2006).  In general, KLa values range from 100 – 300 h-1 in standard 
stirred-tank bioreactors of volumes varying from 30 to 50000 L (Trilli, 1986).  A 
range of miniature bioreactors have been reported to achieve a KLa of 360 h-1 
(Lamping et al., 2003), 480 h-1 (Betts et al., 2006), and even as high as 1600 h-1 
(Puskeiler et al., 2005), the later values being close to the level achieved in 
industrial scale bioreactors.  However, it has been reported that as these systems 
have only produced biomass concentrations below 10 gDCWL-1 they have yet to 
be truly challenged in maintaining high cell density cultures (Bareither and 
Pollard, 2010).  Only the “Bioreactor Block” has shown promise in culturing 
cells of Bacillus subtilis up to 50 gDCWL-1 which was achieved using a 
intermittent feeding regime (Knorr et al., 2007). 
 
It is important that small-scale systems can mimic conditions and productivity 
that would be expected at larger scales of operation (Gill et al., 2008).  Due to the 
geometrical similarities matched performance to conventional bioreactors has 
been reported in 10 mL miniature bioreactors using a matched gassed power per 
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unit volume (Pg/V) approach (Betts et al., 2006) and in 100 mL (Gill et al., 2008) 
and 2 mL (Kostov et al., 2001) miniature bioreactors using a matched KLa.  
Therefore, modelling miniature bioreactors on lab scale systems is clearly an 
advantage in terms of providing scalable data.  Furthermore, the importance of 
matching critical process parameters is also demonstrated where KLa is often the 
parameter of choice in aerobic systems.   
 
Miniature stirred systems are currently being applied to areas of process 
optimisation, media and strain development and therapeutic drug development 
(Betts and Baganz, 2006).  In particular the miniature bioreactor system reported 
by Betts et al. (2006) has been shown to effectively mimic conventional stirred 
tank reactor cell cultivations of varying rheology, shear-sensitivity and oxygen 
demand, demonstrating its verstatility with a range of microorganisms.  In 
general, miniature bioreactor systems at present have proved to be scalable, able 
to carry out parallel operations and can utilise sophisticated technology for the 
monitoring and control of critical parameters.  However the degree of throughput 
cannot yet match that of microtiter plates.  For example, while a variety of 
miniature stirred bioreactor systems do utilise the standard microplate format as 
yet there are limited reports of stirred bioreactor technologies being applied to 
more than 48 vessels limiting the progression of this technology to the ultra-high 
throughput level.  The ability to increase the number of parameters which can be 
rapidly assessed is particularly important when developing a process for a new 
biological system especially if raw materials are rare and/or expensive.  For this 
reason microtiter plates are potentially a more suitable method to achieving this 
goal.  
 
1.2.1.3 Miniature Shaken Systems 
 
In shaken systems fluid mixing, heat and mass transfer are achieved via shaking 
rather than using mechanical agitation.  Shake flasks are one of the earliest forms 
of shaken systems and have been widely used due to their simple operation, 
inexpensiveness, lack of mechanical complications and reproducibility for a 
range of industrially relevant cell cultivations.  In particular, they have been used 
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for bacterial (Losen et al., 2004), yeast (Guarna et al., 1997), fungi (Punt et al., 
2002), animal (Micheletti et al., 2006), insect (Yamaji et al., 1999) and plant cell 
culture (Dörnenburg, 2010).  Shake flask operation had remained unchanged for 
over fifty years with additions and sampling being carried out manually and no 
incorporation of online monitoring methods until quite recently (Weuster-Botz et 
al., 2001; Betts and Baganz, 2006).  Despite such attempts to improve shake 
flasks this system has primarily remained as a screening and inoculum expansion 
tool (Bareither and Pollard, 2010).  Major drawbacks include the difficulty in 
robotic handling, due to their shape and size, and limitations in miniaturisation 
and parallelisation (Duetz and Witholt, 2004).  Furthermore, maintaining feed 
capability can be difficult which is of industrial relevance and the lack of 
similarity to stirred systems can make scale-up problematic (Bareither and 
Pollard, 2010).  Sampling also requires removing the flask from optimum culture 
conditions where agitation and oxygen supply is interrupted.  Such challenges 
have led to the development and use of alternative high-throughput microtiter 
plate formats. 
 
Shaken microtiter plates were initially applied as analytical tools predominantly 
for screening in enzyme and gene assays (Persidis, 1998).  They are already an 
established technology for high and ultra-high throughput (Major, 1998; 
Sundberg, 2000) processing and, more recently, this system has also been 
adopted for bioprocess studies.  Plates come in a range of sizes from 6 up to 
3456-well plates with volumes ranging from 3-3000 µL.  This feature makes 
microtiter plates attractive in an effort to speed up bioprocess development 
particularly in the area of biocatalytic processes where there is a requirement to 
screen large libraries of biocatalysts before process optimisation can begin.  In 
the case of the 3456-well plate format ultra-high throughput screening can 
process 105 compounds per assay per day (Sundberg, 2000).   
 
Microtiter plates are available in different geometries and the application 
determines the most suitable one.  The wells can be round, square and more 
recently flower petal designs have also been reported (Funke et al., 2009).  While 
surface aeration can be a limiting factor to efficient oxygen transfer (Lamping et 
al., 2003), well geometry selection can help to override this issue.  It has been 
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reported that the square geometry is particularly well suited for aerobic cultures 
as it aids mixing and oxygen transfer (Duetz and Witholt, 2001).  The volumetric 
activity of oxidative enzymes has also been found to be higher in square well 
formats than in round wells (Doig et al., 2002).  Higher turbulence levels due to 
the baffling effect of square edges promoting gas-liquid mass transfer have been 
suggested as a possible reason for the results observed (Doig et al., 2002; Betts 
and Baganz, 2006).  
 
This effect becomes more pronounced as the number of edges in a well increases 
where the introduction of baffles into a circular microtiter plate has been found to 
double the oxygen transfer capacity (Funke et al., 2009).  A range of thirty 
baffled microtiter plates have been designed by Funke et al. (2009) and these 
were tested to maximise the oxygen transfer whilst avoiding out-of-phase mixing 
conditions, maximise well fill volume and enable online-monitoring.  From this 
study a 6-petal flower shaped well geometry which redirects the flow of the 
rotating liquid as baffles would, was found to fulfil all the above requirements 
producing KLa values above 500 h-1 and enhanced growth of microbial cultures.  
This value is nearly double that generally achievable in conventional microtiter 
plates (Duetz, 2007).  It is important to note that Funke et al. (2009) measured 
KLa by using the sulphite oxidation method which has been claimed to 
overestimate mass transfer rates (Linek et al., 2004).  However, the research 
clearly illustrates the benefits of baffled geometries and such improvements in 
oxygen transfer rates have clear implications for use with oxidative 
bioconversions.  Microwell plates can also be of a standard geometry (300 µL) or 
a deep well format (2 mL) where an increased fill volume increases the culture 
capacity. 
 
In addition to well geometry, the shaking diameter, intensity of orbital shaking 
and fill volume are also key variables in the gas-liquid mass transfer and mixing 
process (Duetz and Witholt, 2001; Lye et al., 2003; Duetz and Witholt 2004).  
Greater shaking diameters increase the surface area to volume ratio in the well, 
promoting vertical mixing and turbulent flow and contributing to improved 
oxygen transfer rates (Duetz and Witholt, 2001).  Increasing the shaking intensity 
also promotes oxygen transfer and may also be required if a small shaking 
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diameter is used.  Hermann et al. (2003) reported that a smaller critical shaking 
frequency is required at higher shaking diameters to increase the maximum 
oxygen transfer capacity.  In-phase conditions have been defined as those where 
the bulk fluid moves in-phase with the shaking platform (Büchs et al., 2001; 
Duetz and Witholt, 2004).  At high agitation rates, or when using baffled 
geometries, out-of-phase mixing can occur where the liquid does not circulate in 
phase with the orbital motion of the shaker resulting in splashing or spillage of 
the well contents (Duetz and Witholt, 2004; Betts and Baganz, 2006).  
Considering the size of microwell formats, fill volume is also noted to have an 
influence on air-liquid mass transfer (John et al., 2003; Kensy et al., 2005; Funke 
et al., 2009) where KLa has been reported to be inversely proportional to well fill 
volume (John et al., 2003).  However, investigations on the effect of fill volume 
on KLa are limited and it would be worth investigating this parameter further to 
determine the extent to which this factor can control oxygen levels in microwells.  
 
Some challenges are usually encounted when using microwell plate formats.  
Firstly, liquid evaporation can prevent their application for extended cultures.  
This issue can be tackled by using an appropriate plate cover.  One such system 
designed by Duetz and Witholt (2001) has been shown to prevent well-to-well 
contamination, excessive evaporation, airborne contamination and maintain 
sufficient aeration rates.  Alternatively, a sacrificial sampling method can ensure 
that the well content is not depleted excessively (Doig et al., 2002).  Secondly, 
the use of small volumes can make the incorporation of monitoring and control 
devices quite chanllenging.  Nevertheless, as covered in section 1.2.1.2, the 
miniaturisation of sensing equipment has been successfully developed and 
applied to small culture vessels.  Sensing patches are probably the best option as 
they do not interfere with the culturing environment however fibre optics have 
also been successfully reported to work in well format (Islam et al., 2008; 
Ferreira, 2008).  
 
The most impressive feature of microwells is the capacity to accommodate the 
need for multi-variable studies and as such it is important that such studies are 
conducted in a robust and timely manner.  This can be achieved through 
automated processing whereby the microplate footprint and dimensions makes 
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them readily amenable to automation.  This aspect will be discussed in detail in 
section 1.2.2.  Features of microtiter plates have highlighted them as an attractive 
option for bioprocessing applications and have already been utilised in a number 
of areas. 
 
1.2.1.3.1 Bioprocess Applications of Microwells 
 
Several works in the published literature have demonstrated the use of 
microwells for individual unit operations including cell cultivation, 
bioconversion and downstream processing. 
 
Microwell technology has been applied to the cultivation of a number of 
microorganisms including gram-negative bacteria, gram-positive bacteria and 
actinomycetes.  Using a square well format Duetz et al. (2000) demonstrated the 
growth of 48 different Pseudomonas and Rhodococcus strains.  A novel 
development in this work was a replication system capable of extracting volumes 
from frozen bacterial glycerol stocks without defrosting the whole stock.  Using 
the same system Minas et al. (2000) cultured Streptomyces in 96-deep square 
well format where biomass concentrations and secondary metabolite production 
were found to be similar to both shake flask and bioreactor cultivations.  
Microwells have also been applied to the culture of Saccharopolyspora 
erythraea CA340 producing the polyketide antibiotic erythromycin (Elmahdi et 
al., 2003).  In this work Elmahdi et al. (2003) demonstrated the importance of pH 
control at the microscale and reported enhanced maximum specific growth rates, 
biomass concentrations and product synthesis when pH control was used.  In 
addition the results observed at the microscale were found to be similar to those 
obtained in a 7 L stirred tank reactor.  One final example of microwell formats 
being used to culture a range of microorganisms is reported by Isett et al. (2007) 
who demonstrated that a 24-well plate miniature bioreactor system could be 
applied to Saccharomyces cerevisiae, E. coli and Pichia pastoris cultivations.  
When culturing Pichia pastoris with oxygen and pH control, ammonia and 
oxygen blending and a controlled glycerol feeding strategy, the miniature 
bioreactor was able to maintain biomass levels up to 278 gwcwL-1 (Isett et al., 
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2007).  Such studies confirm microwell techniques for screening libraries of 
microorganisms and evaluating physiological parameters that have an impact on 
growth and product synthesis.     
 
Microtiter plates can be used for a variety of cell types including mammalian 
culture (Chen et al., 2009).  For example, VPM8 hybridoma cells in suspension 
culture have been investigated for antibody production and shown reasonable 
similarity to stirred bioreactor cultures in terms of maximum cell densities 
(Micheletti et al., 2006).  In addition, culture medium optimisation of Chinese 
hamster ovary cell (CHO) line cultures has been reported (Deshpande et al. 
2004).  In the area of bioprocessing there are also reports of microwell 
geometries being applied for the investigation of yeast (Hammonds et al., 1998; 
Weis et al., 2004), fungi (Bills et al., 2008) and algae (Skjelbred et al., 2012) 
culture. 
 
Data collection on enzyme activity in bioconversions can also greatly benefit 
from the use of microtiter plates.  A simple, efficient and timely method has been 
described by Stahl et al. (2000) who employed 24-well microtiter plates to 
effectively screen libraries of yeast and rhodococci for bioconversion activity.  
Among the 240 strains tested, 78 % were found to be positive when tested for the 
bioreduction of 6-bromo-%-tetralone to 6-bromo-%-tetralol (Stahl et al., 2000).  
This method proved to outperform the traditional screening methods as it 
reduced manual handling, screening initiation time and analytical operation time 
by utilising a robotic system capable of preparing assays directly from 24-well 
plate formats.  Methods to determine kinetic parameters such as kcat and km were 
also established.  Parallel pH assays in 96-well formats were developed by John 
and Heinzle (2001) to screen for hydrolase activity.  While the assay was 
developed using penicillin acylase to hydrolyse 4-nitrophenyl acetate, the 
method could be applied to different reactions where acids or bases are 
consumed or released (John and Heinzle, 2001).  The Baeyer-Villiger oxidation 
is one such reaction which has been investigated using E. coli expressed CHMO 
(Doig et al., 2002; Ferreira-Torres et al., 2005).  Marques et al. (2007, 2009) 
reported using microtiter plates for multistep biotransformation in two-liquid 
biphasic systems.  The method would be suitable for systems using substrates 
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and/or products which are poorly water soluble or toxic to the cell.  Similarly, 
Grant et al. (2012) developed a microwell based approach for the 
characterisation of two-liquid phase systems namely the bio-oxidation of 
alkanes.  The high-throughput enzymatic performance and stability in microwell 
formats has also be demonstrated by Rachinskiy et al. (2009) where the effect of 
extreme conditions on enzymes over short time frames could be assessed. 
 
Being able to predicatively evaluate growth and bioconversion conditions early 
on at the microscale have clear benefits in terms of reduced cost, however the 
impact of these upstream processes on downstream unit operations is also 
important.  One particular area which has been focussed on for microscale 
studies is filtration (Chandler and Zydney, 2004; Vandezande et al., 2005).  A 
system comprising both a commercial and custom-designed well filter plate 
integrated within a robotic platform has been shown to efficiently evaluate the 
impact of upstream processing conditions on microfiltration (Jackson et al., 
2006).  Cell type, buffer and media composition were all shown to affect the 
specific cake cell resistance during microscale normal flow filtration (Jackson et 
al., 2006).  Following on from this work Rayat et al. (2010) investigated the 
effects of cell disruption on microscale microfiltration performance.  In the area 
of purification an assay was developed to investigate purification adsorbents in 
96-well plate format (Welch et al., 2002).  Identified adsorbents could then be 
applied for impurity removal from process streams and Welch et al. (2002) 
demonstrated a quick and easy route to purification problems which is 
compatible with a range of separation types.  In addition, bioconversion products 
have been recovered using microwell approaches (Lander, 2003).  Lander (2003) 
used resins to bind CHMO bioconversion products in microwells where the 
resulting binding capacity was subsequently used to inform the design of in-situ 
product removal operations.  This is a particularly useful approach where product 
inhibition occurs, a typical limitation of many biocatalytic processes.  The ability 
to assess such methods at the microscale could also cut down the costs associated 
with selecting the best final product purification approach during initial 
developmental stages.  In the area of chromatography there are some high-
throughput chromatographic studies which have been reported based on ion 
exchange (Rege et al., 2004; Mazza et al., 2002) and the miniaturization of 
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protein purification (Rege et al., 2006).  Additionally, microtiter filtration plates 
are available for nickel chelate affinity chromatography for protein purification 
(Holz et al., 2002).  Filter plates are a common scale down separation technique 
and have been combined with automated dispensing to ensure rapid and 
reproducible transfer of resins and/or buffers (Coffman et al., 2008).  Therefore 
such approaches are beneficial for chromatography development studies and 
have the capacity to screen multiple purification options simultaneously (Chhatre 
and Titchener-Hooker, 2009).  The use of microscale techniques have the 
potential to enable the effective evaluation of interactions between unit 
operations in a complete bioprocess.  In particular, due to the recent uptake of 
microwells for upstream process development, it is important to apply them more 
extensively to the downstream operations thus preventing these from becoming a 
processing bottleneck. 
 
Due to the fact that microtiter plates are not mechanically agitated it is expected 
that these do not effectively mimic the behaviour of large-scale processes, 
occurring in aerated stirred tank systems.  However, a number of studies have 
been published proving the reproducibility of data collected at the microscale to 
those achieved in lab scale systems.  KLa values of 130 h-1 were estimated from 
measured dissolved oxygen concentrations during microbial culture in 96 round-
bottomed microtiter plates and John et al. (2003) reported these values as being 
similar to a typical KLa achieved in moderately stirred bioreactor.  Values up to 
241 h-1 have also been reported in square deep well geometries due to the 
reported improved mixing and oxygen transfer capabilities (Duetz et al., 2000; 
Islam, 2007; Ferreira-Torres, 2008).  KLa values up to 600 h-1 were achieved 
using a baffled 24-well microtiter plate (Funke et al., 2009).  In the case of 
cellular cultivation the provision of oxygen unlimited conditions is desirable for 
effective study of growth and product formation.  Previous works have indicated 
the potential for scale-up of microwell cultivations by matching the culture 
conditions at both scales.  For example Isett et al. (2007) reported similar 
dextrose utilisation and oxygen uptake rate of E. coli BL21 cultures between 
microscale and a 20 L bioreactor even though differences in pH and dissolved 
oxygen levels were reported.   
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Traditionally successful scale-up is demonstrated when defined engineering 
conditions, such as KLa or P/V, are kept constant.  A constant KLa has more been 
used where growth and/or bioconversion data from microwell plates have been 
reproduced in 1.4 L (Micheletti et al., 2006; Kensy et al., 2009), 2 L (Ferreira-
Torres et al., 2002), 5 L (Marques et al., 2009) 7.5 L and 75 L (Islam et al., 2008) 
stirred bioreactors using microbial systems.  Doig et al. (2002) also demonstrated 
that microwell systems could reasonably replicate substrate inhibition kinetics 
observed in a 2 L stirred tank reactor, confirming the use of microwells to 
successfully collect quantitative kinetic data.  Protein formation has been 
effectively scaled up with microwell protein yields reproduced in 7.5 L and 75 L 
reactors (Islam et al., 2008) and 1.4 L stirred bioreactors (Kensy et al., 2009) at 
matched KLa conditions.  By utilising a high-throughput microwell-based screen 
Marques et al. (2012) recently identified some enhanced siderophore producing 
strains.  When the microtiter plate bioprocess was scaled up on the basis of a 
matched KLa approach the overall volumetric siderophore productivity was 
maintained in a 5 L stirred tank reactor (Marques et al., 2012).   
 
In the case of mammalian systems power consumption has been tested as a scale-
up parameter between microwell plates and a 5 L stirred bioreactor (Micheletti et 
al., 2006).  The data achieved was not identical nevertheless there was similarity 
between growth profiles of VPM8 hybridoma cells providing a basis for scale 
translation studies.  Chen et al. (2009) later reported the feasibility of using 24 
well microplates as an effective scale down tool for CHO cell culture process 
development.  It was established that cell growth, metabolite profiles, protein 
titre and quality from a microscale and 2 L stirred reactor CHO cell culture were 
within typical cell culture process variations however no specific scale-up 
criteria was followed.  Both bioreactors were seeded at the same initial cell 
density, using the same cells and cultured with the same media which enabled 
comparable data to be obtained between both scales (Chen et al., 2009).   
 
Finally, scale translation has also been observed in some of the microwell based 
downstream processing operations.  Notably Jackson et al. (2006) found 
microscale results using filter plates to be comparable to a conventional 
laboratory scale membrane cell.  Therefore by setting up consistent cultures 
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conditions or by maintaining crucial engineering parameters on scale-up 
microwell approaches have been shown to provide data which are similar to 
those achieved at lab scale.  
 
The uptake of microtiter plates for bioprocess evaluation of a range of systems 
for both upstream and downstream operations has increased in the last ten years 
due to their high-throughput capabilities.  In each of these areas multiple factors 
can be tested to achieve optimum processing performance and effective scale-up.  
In particular, the importance of investigating the interactions between changes 
occurring in upstream processing operations on subsequent downstream 
operations is crucial.  Challenges are also faced in developing scale down 
downstream replicates in line with the advances achieved in upstream process 
development to prevent this from becoming the process bottleneck.  In addition 
faster analytics are required to cope with the increase in data collection.  From 
recent developments it is clear that microtiter plates are a promising technology 
platform for whole bioprocess development studies.  While considerable work 
has been carried out on individual unit operations, limited effort has been 
directed to develop and integrate multiple microscale process steps. 
 
1.2.1.3.2 Bioprocess Applications of Whole Process Approach 
 
If the cost and time savings of performing a single unit operation at the 
microscale are desirable, the implications of being able to carry out a whole 
process from start to finish in microwell geometry would significantly enhance 
these benefits.  In order to quantify the effects of changes made on individual 
stages in a bioprocess the development of linked process sequences in required.  
A good example concerns biocatalysts production for the synthesis of 
pharmaceutically active compounds.  Genetic modifications to host cells can 
cause changes in substrate specificity (Raillard et al., 2001; Matsumura and 
Ellington et al., 2001), alterations in substrate uptake (Mirjalili et al., 1999) and 
unexpected by-product formation (Stassi et al., 1998).  Combining a series of 
unit operations means such effects can be effectively evaluated.  It was 
previously mentioned how Jackson et al. (2006) used differing feed streams to 
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determine the effects on microfiltration performance.  Therefore upstream 
processing conditions can have effects on the choice of solid-liquid separation 
and this could be more rapidly evaluated if an appropriate microscale sequence 
was developed.   
 
A microscale process for high-throughput expression of cDNAs in yeast was 
described by Holz et al. (2002).  Clone selection, growth, protein expression and 
protein purification were each carried out at the microscale.  However, this 
process was focussed on microwell based screens for protein production and 
eventual gene characterisation rather than on bioprocess optimisation or on 
informing large-scale protein expression.  A clear motivation for mimicking 
process sequences at the microscale is to predict the performance in larger scale 
pilot plant trials therefore conditions used at the microscale can ultimately be 
used to design larger scale reactor conditions (Hibbert et al., 2005).  This can be 
critical for evolving enzymes where microscale studies have identified the 
desired ideal properties and characteristics.  For example, if a microscale screen 
shows an enzyme to remain active under extreme temperatures, this should also 
hold true in a bioreactor environment where enzyme deactivation or denaturation 
can occur due to oxidation (Mozhaev and Martinek, 1982) and hydrolysis 
(Srinivas and Panda, 1999).   
 
An initial demonstration of automated process sequences was addressed by 
Ferreira-Torres et al. (2005) which involved linked growth, induction and 
bioconversion steps carried out using a Packard Multiprobe II robot.  The system 
was able to evaluate recombinant whole cell biocatalysts libraries for the 
synthesis of chiral lactones.  A similar approach was employed for an E. coli 
biocatalyst expressing Transketolase enzyme using a Tecan robot (Micheletti et 
al., 2006).  In both cases results obtained at the microscale demonstrated a 
quantitative agreement in terms of maximum specific growth rate and final 
biomass concentration to those measured in lab scale bioreactors.  It is therefore 
of interest to apply this methodology to an increased number of biocatalytic 
systems in particular those which are newly identified or have yet to be 
characterised to allow for quick identification of efficient industrial biocatalysts.  
Such systems will be discussed in section 1.2.3.1.2.  In the studies described by 
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Ferreira-Torres et al. (2005) and Micheletti et al. (2006) complete ‘walk away 
operation’ was not achieved and many steps still required manual intervention.  
Additionally the process sequences were only used for a limited number of 
studies as a proof of concept.  They were not applied extensively for process 
sequence optimisation which is required if microwell based process sequences 
are to be accepted as low cost design and development platforms.  
 
In bioprocessing the scalability of a microwell whole process sequence plays a 
crucial role for process development as the production of biopharmaceuticals 
will inevitably need to be developed and manufactured at scale.  Whereby 
reliable and reproducible bioprocess data from every step in the development 
cycle can be made available from a miniaturised automated system early on, 
optimisation studies can follow and lead to shorter product release times.  For 
this reason there are continual efforts to increase the range of unit operations 
which can be studied in microwell format and to apply the knowledge gained 
from established automated process sequences to the analysis of larger libraries 
of evolved biocatalysts (Ferreira-Torres et al., 2005; Micheletti et al., 2006).  The 
standardization of microwell plates makes them readily available for the 
incorporation with automation platforms as already highlighted.  The benefits 
and advances of automation will therefore be discussed in the following section.  
 
1.2.2 Process Automation 
 
1.2.2.1 Overview of Automation Technology 
 
There is a current industrial need for bioprocess automation to ‘guarantee 
constant high quality standards,’ ‘with high levels of precision, and to gain 
independence from specific personnel’ which can be achieved through automated 
execution and analysis of bioprocessing steps (Sonnleitner, 1997).  In currently 
available platforms there are two commonly used robotic arms, including one 
used for liquid handling operations and another capable of transferring plates and 
devices from different locations on the robotic deck.  The use of automation can 
provide significant advantages.  Firstly the labour requirement is reduced where 
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repetitive tasks, such as preparing culture plates and growth monitoring, can be 
automated.  Depending on the level of automation the roles of a laboratory 
worker can change considerably whereby major responsibilities will move away 
for culture maintenance and towards data analysis, process improvement and 
other developmental activities.  This ultimately can lead to facilities with 
increased productivity.  
 
Problems in bioprocesses often originate from two sources, namely human error 
and a lack of process understanding, both resulting in unexpected outcomes.  
Automation can remove human error and increase processing consistency.  If a 
robot is programmed correctly then it has the capability to run for 24 hours 
without any reduction in processing performance and with a high degree of 
consistency.  There is therefore a considerable reduction in production downtime 
where batch processes could be run back-to-back and overnight with the 
requirement of a single operator for monitoring and control.  Moreover, 
overnight sampling increases the understanding of rate kinetics and the process 
which can increase the success of process targets being achieved (Bareither and 
Pollard 2010).  An automated system can also cope with a larger number of 
strains or target compounds enabling rapid identification of growth or expression 
conditions.  This is clearly desirable in bioprocessing where the number of 
variables affecting a process is often considered a bottleneck.   
 
1.2.2.2 Automated Robotic Platforms 
 
There are a number of commercially available robotic platforms which have been 
specifically developed to meet the bioprocessing needs.  These are supplied by a 
variety of manufacturers including Gilson, Perkin Elmer, Tecan and The 
Automation Partnership.  Specific features, as already mentioned, include 
pipetting and movement arms along with barcode readers for tracking plates, 
shakers with heating and cooling capacity for cell cultivation, vacuum filtration 
for separation steps and automated washing systems.  Many are also housed 
within biosafety cabinets to ensure aseptic operation.  While the benefits of 
automation have been realised for some time (Sonnleitner, 1997), only recently 
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and with the availability of automated platforms has there been a greater interest 
in applying automation for process development.   
 
1.2.2.2.1 Application for Microscale Process Development 
 
Automation platforms have been applied in both miniature stirred and miniature 
shaken systems.  In the case of miniature stirred systems Puskeiler et al. (2005), 
Weuster-Botz et al. (2005) and Knorr et al. (2007) reported the use of a Tecan 
automated robot for the robotic sampling, analytics and pH control integrated 
with for the “Bioreactor Block”.  The high degree of automation and control 
makes the system well suited for the optimisation of bioconversion reaction 
conditions.  One disadvantage of the “Bioreactor Block” was that, although DOT 
could be monitored, only 8 out of 48 reactors could be simultaneously 
monitored.  More recently an impressive technology developed by The 
Automation Partnership called the ambrTM (automated microscale bioreactor) 
system has been developed (Bareither and Pollard, 2010).  This comprises 24, 10 
mL working volume disposable cell culture reactors on the deck of a liquid 
handling robot.  Sampling, additions and intermittent feeding regimes can all be 
automated using sterile processing and the system has been developed for 
mammalian cell culture.  DO and pH are also measured using sensor patches on 
the base of each reactor.   
 
Automation and integration with associated equipment is easier when working 
with microwell geometries due to their standard footprint of 86 X 128 mm2 and a 
typical height of 14 mm (Lye et al., 2003).  They can be stacked or placed in 
racks allowing multiple plates to be used for higher throughput processing.  A 
commercially available micro fermentation system has been developed by m2p-
labs which allows real time monitoring of biomass, pH, DOT and fluorescent 
proteins.  Huber et al. (2009) used this system with an automated liquid handling 
robot and described high-throughput cultivations along with recombinant protein 
expression.  This system has not been linked with other microwell based 
operations however Huber et al. (2009) did report that continual work into 
combining this approach with small-scale downstream processing techniques and 
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analytical assays was underway.  A microscale automated screening approach for 
optimisation of protein refolding has recently been described (Ordidge et al., 
2012).  In this study it was demonstrated how the automated approach was 
suitable to carry out refold screening of a large number of experimental 
conditions which is required to identify the best conditions to increase active 
protein yields.  A combination of growth and bioconversion has already been 
mentioned where automated platforms including the Packard Multiprobe II robot 
(Ferreira-Torres et al., 2005) and a Tecan Genesis (Micheletti et al., 2006) robot 
were utilised to demonstrate the potential for process automation and the 
respective shortcomings discussed.  A crucial advantage of automation is the 
ability to create linked process sequences all using the same microwell format 
enabling a better understanding of process interactions which will be investigated 
further in this thesis.  
 
A field that can significantly benefit from the use of automated microscale 
techniques is biocatalysis.  Chemical oxidations typically require quantities of 
toxic or highly reactive reagents resulting in waste treatment and disposal 
difficulties.  Applying automated microscale approaches can enable 
identification of sustainable biocatalytic alternatives for industrial 
pharmaceutical synthesis.  Biocatalytic systems have been criticised due to the 
relatively slow implementation time.  This is because of the number of steps 
required in the development of a bioconversion process, which include 
biocatalysts screening steps and selection of suitable operational conditions for 
production and bioconversion (Fernandes, 2010).  Advantages of automation 
include faster biocatalysts library evaluation and rapid identification of 
industrially relevant substrates which is particularly desirable especially when 
substrates and associated cofactors for enzymatic synthesis can be costly raw 
materials at scale.  Ultimately this leads to accelerated translation from discovery 
to pilot plant production (Lye et al., 2003).  
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1.2.3 Bioconversions 
 
There is a current need to establish more productive biocatalytic processes to 
enable a greater industrial uptake.  Biocatalysts can either be in the form of 
whole cells or isolated enzymes.  Typically hydrolytic or isomerisation reactions 
are conducted by isolated/purified enzymes as they do not require cofactor 
regeneration, however removal of enzymes from their natural environment can 
be detrimental.  In the case of reactions requiring cofactor recycling or 
regeneration, whole cells are preferred as it is easier and less expensive to utilise 
the cells natural ability to regenerate cofactors (Schmid et al., 2001).  Isolation 
and purification increases costs therefore, as long as other host cell enzymes do 
not have a negative influence on the reaction, it is usually more economical to 
use whole cells.  Moreover, enzymes within their natural environment can be 
more stable where they are protected from shear forces with a resultant longer 
half-life in bioreactor systems (Duetz et al., 2001).  
 
Bioconversions utilising biocatalysis over chemical synthesis have many 
advantages and thus have become an attractive option in the synthesis of 
pharmaceuticals and optically pure fine chemicals as well as for the production 
of food and detergents (Duetz et al., 2001; Lye et al., 2003).  In particular, the 
high regio, stereo and enantioselectivity possessed by a biocatalyst often result in 
fewer by-products produced while blocking/de-blocking steps are not required 
(Schmid et al., 2001).  In the case of high regioselectivity this increases the 
degree of certainty that a particular product will or will not be made due to the 
biocatalyst having a particular preference for the direction of bond making or 
bond breaking (Tramper, 1996).  Biocatalysts also reduce the number of reaction 
steps required and can operate under mild conditions using cheap and clean 
reagents (Tramper, 1996; Strukul, 1998).   
 
For these reasons there has been an increase in the number of industrial 
applications for biocatalytic processes (Tramper, 1996; Schmid et al., 2001).  For 
example penicillin acylase from E. coli is used to produce 6-aminopenicillanic 
acid.  This is a one step process whereas the chemical route would require three 
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reaction steps and would operate under extreme conditions (Tramper, 1996). 
Other successful industrial examples are the use of xylose isomerase for the 
production of high fructose corn syrup (Jensen and Rugh, 1987), the synthesis of 
phenolic resins using peroxidases and the hydration of acrylonitrile into 
acrylamide catalysed by nitrile hydratase (Nagasawa and Yamada, 1990).  In line 
with these successes it is of interest to increase the number of biocatalytic 
systems which can be applied for industrial processes.  Oxidative biocatalysts are 
a promising group which have yet to be fully exploited at this scale.  
 
1.2.3.1 Oxidative Bioconversions 
 
Oxidative bioconversions incorporate oxygen into the substrate.  They are 
particularly useful in synthetic chemistry to carry out a range of reactions such as 
epoxidations to produce styrene oxide and ethylene oxide, sulfoxidations for the 
production of dimethyl sulfoxide (DMSO), hydroxylations for steroid 
hydroxylation and the Baeyer-Villiger oxidation for antibiotic synthesis (Leak et 
al., 2009).  Due to the industrial application of many of these reactions there is 
currently a need for the widespread usage of these bioconversions.  The 
limitations of chemical synthesis has already been discussed, moreover chemical 
oxidations present additional problems whereby the requirement of high energy 
oxidants and flammable solvents is a safety concern often limiting large-scale 
industrial production (Blaser and Federsel, 2011).  Biocatalysis is identified as a 
potential route forward in achieving simpler, cleaner, cheaper and more specific 
processes.  However, the use of oxygenases also pose limitations including the 
requirement of co-factors, they can consist of multiple components which are 
sometimes membrane-bound, they can be unstable and reactions often require 
biphasic systems due to products or substrates not being water soluble (Van 
Beilen et al., 2003).  Reactions utilising molecular oxygen can cause the 
formation of reactive oxygen species or radicals which can be detrimental 
resulting in biocatalysts inactivation (Leak et al., 2009).  Such drawbacks can 
cause significant bottlenecks preventing efficient biocatalytic oxygenation 
processes being developed due to poor operational stability (Duetz et al., 2001).   
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Using whole cells is a useful method to tackle such issues as they have the ability 
to naturally remove reactive oxygen species which may be generated and can 
naturally regenerate essential cofactors.  By utilising in-situ resin-based substrate 
feeding and product removal Hilker et al. (2008) operated a kilogram scale whole 
cell Baeyer-Villiger oxidation.  This allowed increased substrate concentrations 
to be processed thus developing an industrially suitable method for asymmetric 
synthesis.  In the case of the isolated enzyme approach, using the same whole 
cell system Zambianchi et al. (2002) has shown the use of isolated 
cyclohexanone monooxygenase and a NADPH regeneration system can yield 
products with high optical purity.  However, the high cost of using cofactor 
regeneration systems still makes isolated enzyme systems undesirable.  
Commercial examples include the use of oxygenases for steroid hydroxylation 
for the production of corticosterone (Van Beilen et al., 2003) and for the 
production of Pravastatin (Serizawa and Matsuoka, 1991) which is used to lower 
cholesterol.  Additionally a number of biotechnology companies have previously 
used oxidative microbes for sterol side-chain degradation which can result in the 
formation of pharmacologically active steroids (Kieslich, 1991).  Oxidative 
systems therefore have been commercially exploited and are of great interest to 
both pharmaceutical and agrochemical industries due to the production of 
enantiomerically pure compounds justifying the requirement for continual 
research in this area to overcome many of the limitations already mentioned.  
Two such oxidative systems are Baeyer-Villiger monooxygenases and 
cytochrome P450s which have been investigated in this work. 
 
1.2.3.1.1 Baeyer-Villiger Monooxygenases 
 
The Baeyer-Villiger oxidation involves the oxidation of a ketone to an ester in 
the presence of a peroxy acid which acts as the oxidising agent (Baeyer and 
Villiger, 1899; Kamerbeek et al., 2003).  Reaction scheme 1.1 shows a schematic 
diagram of the steps in a Baeyer-Villiger oxidation.  An intermediate step 
involves the formation of a Criegee adduct when the ketone is attacked by a 
nucleophilic peroxy acid, then the intermediate is transformed into an ester and 
carboxylic acid (Criegee, 1948; Kamerbeek et al., 2003). 
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Reaction Scheme 1.1 Scheme removed due to copyright issues. 
 
 
The Baeyer-Villiger oxidation has a number of applications in organic chemistry 
including antibiotic, steroid synthesis and pheromone synthesis which are 
utilised in agrochemistry as well as synthesis of monomers for polymerization 
(Strukul, 1998).  The main reason why this reaction has been successful lies in a 
number of key properties.  Firstly, the presence of many functional groups does 
not restrict the reaction and oxidation of unsaturated ketones will generally 
proceed.  Secondly, the reaction is generally stereoselective and thus the 
regiochemistry of a reaction can be controlled (Strukul, 1998).  Finally, there are 
a number of peroxy acids which can participate in the reaction (Strukul, 1998). 
 
The production of spent carboxylic acids from the Baeyer-Villiger reaction need 
to be separated and disposed of which is not really feasible during large-scale 
industrial operations (Strukul, 1998).  Many of the oxidants used in this reaction 
can also be toxic and unstable (Alphand et al., 2003).  A possible alternative is to 
use transition metal catalysts for Baeyer-Villiger oxidations, however these have 
not been extremely successful as the reaction mechanism is not completely 
defined (Strukul 1998).  A clear solution is represented by biocatalysis which has 
a number of benefits over chemical synthesis as previously discussed.   
 
Baeyer-Villiger monooxygenases (BVMOs) are enzymes which, by employing 
molecular oxygen, can catalyse the nucleophilic oxygenation of cyclic or linear 
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ketones and generate the corresponding esters (Willetts, 1997).  BVMOs have 
also been found capable of electrophilic oxygenation of heteroatoms, an example 
being where sulfoxides are formed from organosulfides (Secundo et al., 1993).  
In particular, they have the ability to catalyse a wide variety of oxidative 
reactions in a regio- and enantioselective manner which can be difficult and often 
impossible to conduct chemically (Kamerbeek et al., 2003).  Furthermore, such 
reactions can be carried out under mild and aqueous conditions.  In combination 
with their broad substrate scope, Blaser and Federsel, (2011) state that BVMOs 
are currently the most advantageous biocatalysts for asymmetric Baeyer-Villiger 
oxidations.  While there are a number of BVMOs which can synthesise 
industrially useful compounds (Tressl et al., 1978; Levitt et al., 1990; Carnell et 
al., 1991) no industrial process has yet to incorporate a BVMO catalysed step.  
This is mainly due to low volumetric productivities, product and substrate 
inhibition and cofactor requirements which in general limit many oxidoreductase 
catalysed bioconversions (Schulze and Wubbolts, 1999).  A number of BVMOs 
have been cloned and expressed including cyclopentanone monooxygenase 
(Iwaki et al., 2002), cyclododecanone monooxygenase (Kostichka et al., 2001), 
steroid monooxygenase (Morii et al., 1999) and 4-hydroxyacetophenone 
monooxygenase (Kamerbeek et al., 2001).  The most studied BVMO in terms of 
biocatalytic properties is cyclohexanone monooxygenase (CHMO). 
 
1.2.3.1.1.1 Cyclohexanone Monooxygenase 
 
Cyclohexanone monooxygenase (CHMO) from Acinetobacter calcoaceticus 
NCIMB 9871 is, at present, the best characterised BVMO.  It was first 
discovered in 1975 where the bacterium was able to grow on cyclohexanol as a 
sole carbon source (Donoghue and Trudgill, 1975).  It is NADPH and oxygen-
dependent and has a molecular mass of 59 kDa.  DNA sequencing was initially 
conducted by Chen et al. (1988) where CHMO was found to contain 542 amino 
acids however a corrected sequence was later published by Iwaki et al. (1999).  
Its ability to catalyse the stereoselective Baeyer-Villiger oxidation of a wide 
range of ketones means there is potential for industrial application (Alphand et 
al., 2003).  Different types of commercially interesting lactones could potentially 
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be produced via CHMO.  For example, monocyclic lactones are used in the 
production of anti-tumour compounds and as intermediates in the synthesis of 
potent drugs for hypertension treatment, while hydroxylated lactones are 
components of immunosuppressant drugs (Alphand et al., 2003).   
 
However, the use of the wild type strain has a number of undesirable features 
namely it being a class 2 pathogen, cyclohexanol is a toxic carbon required for 
enzyme induction (Trudgill, 1990) and it contains an active hydrolase which 
needs to either be removed or inhibited before biotransformation (Stewart et al., 
1996).  The purified enzyme presents an additional difficulty and would require 
an efficient cofactor recycling process as the enzyme is NADPH-dependant 
whereby the addition of stoichiometric amounts of NADPH during large-scale 
synthesis would be too expensive (Abril et al., 1989).   
 
These implicit limitations have led to the development of a number of 
recombinant systems.  One of the first was described by Chen et al. (1988) using 
E. coli to overexpress CHMO.  A few years later Stewart et al. (1996) developed 
a recombinant yeast expressing CHMO, however as yeast contains an alcohol 
dehydrogenase, reduction of the starting ketone occurred and no improvement in 
usable substrate concentration was achieved (Stewart et al., 1996).  Similarly, 
Chen et al. (1999) found that native yeast enzymes compromised the efficiency 
of CHMO oxidations while this was not found to be an issue with E. coli 
expression hosts which did not possess any competing oxidative enzymes.  A 
study conducted by Doig et al. (2001) aimed at overcoming these limitations 
through the establishment of a recombinant E. coli expressing CHMO.  This was 
developed through a series of plasmid constructs which began with cloning the 
CHMO gene from Acinetobacter calcoaceticus NCIMB 9871 to produce a 
construct pQR210 enabling CHMO induction from E. coli using 
isopropylthiogalactoside (IPTG).  This system was improved further by replacing 
IPTG induction with L-arabinose to create the recombinant E. coli TOP10 
[pQR239] which is non-pathogenic, easy to grow, it is lactose hydrolase ($-
galactosidase) free and, as it is a whole cell biocatalyst, takes advantage of the 
intracellular recycling of NADPH (Doig et al., 2001).  The use of an L-arabinose 
inducible promoter represents a cheaper alternative to IPTG and thus makes it 
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more attractive for large-scale production (Doig et al., 2001).  A number of other 
recombinant bacterial strains have been developed to carry out Baeyer-Villiger 
type oxidations using the CHMO gene from Acinetobacter calcoaceticus 
NCIMB 9871 (Cheesman et al. 2001; Doo et al., 2009).  Such studies have 
demonstrated that microbial strains can be genetically engineered to express 
CHMO which are a useful substitute to purified enzymes and can provide 
chemical and optical yields comparable to those obtained using traditional 
methods (Chen et al., 1999).  
 
Once an appropriate recombinant system is available, in view of achieving 
improved biocatalytic systems for oxidative bioconversions, strategies are 
focussed on defining the best bioprocess steps for effective production at scale.  
This can involve optimising growth, expression and enzymatic activity.  Progress 
has already been achieved with CHMO expressed from E. coli TOP10 [pQR239] 
and will be taken further in this thesis.  Stemming from the initial 
characterisation studies in 2001, work has been done to demonstrate biocatalyst 
production at a range of scales from the microscale (Doig et al., 2002) up to 300 
L stirred tank bioreactor scale (Doig et al., 2001).  In particular, conditions 
impacting the CHMO specific activity have been evaluated including growth 
temperature and pH, inducer concentration and induction time, reductant type 
and reductant concentration.  By increasing the level and activity of CHMO it 
can be used for efficient bioconversion processes where the majority of work has 
focused on the substrate bicyclo[3.2.0]hept-2-en-6-one.  The use of this substrate 
has become the standard reaction when testing for asymmetric Baeyer-
Villigerase oxidations (Doig et al., 2003).  The CHMO catalysed Baeyer-Villiger 
oxidation of bicyclo[3.2.0]hept-2-en-6-one yields the regio-isomeric lactones (-)-
(1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one and (-)-(1R,5S)-3-
oxabicyclo[3.3.0]oct-6-en-2-one as shown in reaction scheme 1.2.   
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Reaction Scheme 1.2 CHMO catalysed oxidation of bicyclo[3.2.0]hept-2-en-6-
one to (-)-(1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one and (-)-(1R,5S)-3-
oxabicyclo[3.3.0]oct-6-en-2-one. 
 
Shipston et al. (1992) found this enantioselectivity could not be achieved 
chemically using standard peracid and alkaline peroxide mediated oxidations 
making this an attractive biocatalyst.  Bicyclo[3.2.0]hept-2-en-6-one and the 
related products have been found to be inhibitory to the whole cell biocatalysts 
(Shitu et al., 2009) and thus methods to overcome this issue have involved 
working below inhibitory limits or better still using reactant feeding and in-situ 
product removal approaches as described by Doig et al. (2002) and Hilker et al. 
(2008).  In addition, CHMO expressed from E. coli TOP10 [pQR239] has been 
tested with a range of other substrates including cyclohexanone and 
cyclopentanone (Doig et al., 2003; Ferreira-Torres et al., 2005), racemic bicyclic 
diketones (Ottolina et al., 2005), 1,3-diathiane (Zambianchi et al., 2004) and %-
substituted cyanocylohexanones (Berezina et al., 2007).  Therefore investigating 
multiple parameters and screening useful reactions is a demanding process and a 
move towards microscale approaches can offer a reliable solution as already 
discussed in section 1.2.1.1.  Doig et al. (2002) initially demonstrated the 
successful application of microscale processing to quantify Baeyer-Villiger 
oxidation kinetics.  This work was then extended by Ferreira-Torres et al. (2008) 
who demonstrated a microscale two-step part automated process sequence for 
evaluating whole cell CHMO libraries.  Notably, the reproduction of growth and 
bioconversion kinetics collected from microwell studies in a 2 L stirred 
bioreactor confirmed the use of microwell technologies for process design and 
investigation (Ferreira-Torres et al., 2008). 
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1.2.3.1.2 Cytochrome P450s 
 
Cytochrome P450 proteins have been studied since 1958 when they were first 
identified in the mammalian liver and found to be essential for drug metabolism 
(Klingenberg, 1958; Garfinkel, 1958).  The P450 term originates from the 
absorption band exhibited at 450 nm when the protein is bound with carbon-
monoxide which was first reported by Omura and Sato (1964) and is now used to 
identify the presence of active cytochrome P450s.  Cytochrome P450s are 
enzymes belonging to a superfamily of haemoprotein monooxygenases found in 
both prokaryotes and eukaryotes (Degtyarenko and Archakov, 1993).  Each 
cytochrome P450 is identified by a name all of which begin with the abbreviation 
CYP followed by a number representing the P450 family, a letter representing 
the subfamily and a number representing the individual gene such as CYP3A7 
(Nebert and Nelson, 1991).  The number can also be associated with the function 
of the enzyme where CYP21 is a steroid 21-hydroxylase however this is not 
always the case.  This naming system only began in 1991 thus in some cases the 
original name may be used such as P450BM3 also known as CYP102.  
 
1.2.3.1.2.1 The Cytochrome P450 Reaction Repertoire  
 
Cytochrome P450s can carry out a range of oxidative reactions, however, 
hydroxylations are the most typical.  Reaction scheme 1.3 shows the substrate is 
hydroxylated to form a hydroxylated metabolite and water. 
 
! 
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Reaction Scheme 1.3 Cytochrome P450 mediated hydroxylation. RH represents 
the substrate. 
 
The ability of P450s to carry out hydroxylations in a regiospecific and 
stereospecific manner highlights them as highly useful biocatalysts as such 
reactions are difficult to achieve using chemical methods (Speight et al., 2004).  
Depending on the host organism the function of P450 enzymes may vary.  In the 
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case of prokaryotes, P450s are in a soluble form and used to detoxify 
xenobiotics, synthesise antibiotics and for fatty acid metabolism (Werck-
Reichhart and Feyereisen, 2000).  Plants use P450s for the synthesis of fatty 
acids and cutins (Bolwell et al., 1994).  The synthesis of membrane sterols and 
mycotoxins is a common use in fungi (Werck-Reichhart and Feyereisen, 2000), 
whereas in bacteria they degrade numerous natural substrates (Celik et al., 2005 
b).  The function in animals can also be applied to the biosynthesis of steroids 
and hormones as well as having an important role in detoxification pathways 
(Werck-Reichhart and Feyereisen, 2000; Celik et al., 2005 b).   
 
It is clear that the functions of cytochrome P450 enzymes are vast and the 
diversity of enzyme sources is considerable.  For these reasons P450s have 
evolved to be able to catalyse a range of reactions such as isomerisations, 
dehydrogenations, dimerizations and carbon-carbon bond cleavage as well as 
many other pivotal reactions in drug metabolism.  There is therefore a significant 
commercial interest in these enzymes.  Ongoing research is being conducted 
using P450s to predict drug metabolism to prevent adverse side effects of drugs 
and to tailor enzymes to carry out specific functions by using methods such as 
site directed mutagenesis.  It has been reported that the human liver enzyme 
CYP2D6 could be used to determine an individual’s reaction to antipsychotics 
and antidepressants (Werck-Reichhart and Feyereisen, 2000).  A recombinant E. 
coli system capable of carrying out the hydroxylation of %-ionone and $-ionone 
to mono-hydroxylated derivatives by over-expressing cytochrome P450SU1 
(CYP105A1), P450SU2 (CYP105B1) and P450 soyC (CYP105D1) with high 
regioselectivity has also been investigated (Celik et al., 2005 a).  Due to the fact 
that compounds such as ionones contain aroma elements from plant oils, the 
perfume and cosmetic industry are also showing interest in the utilisation of the 
reaction ability of P450s (Celik et al., 2005 a).  
 
The synthetic potential of these biocatalysts is impressive, however, due their 
instability, complexity and in most cases low catalytic activity biotechnological 
use has been limited (Bernhardt, 2006).  Presently, there are some commercial 
processes which utilise P450 catalysed steps.  This includes steroid production 
such as hydrocortisone (Sonomoto et al., 1983; Szczebara et al., 2003) and 
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cortisone (Peterson et al., 1952) and statin production such as Pravastatin.  The 
P450 gene CYP75A has also been used in creation of transgenic plants in 
particular production of blue roses (Holton et al., 1993) and creation of 
multicoloured carnations (Fukui et al., 2003).  Considerable time is needed to 
generate adequate knowledge of the P450 system, as demonstrated by the 
aforementioned examples, in order to enable industrial process development 
(Bernhardt, 2006).  It is therefore clear that establishing a platform for efficient 
P450 expression and bioconversion investigation has the potential to increase the 
industrial uptake of P450 catalysis and extend it to bioremediation, fine chemical 
synthesis and development of herbicide resistant plants (Celik et al., 2005 b). 
 
1.2.3.1.2.2 Classification of Cytochrome P450s 
 
Electrons from NAD(P)H are utilised by many P450s to activate molecular 
oxygen and initiate the regio and stereo oxidative attack of target substrates 
(Werck-Reichhart and Feyereisen, 2000).  In P450-containing monooxygenase 
systems these electrons are delivered to the catalytic site by crucial protein 
components and thus are typically classified on the number they contain 
(Degtyarenko and Archakov, 1993).  For this reason cytochrome P450s fall 
under the category of external monooxygenases due to their requirement of 
external electron donors (Bernhardt, 2006).  Presently, there are three well-
established classes along with a new class four, where the first example was 
reported in 2002 (Roberts et al., 2002).  Since the 1980s a number of unusual 
electron transfer chains have been identified for a range of P450s taking the 
number of P450 classes up to ten and these have been reviewed by Hannemann 
et al. (2007). 
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1.2.3.1.2.2.1 Class I  
 
 
 
 
 
 
 
 
Figure 1.1 Figure removed due to copyright issues. 
 
Class one are three-component (or protein) systems consisting of a FAD-
containing flavoprotein (NADPH or NADH-dependant reductase), an iron-sulfur 
protein (ferredoxin) and a P450 as shown in Figure 1.1.  They are typically found 
in mammalian mitochondrial cells involved in steroid metabolism (Fulco, 1991) 
and bacterial systems which have a range of uses including xenobiotic 
metabolism (Taylor et al., 1999) and the production of secondary metabolites 
(Bernhardt, 2006).  Mitochondrial P450s are membrane bound and the reductase 
is membrane associated, while the ferredoxin component is soluble (Fulco, 
1991).  This feature can make heterologous expression in E. coli difficult where 
functional activity is often low due to generation of insoluble precipitates (Arinc 
et al., 1999).  Moreover, the lack of a P450 reductase means activity needs to be 
reconstituted by isolation and solubilisation of membranes along with the 
addition of an appropriate P450 reductase (Arinc et al., 1999).  An example of a 
mammalian class P450 includes P450scc (CYP11A1) from adrenal 
mitochondrial cells.  This is involved in cholesterol side chain cleavage which 
results in the conversion of cholesterol to pregnenolone, a rate limiting step in 
steroid hormone biosynthesis (Hannemann, 2007).  In general, the bacterial 
P450s and electron-transfer components are soluble.  One of the best 
characterised class one cytochrome P450s is P450cam (CYP101) from 
Pseudomonas putida.  P450cam has three fractions including a putidaredoxin 
reductase, an iron sulfur protein (putidaredoxin) and the cytochrome P450cam 
(Katagiri et al., 1968).  It is also the first cytochrome P450 to have its crystal 
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structure determined (Sevrioukova et al., 2004).  It catalyses the regio and 
stereospecific hydroxylation of (1R)-(+)-camphor to 5-exo-hydroxy camphor 
(Katagiri et al., 1968) and is now established as the model bacterial cytochrome 
P450 for the study of other P450 monooxygenases (Celik et al., 2005 b).   
 
1.2.3.1.2.2.2 Class II  
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Figure removed due to copyright issues. 
 
Figure 1.2 shows a class two P450.  Class two are two-component systems 
consisting of FAD/FMN-containing NADPH-dependant P450 reductase and a 
P450 and are commonly found in eukaryotic microsomal systems.  The role of 
this class of P450 in mammals include oxidative metabolism of fatty acids, 
steroids and prostaglandins along with environmental toxins and carcinogens 
(Hasler et al., 1999).  They can also be found in plants and are involved in cutin 
and lignin barrier synthesis as well as production of defence substances (Bolwell 
et al., 1994).  While less common a prokaryotic two-component system was 
reported from Streptomyces carbophilus (Serizawa and Matsuoka, 1991).  This 
prokaryotic P450, P450sca (CYP105A3) catalyses a hydroxylation reaction of 
mevastatin to pravastatin.  Previous to this work all two-component systems 
reported were membrane bound and this was the first example of a prokaryotic 
system which was soluble with the potential to be more readily utilised for its 
reaction ability (Serizawa and Matsuoka, 1991). 
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1.2.3.1.2.2.3 Class III 
 
 
 
 
 
 
 
Figure 1.3 Figure removed due to copyright issues. 
 
Class three are one-component systems consisting of a single polypeptide as 
shown in Figure 1.3 and have been identified in various prokaryotes and 
eukaryotes.  The first identified example was P450BM3 (CYP102A1) which has 
been intensively studied from Bacillus megaterium and has a haem and flavin 
domain (Nahri and Fulco, 1986) and is a soluble catalytically self-sufficient fatty 
acid monooxygenase.  For this reason it is the most catalytically active of all 
P450s with a specific activity of greater than 4500 moles substrate 
oxygenated/mole of haem/minute (Fulco, 1991).  It has been stated that the 
transfer of electrons to the P450 is often the rate-limiting step in catalysis 
(Bernhardt, 2006) and, as observed from P450BM3 this is not an issue when the 
electron transport functions and substrate oxygenation function are combined 
into one molecule.  Due to the structural advantage of this system it is currently 
used as a model for mammalian hepatic P450 systems as the electron transfer 
system operates in a similar fashion (Warman et al., 2005).  In this way isolation 
of the membrane-embedded hepatic P450 systems can be avoided.   
 
Following the discovery of P450BM3 two other one-component systems from the 
same strain Bacillus megaterium were identified and expressed in E. coli and 
characterised using spectroscopic and enzymatic techniques (Gustafsson et al., 
2004).  This included CYP102A2 and CYP102A3 which had similarities in 
sequence and amino acid identities to P450BM3 but clear differences were 
observed in fatty acid binding preference and hydroxylation products 
demonstrating a difference in cellular roles within the source strain.  A number 
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of class three P450s have now been identified with similar enzymatic traits to 
P450BM3 such as P450foxy (CYP505A1) isolated from the fungus Fusarium 
oxysporum which is self-sufficient has high catalytic turnover and similar 
molecular mass (Nakayama al., 1996).  The hydroxylation of fatty acids also 
seems to be a common feature with many of the one-component systems. 
 
The use of P450s can be limited especially eukaryotic systems which compared 
to bacterial have lower catalytic rates are typically insoluble and do not always 
express well in heterologous hosts (Bernhardt, 2006).  Moreover, the complex 
electron transport systems limit the use.  Self-sufficient P450s such as class three 
are more useful as they do not require the participation of additional proteins as 
they are already bound to the required protein components and this makes them 
good candidates for industrial applications (Liu et al., 2006).  It is possible to 
clone the genes of these P450s into recombinant strains to gain a better 
understanding of how these systems work and increase the yield to enable the 
exploitation of the benefits of their catalytic ability.  In view of the benefits of 
self-sufficient systems there is an interest in class four P450s which present a 
novel electron transport chain.   
 
1.2.3.1.2.2.4 Novel Class IV 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Figure removed due to copyright issues. 
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In 2002 a new class of cytochrome P450 enzymes was identified from 
Rhodococccus sp. strain NCIMB 9784 (Roberts et al., 2002) by using a 
polymerase chain reaction based methodology and shown in Figure 1.4.  This 
strain of microorganism was of particular interest due to their role in the 
transformation of a range of xenobiotic compounds (Finnerty, 1992).  The 
structure of this P450 differs from that of the classes already mentioned in that 
the C-terminal reductase is made up of a FMN-binding, NADH-binding and iron 
sulfur protein centre which closely resembles a dioxygenase reductase.  Electrons 
are transferred through the FMN centre and the iron sulfur protein to the active 
site.  This new P450, P450RHF (CYP116B2) does share a common feature with 
P450BM3 in that the activity of the enzyme is located at the N-terminal and it is 
another example of a self-sufficient single polypeptide system.  Both the natural 
function and substrate specificity of this enzyme were unknown and due to the 
fused composition of this P450 to the required reductase it was cloned into an E. 
coli expression system whereby its ability to carry out the O-dealkylation of 7-
ethoxycoumarin to 7-hydroxycoumarin was observed.  
 
Liu et al. (2006) has reported the cloning, expression and characterisation of 
another P450 belonging to class 4, CYP116B3.  It was identified in Rhodococcus 
rubber strain by using microbial strain screening and the protein sequence had a 
93 % identity to P450RHF (Roberts et al., 2002).  This P450 was found to 
hydroxylate a broad range of aromatics indicating the potential for 
bioremediation and synthesis applications.  P450SMO which also has 73 % 
protein sequence identity to P450RHF has recently been expressed in E. coli and 
has been found to be an attractive biocatalyst for asymmetric synthesis or 
enantiopure sulfoxides (Zhang et al., 2010). 
 
Hussain and Ward (2003 a, 2003 b) demonstrated the creation of three fused 
P450 systems.  This includes P450SU1 and P450SU2 where Streptomyces 
griseolus is the source of P450 and ferredoxin and Streptomyces coelicolor is the 
source of the ferredoxin reductase (Hussain and Ward, 2003 b).  In addition the 
fused system incorporating P450 soyC and ferredoxin from Streptomyces griseus 
and ferredoxin reductase from Streptomyces coelicolor is described (Hussain and 
Ward, 2003 a).  In common with class three P450s and the novel class four they 
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are all self-sufficient single polypeptide systems receiving electrons from 
NADPH-cytochrome P450 reductase fused to the P450.  Previous to these works 
a minimal number of prokaryotic P450 system ferredoxin reductases had been 
purified and characterised due to low expression compared to cytochrome P450s 
and unstable nature (Ramachandra et al., 1991).  However, Hussain and Ward 
(2003 a, 2003 b) demonstrated that cloning the genes encoding the ferredoxin 
reductase downstream of the P450 and ferredoxins and coexpressing them 
stabilised the folded active form of the P450.  This also resulted in greater whole 
cell biotransformation ability. 
 
1.2.3.1.2.2.4.1 Cytochrome P450SU1 and P450SU2 
 
Cytochrome P450SU1 and P450SU2 were found to be sulfonylurea herbicide 
metabolising enzymes in Streptomyces griseolus (O’Keefe et al., 1991).  They 
were found to be enzymatically inactive alone, requiring an electron transport 
system.  The activity could be reconstituted in the presence of the ferredoxins 
Fd-1 and Fd-2 from Streptomyces griseolus and an appropriate ferredoxin 
reductase (O’Keefe et al., 1991).  This prompted the work conducted by Hussain 
and Ward (2003 b) to trial a ‘mix and match’ system combining components 
from two different strains.  It was found that these systems could be expressed in 
E. coli, and high level expression of both P450SU1 and P450SU2 were found 
using E. coli BL21 Star (DE3)pLyS [pQR367] (referred to here on as E. coli 
[pQR367]) and E. coli BL21 Star (DE3)pLyS [pQR368] (referred to here on as 
E. coli [pQR368]) respectively.  The increase in the level of catalytically active 
P450 expressed of 55 nmol per g of soluble protein for P450SU1 and 413 nmol 
per g of soluble protein for P450SU2 was achieved through strain selection and 
the introduction of the ferredoxin reductase.  The addition of haem precursor 
alpha-aminolevulinic acid (ALA) and ferric chloride (FeCL3) were also 
highlighted as enhancing active P450SU2 levels.  These systems were tested for 
their hydroxylation activity and found to successfully convert 7-ethoxycoumarin 
to 7-hydroxycoumarin.  They have also been successful in metabolising %-
ionone to 3-hydroxy-%-ionone and $-ionone to 4-hydroxy-$-ionone with a high 
degree of regioselectivity (Celik et al., 2005 a).  Compared to the wild type 
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system Streptomyces griseolus, no enantioselectivity was observed when 
catalysing $-ionone (Celik et al., 2005 a).  This work is a nice demonstration of 
the ferredoxin reductase of Streptomyces coelicolor being able to donate 
electrons to non-native ferredoxins.   
 
Unlike membrane-bound human counterparts the advantage of the Streptomyces 
species is the provision of soluble P450 enzymes with a broad substrate 
specificity.  Moreover, this species is involved in producing about two-thirds of 
the naturally occurring antibiotics and secondary metabolites thus have a high 
biotechnological relevance (Bernhardt, 2006).  Hussain and Ward (2003 b) state 
that the fused recombinant system has the potential to prepare drug metabolites 
in quantity to assess their toxicological effects.  Alternative methods using media 
additions have been found to improve enzymatic expression of a range of P450 
systems which could potentially further improve the method described by 
Hussain and Ward (2003 b).  
 
Using P450 soyC Taylor et al. (1999) reported that components termed as P450 
activators including $-benzoflavone and $-benzoflavone could stimulate activity.  
It was found that these P450 activators could bind near to the active site and 
influence the bioconversion of particular substrates.  $-benzoflavone was also 
found a few years earlier to also activate P450 3A4 from human liver (Ueng et 
al., 1997).  It is well documented that haem precursors such as ALA, and the iron 
containing media supplements hemin and FeCl3 improve P450 yields.  ALA is 
most predominately used in many studies where there are reports of two fold 
(Imai et al., 1993), four fold (Taylor et al., 1999, Richardson et al., 1995) and 
even 20 fold (Jansson et al., 2000) increases in expression levels of various 
P450s.  Gillam et al. (1995) actually report it being essential for heamoprotein 
production.  This haem precursor is also typically used in combination with 
FeCl3 where a 32 % increase in active P450 was reported when ALA and FeCl3 
were used in combination (Hussain and Ward, 2003 b).  Jansson et al. (2000) 
also reported an increase in the active P450 yield on addition of both ALA and 
FeCl3.  Zhang et al. (2010) found that the expression of P450SMO was increased 
by 10 % when media was supplemented with FeCl3.  It is possible that FeCl3 
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increases the yield of active P450 by providing a source of iron for correct haem 
formation, as iron levels regulate ALA synthase which is an important enzyme in 
haem synthesis.  It has also been suggested that it compensates for the lack of 
iron in E. coli (Kubota et al., 2005).  In the case of hemin, which is the oxidised 
form of haem, this cofactor can trigger other enzymes in the haem biosynthetic 
pathway as well as increase haem enzyme activity (Lu et al., 2010).  Reports 
using a Baculovirus expression system for human cytochrome P450 have 
indicated the advantage of using hemin where a 10-fold increase in P450 content 
was observed when hemin was added to the culture.  In the same study the time 
of addition was also found to affect expression (Chen et al., 1996).  Controversial 
information has been published regarding the inclusion of trace elements and 
thiamine during culture and have been noted to enhance P450 expression 
(Shimada et al., 1998; Gillam et al., 1995; Fischer et al., 1992), although other 
sources do state they are not essential for expression (Phillips and Shephard, 
2006; Jansson et al., 2000).  Finally, P450 gene expression has been found to be 
enhanced by glycerol and sugar supplementation (Kagawa and Cao, 2001).  In 
the case of a microsomal P450, arabinose was found to enhance expression by 
inducing an osmotic stress response and was reported to play a crucial part in 
formation of functional proteins (Kagawa and Cao, 2001).  The availability of a 
high-throughput approach would be beneficial to rapidly test a number of these 
media supplements and could be used to optimise P450 expression and 
bioconversion performance. 
 
1.2.3.1.2.3 Application of High-throughput Approaches  
 
Due to the associated complexities of the P450 electron transport systems so far 
it has been difficult to select target P450 enzymes from large variant libraries and 
effectively carry out preparative scale biotransformation (Speight et al., 2004).  
Therefore, work has been carried out in an attempt to speed up this process by 
developing rapid P450 identification methods.  Speight et al. (2004) initially 
developed a method whereby fully randomized active site libraries were 
generated and biotransformation were carried out in 96-well plates to identify 
P450cam variants having the desired activity.  Celik et al. (2005 b) has proposed 
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an alternative approach based on the production of an indigo dye from P450cam 
mutants.  Celik et al. (2005 b) claimed this method increased the number of 
mutants that could be screened in parallel by conducting the screen directly from 
agar plates.  In order to increase the dealkylation activity of CYP116B3 a high-
throughput screening system was used to test 7800 variants (Liu et al., 2010).  
This system involved cultivation of variants in microwell plates followed by a 
fluorescence assay based on the production of 7-hydroxycoumarin.  
 
There is a current interest in gaining more information in a timely manner about 
novel P450 systems due to the catalytic activity they may possess.  High-
throughput approaches have been used to screen libraries of P450 enzymes for 
bioconversion activity.  However, as yet there has been little emphasis on whole 
bioprocess evaluation of a P450 expression system for eventual large-scale 
production.  In order for a biocatalytic process to be effectively utilised there 
needs to be a distinct process in place where cells are cultured, enzyme is 
expressed, bioconversion conducted and products extracted.  Each step needs to 
be tested to identify constraints and process interactions for the creation of an 
optimised process and by establishing high-throughput methods capable of this, 
can this goal be achieved.  Therefore it is of interest in the present study that an 
automated microwell process sequence for kinetic evaluation of whole cell P450 
biocatalysts is developed.  There is a particular emphasis on working towards 
being able to predicatively scale-up the microwell process so that information 
collected can inform large-scale process development.  This approach is required 
if an industrially relevant process is to be designed and optimised in a shortened 
timeframe. 
 
1.3 Conclusions of the Literature Survey 
 
It is evident from a detailed review of the literature that miniaturisation is a clear 
route able to meet the demands for lower costs and reduced biologic 
developmental timelines.  When a new biologic is identified, whether this is a 
compound of biopharmaceutical interest or a biocatalyst capable of metabolising 
a pivotal step in the production of antibiotics, the experimental burden can be 
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quite significant.  The biological nature inherently means an investigation of 
growth conditions, expression conditions, product stability, product half-life and 
purification methods is necessary to name a few.  It has been found that 
microscale technologies can be applied in all these areas.  In particular microtiter 
plates are a promising format that enable parallel investigation of multiple 
variables while requiring a reduced quantity of often scarce and expensive raw 
materials.  Plate formats have an unmatched high-throughput capacity not only 
because of the number of wells available as miniature bioreactors but because 
multiple plates can be stacked for storage and then used or analysed in sequence.  
Furthermore, the range of geometries available help cater for the needs of 
multiple organisms or application purposes.  While geometrical differences to 
conventional stirred systems do present variations in fluid hydrodynamics and 
mixing regimes this has not hindered the reproduction of data collected between 
both configurations indicating microtiter plates as a tool for predictive scale-up.  
Moreover, their standard size and shape means they can be readily incorporated 
with robotic platforms for automated processing.  Thus moving towards 
automation is crucial in terms of increasing consistency and productivity, 
whereby mundane repetitive tasks can be automated and manpower potentially 
delegated to developmental activities requiring problem solving and critical 
thinking. 
 
The area of oxidative bioconversion was highlighted due to the vast 
biotechnological potential including fine chemical synthesis, bioremediation, 
antibiotic and steroid synthesis, drug metabolism and flavour and detergent 
production.  While some industrial processes do utilise steps catalysed by 
oxidative enzymes, this has taken over a decade of developmental research to 
generate the necessary knowledge for effective implementation and this is due to 
two distinct reasons.  Firstly, this is due to biocatalyst properties such as 
instability, low catalytic rates and system complexity and, secondly, to the slow 
speed at which libraries are screened and operational conditions for production 
and bioconversion selected.  It is of interest to develop cleaner, cheaper and more 
specific environmentally compatible biocatalytic approaches for oxidative 
reactions.  This is considering the undesirable features of chemical routes 
including the requirement of toxic and unstable solvents/reagents which poses 
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safety issues making large-scale production undesirable, the lack of 
regioselectivity making access to particular products impossible, and the 
operation under extreme conditions.  In an effort to accelerate the 
implementation of sustainable oxidative biocatalytic processes, automated 
microscale technologies are highlighted for process development and 
investigation and will be the focuss of this thesis.   
 
1.4 The Present Contribution 
 
Presently, the majority of microscale based technologies have been used either as 
screening tools or to characterise individual unit operations.  There has been a 
limited focus on linking microscale unit operations to enable an investigation of 
process interactions and to be used as an effective small-scale model for 
bioprocess design and development.  The aim of this thesis is to apply such 
approaches to novel biocatalytic systems, which has not been previously 
reported, and could be used for systematic characterisation prior to committing 
time and resources to large-scale biological improvement strategies.  
 
The first objective of the thesis is the development of a fully automated generic 
microscale platform.  Specific aims of this platform would include a 
demonstration of robustness to enable process consistency, an increased 
throughput enabling multiple conditions to be evaluated in a single run and the 
ability to save time and effort compared to manual operations without 
compromising precision and accuracy of data collection.  Due to the vast 
biotechnological applications of oxidative biocatalysts and with a wider view for 
better exploitation of the catalytic versatility, the microscale platform was 
initially developed using the CHMO expressing recombinant strain E. coli 
TOP10 [pQR210].  Fernandes and Cabral (2006) have stated that ‘the core of 
most bioprocesses is a biotransformation or fermentation step and its 
characterisation and optimisation is a key issue for the design of an effective and 
competitive process’.  The second objective was to demonstrate the platform 
could be used for whole bioprocess optimisation to enable quicker identification 
of process constraints and limitations.  With a working generic platform in place 
the third objective was to demonstrate it could be applied to novel systems in 
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particular those which have yet to be investigated or probed for specific growth, 
expression and activity requirements.  The number of P450 catalysed reactions 
used in industrial synthesis is low, however, the availability of self-sufficient 
systems overcoming inherent limitations could be a way forward to increase the 
industrial uptake.  A number of novel self-sufficient systems have recently been 
reported, therefore it was considered important to show the methodology could 
be applied to the P450 systems developed by Hussain and Ward (2003 b).  This 
included E. coli [pQR367] expressing P450SU1 and E. coli [pQR368] expressing 
P450SU2 where the microscale approach was adapted to culture, express and 
conduct whole cell bioconversions using these novel systems.  It is important that 
optimisation objectives perform similarly in model and production systems 
(Freyer et al., 2004) if they are to effectively inform developmental activities at a 
reduced cost and within a shortened timeframe.  Thus the fourth and final 
objective was to investigate the potential for automated microscale approaches to 
be predictive of laboratory and pilot scale operations.    
 
1.5 Outline of the Thesis 
 
The thesis will examine the hypothesis that high-throughput automated 
microscale approaches can be used for the development and investigation of 
novel oxidative biocatalytic processes. 
 
Chapter 1 presented the overall context of the research with an introduction to 
the thesis hypothesis.  It details a literature survey reviewing the current 
advancements in the areas of microscale technologies, automation and 
bioconversion and highlights those requiring further investigation.  This chapter 
concludes with the major findings of the literature survey and the present 
contribution of this thesis to the field of research. 
 
Chapter 2 documents the materials and methods used to conduct all experimental 
procedures used in the generation of thesis results discussed in Chapters 3 to 6. 
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Chapter 3 describes the methodology used in the design and development of a 
fully automated generic microscale platform for the investigation of whole cell 
oxidation biocatalytic processes.  E. coli TOP10 [pQR210] expressing CHMO is 
used as an exemplary system to test the platform. 
 
Chapter 4 describes how the generic microscale platform developed in Chapter 3 
was used for the whole bioprocess evaluation of the oxidative biocatalyst CHMO 
expressed from the recombinant system E. coli TOP10 [pQR210]. 
 
Chapter 5 describes the application of the generic microscale platform for the 
investigation of two novel cytochrome P450 expression systems E. coli 
[pQR367] expressing P450SU1 and E. coli [pQR368] expressing P450SU2.  In 
particular the microscale platform is used to improve the biocatalytic 
performance by assessing the impact of media supplementation on the O-
dealkylation of 7-ethoxycoumarin to 7-hydroxycoumarin. 
 
Chapter 6 describes the methodology used to examine the potential for predictive 
scale-up of automated microscale approaches.  A optimised process sequence 
identified from whole bioprocess evaluation of E. coli TOP10 [pQR210] 
expressing CHMO is scaled up to 75 L pilot plant scale, and a improved system 
for 7-ethoxycoumarin bioconversion using E. coli [pQR367] expressing 
P450SU1 and E. coli [pQR368] expressing P450SU2 is scaled up to 7.5 L 
laboratory scale. 
 
Chapter 7 presents the overall thesis conclusions and suggestions for future 
work. 
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2 Materials and Methods 
 
2.1 Materials 
 
2.1.1 Chemicals  
 
Yeast extract, tryptone (LP0042), bacteriological peptone (LP0037) and 
bacteriological agar were obtained from Oxoid limited (Basingstoke, UK).  
Sodium chloride, ampicillin sodium salt, bicyclo[3.2.0]hept-2-en-6-one (98 %), 
(-)-(1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one (99 %), sodium phosphate 
monobasic and dibasic, potassium phosphate monobasic and dibasic, (1R)-(+)-
camphor (98 %), (1R)-(-)-fenchone (98 %), (3R,6RS)-(+)-dihydrocarvone (98 
%), norcamphor (98 %), cyclohexanone (99.5 %), cycloheptanone (99 %), 
cyclooctanone (98 %), &-caprolactone (99 %) dimethyl sulfoxide (DMSO), 
broadbean peptone (50209041), tryptone pancreatic digest from casein 
(LP0042R), 5-aminolevulinic acid hydrochloride (ALA), D-ribose, D-glucose, 
D-fructose, maltose, Bradford reagent, dithiothreitol (DTT) %-naphthoflavone, 
ethylenediaminetetraacetic acid (EDTA), trace elements, thiamine, 
polypropylene glycol 2000 (PPG), Laemmli 2X concentrate sample buffer, 
isopropylthiogalactoside (IPTG) and bovine serum albumin (BSA) were obtained 
from Sigma-Aldrich Company Ltd (Poole, UK).  Glycerol, ethyl acetate, hemin 
and naphthalene were obtained from Alfa Aesar (Lancashire, UK).  Soyabean 
peptone (70178), peptone from casein pancreatic digest (21509031), peptone 
from casein tryptic digest (70172) and tryptone enzymatic digest from casein 
(95039) were obtained from Fluka (Poole, UK).  Peptone (P/1160/48), Iron (III) 
chloride hexahydrate (FeCl3), phenylmethylsulfonyl fluoride (PMSF), 7-
hydroxycoumarin (99 %) and TRIS base were obtained from Fischer Scientific 
(Loughborough, UK).  BD Bacto-yeast extract and BD Bactotryptone were 
obtained from Becton Dickinson  (New Jersey, USA).  $-naphthoflavone, 
acentonitrile, methanol, hexane, 7-ethoxycoumarin (99 %) and TRIS HCL were 
obtained from VWR International (Leicestershire, UK).  Sodium dithionite 
(sodium hydrosulphite) was obtained from SLS LTD (Nottingham, UK).  
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Tricine, chloramphenicol and NADPH tetrasodium salt were obtained from 
Merck Chemicals LTD (Nottingham, UK). 
 
2.1.2 Microorganisms 
 
E. coli TOP10 was originally obtained from Invitrogen (Groningen, The 
Netherlands) and Acinetobacter calcoaceticus NCIMB 9871 from NCIMB 
(Aberdeen, Scotland, UK).  The CHMO gene was cloned into E. coli TOP10 
from Acinetobacter calcoaceticus NCIMB 9871 using the vector, pKK223-3, as 
reported by Doig et al. (2001) to produce E. coli TOP10 [pQR210].  
 
E. coli BL21 Star (DE3)pLysS was originally obtained from Invitrogen 
(Groningen, The Netherlands).  Construction of expression vectors harboring the 
genes for P450SU1 its adjacent ferredoxin Fd1 from Streptomyces griseolus and 
ferredoxin NADP reductase SCF15A gene from Streptomyces coelicolor as well 
as the transformation into E. coli BL21 Star (DE3)pLysS to create E. coli BL21 
Star (DE3)pLysS [pQR367] has been described previously by Hussain and Ward 
(2003 b).  Construction of expression vectors harboring the genes for P450SU2 
its adjacent ferredoxin Fd2 from Streptomyces griseolus and ferredoxin NADP 
reductase SCF15A gene from Streptomyces coelicolor as well as the 
transformation into E. coli BL21 Star (DE3)pLysS to create E. coli BL21 Star 
(DE3)pLysS [pQR368] has been described previously by Hussain and Ward 
(2003 b). 
 
2.2 General Methods 
 
2.2.1 E. coli TOP10 [pQR210] 
 
2.2.1.1 Seed Stock Preparation 
 
The overnight culture was prepared by inoculating a single colony of E. coli 
TOP10 [pQR210] in LB-glycerol (10 gL-1 tryptone, 10 gL-1 sodium chloride, 10 
gL-1 yeast extract, 10 gL-1 glycerol and 50 mgL-1 ampicillin added after 
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sterilisation through a 0.2 micron sterile filter) medium pH 7 and grown for a 
total of 14 hours at 37 oC and 200 rpm in an orbital shaker (New Brunswick 
Scientific, Edison, USA).  Forty % v/v glycerol solution was added to an 
overnight culture (20 % v/v final glycerol concentration) and 1 mL aliquots were 
transferred aseptically to sterile eppendorf tubes and stored at -80 oC.  
 
2.2.1.2 Sequencing Analysis 
 
The seed stock prepared as described in section 2.2.1.1 was streaked on fresh 
LB-glycerol agar plates (10 gL-1 tryptone, 10 gL-1 sodium chloride, 10 gL-1 yeast 
extract, 10 gL-1 glycerol, 15 gL-1 agar and 50 mgL-1 ampicillin added after 
sterilisation through a 0.2 micron sterile filter).  Plates were left to grow for 14-
16 hours at 37 oC until single colonies were visualised.  Single colonies were 
then transferred to 10 mL fresh LB-glycerol media and grown for a further 12-16 
hours at 37 oC and 200 rpm in an orbital shaker.  Cells were centrifuged for 5 
minutes at 4000 rpm and the cell pellet processed to extract the plasmid DNA 
using a standard QIAprep Spin miniprep kit protocol.  Plasmid DNA samples at 
a concentration of 50 ng"L-1 along with primers at a concentration of 5 
pmoles"L-1 were sent for sequencing analysis at the Wolfson Institute for 
Biomedical Research and results showed the presence of the CHMO gene and 
sequence homology to the vector, pKK223-3.  This confirmed the plasmid vector 
to be pQR210 as described by Doig et al. (2001) and was used for all CHMO 
studies.  
 
2.2.1.3 Inoculum Preparation 
 
A 1 mL frozen stock of E. coli TOP10 [pQR210] was inoculated into LB-
glycerol growth media under sterile conditions.  Shake flasks were incubated for 
14-16 h overnight at 200 rpm and 37 oC in an orbital shaker until an optical 
density (OD) of 5-6 was reached.  The broth from these cultures was 
subsequently used to inoculate both microscale and pilot plant scale cultivations. 
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2.2.1.4 Shake Flask Cultivations and Bioconversions 
 
100 mL of LB-glycerol media was inoculated with 5 % inoculum in a 500 mL 
baffled shake flask at 200 rpm and 37 oC in an orbital shaker.  Samples were 
taken hourly and used to measure the OD.  Cells were left to grow for a total of 6 
hours after which glycerol was added to the culture to achieve a final 
concentration of 10 gL-1.  The culture was left to incubate with glycerol for 15 
minutes and then a stock of bicyclo[3.2.0]hept-2-en-6-one pre-dissolved in 50 
mM sodium phosphate buffer was added to the culture to a final concentration of 
1 gL-1.  The bioconversion was left for a total of 1 hour where samples were 
taken every 15 minutes for OD measurement and metabolite analysis by gas 
chromatography (GC).   
 
2.2.2 E. coli BL21 Star (DE3)pLysS [pQR367] and E. coli BL21 
Star (DE3)pLysS [pQR368] 
 
Note: E. coli BL21 Star (DE3)pLysS [pQR367] will be referred to as E. coli 
[pQR367] and E. coli BL21 Star (DE3)pLysS [pQR368] will be referred to as E. 
coli [pQR368] in the remainder of the thesis. 
 
2.2.2.1 Production of E. coli [pQR367] and E. coli [pQR368] 
 
Single colonies from agar plates containing E. coli TOP10 [pQR367] and E. coli 
TOP10 [pQR368] were cultured in LB medium pH 7 (10 gL-1 tryptone, 10 gL-1 
sodium chloride, 5 gL-1 yeast extract and 100 mgL-1 ampicillin added after 
sterilisation through a 0.2 micron sterile filter) and plasmid DNA extracted using 
a standard QIAprep Spin miniprep kit protocol.  Competent cells of E. coli BL21 
Star (DE3)pLysS were streaked onto LB agar plates with chloramphenicol (pre-
dissolved in ethanol) and left to grow at 37 oC until single colonies were visible.  
Single colonies were picked and cultured in shake flasks containing LB medium 
(10 gL-1 tryptone, 10 gL-1 sodium chloride, 5 gL-1 yeast extract and 10 mgL-1 
chloramphenicol (pre-dissolved in ethanol)) at 37 oC and 200 rpm in an orbital 
shaker for 14 hours.  40 % v/v glycerol solution was added to the culture (20 % 
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v/v final glycerol concentration) and stored in 1 mL aliquots at -80 oC.  A 1 mL 
aliquot of competent E. coli BL21 Star (DE3)pLysS cells and the plasmid DNA 
of the constructs [pQR367] and [pQR368] were used for transformation (kindly 
conducted by Professor John Ward).  Competent cells and constructs were put on 
ice, 5 µL of each plasmid DNA was added to separate aliquots of competent 
cells, mixed and left for 30 minutes on ice.  The cells were heat socked by 
placing them in a water bath at 37 oC for 30 seconds to enable the plasmid to be 
taken up by the competent cells and then placed back on ice.  The transformed 
cells were combined with SOC nutrient media.  The vials were left to incubate at 
37 oC and 200 rpm for an hour.  Both transformed cells were then spread on LB 
agar plates with ampicillin and chloramphenicol and left to incubate at 37 oC 
overnight until small colonies were visible.  Plates with successful transformants 
were stored at 4 oC in the fridge.   
 
2.2.2.2 Seed Stock Preparation 
 
The overnight culture was prepared by inoculating a single colony of E. coli 
[pQR367] or E. coli [pQR368] in LB (10 gL-1 tryptone, 10 gL-1 sodium chloride, 
5 gL-1 yeast extract, 10 mgL-1 chloramphenicol (pre-dissolved in ethanol) and 
100 mgL-1 ampicillin added after sterilisation through a 0.2 micron sterile filter) 
medium pH 7 and grown for a total of 14 hours at 37 oC and 200 rpm in an 
orbital shaker (New Brunswick Scientific, Edison, USA).  Forty % v/v glycerol 
solution was added to an overnight culture (20 % v/v final glycerol 
concentration) and 1 mL aliquots were transferred aseptically to sterile eppendorf 
tubes and stored at -80 oC.  
 
2.2.2.3 Sequencing Analysis 
 
The seed stock prepared as described in section 2.2.2.2 was streaked on fresh LB 
agar plates (10 gL-1 tryptone, 10 gL-1 sodium chloride, 5 gL-1 yeast extract, 15 
gL-1 agar, 10 mgL-1 chloramphenicol (pre-dissolved in ethanol) and 100 mgL-1 
ampicillin added after sterilisation through a 0.2 micron sterile filter).  Plates 
were left to grow for 14-16 hours at 37 oC until single colonies were visualised.  
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Single colonies were then transferred to 10 mL fresh LB media and grown for a 
further 12-16 hours at 37 oC and 200 rpm in an orbital shaker.  Cells were 
centrifuged for 5 minutes at 4000 rpm and the cell pellet processed to extract the 
plasmid DNA using a standard QIAprep Spin miniprep kit protocol.  Plasmid 
DNA samples at a concentration of 50 ng"L-1 along with primers at a 
concentration of 5 pmoles"L-1 were sent for sequencing analysis at the Wolfson 
Institute for Biomedical Research.  Using the T7 terminator primer of pET21a 
5’-gctagttattgctcagcgg-3’ results showed the presence of the ferredoxin NADP 
reductase SCF15A gene from Streptomyces coelicolor in sequences obtained 
using [pQR367] and [pQR368] samples.  Using the T7 universal primer of 
pET21a 5’-taatacgactcactataggg-3’ results showed the presence of the genes for 
P450SU1 and P450SU2 from Streptomyces griseolus in sequences obtained 
using [pQR367] and [pQR368] respectively.  Seed stock samples therefore 
contained plasmid DNA with the presence of P450, ferredoxin and ferredoxin 
reductase genes and were used for all subsequent cytochrome P450 studies. 
 
2.2.2.4 Inoculum Preparation 
 
A 1 mL frozen stock of E. coli [pQR367] and E. coli [pQR368] were inoculated 
into LB growth media with chloramphenicol and ampicillin under sterile 
conditions.  Shake flasks were incubated for 14 hours overnight at 200 rpm and 
37 oC in an orbital shaker until an OD of 4-5 was reached.  The broth from these 
cultures was subsequently used to inoculate both microscale and laboratory scale 
cultivations. 
 
2.2.2.5 Shake Flask Cultivations and Bioconversions 
 
100 mL Terrific broth (TB) (12 gL-1 tryptone, 24 gL-1 yeast extract, 4 mLL-1 
glycerol, 2.3 gL-1 potassium phosphate monobasic, 12.5 gL-1 potassium 
phosphate dibasic, 10 mgL-1 chloramphenicol (pre-dissolved in ethanol) and 100 
mgL-1 ampicillin, salts and ampicillin were added after autoclaving and filter 
sterilised using 0.2 micron sterile filters) pH 7 was inoculated with 1 % inoculum 
in 500 mL shake flasks and incubated at 37 oC and 250 rpm in an orbital shaker 
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until the cells reached a OD of 0.6-0.8.  The temperature was dropped to 25 oC 
and the agitation to 180 rpm to achieve optimum expression conditions.  Once 
the incubator had reached the correct temperature 1 mM ALA and 0.5 mM FeCl3 
was added to the culture to enhance cytochrome P450 expression and incubated 
at 25 oC and 180 rpm for 20 minutes.  Following this the culture was induced 
using 1 mM IPTG and after 10 minutes of induction 1 mM 7-ethoxycoumarin 
(pre-dissolved in ethanol) added to begin bioconversion.  The culture was left for 
a total of 30 hours where samples were taken regularly to monitor the OD of 
cells and the bioconversion progression. 
 
2.3 Microscale Process Sequences 
 
2.3.1 E. coli TOP10 [pQR210] 
 
2.3.1.1 Manual Operations  
 
2.3.1.1.1 Microwell Based Temperature Study 
 
Wells in five areas of a 96-DSW plate (96-DSW, Becton Dickenson, Franklin 
Lakes, NJ, USA) were filled with 1 mL LB-glycerol medium and left to agitate 
at 1000 rpm and 37 oC on an Eppendorf Thermomixer Comfort (Eppendorf AG, 
Hamburg, Germany) with a orbital shaking pattern and throw of 3 mm.  Using a 
thermocouple the temperature of each well was measured every 10 minutes for 
the first hour and then every hour for a total of 7 hours.  Results of this study are 
shown in Figure 3.6 and indicated a 30-minute warming period was required to 
ensure the medium in the wells was being incubated at the correct temperature.  
A similar study was conducted to determine the time required to cool the 
medium down to 30 oC after a period of incubation at 37 oC. 
 
2.3.1.2 Automated Microscale Linked Process Sequence 
 
A Tecan Genesis platform was used for process automation and setup with all 
required polypropylene 96-DSW culture plates, 96-Standard round well plates 
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(96-SRW, Sarstedt group, Leicester, UK), reagent troughs (Tecan, Reading, UK) 
and disposable microconductive tips (Tecan, Reading, UK).  A sterile 
environment was maintained by using UV sterilisation within a Bigneat class 2 
biosafety cabinet equipped with a laminar airflow system and HEPA filtration.  
The UV sterilisation step was found to be appropriate as LB-glycerol agar plates 
left open for a seven-hour period after a 20-minute sterilisation process showed 
no signs of contamination.  A schematic representation of the process is shown in 
Figure 3.11.  The process begins by addition of 950 "L LB-glycerol media to 
wells of a 96-DSW plate agitated by an Eppendorf Thermomixer Comfort.  The 
plate was left uncovered during the process due to the expected high oxygen 
demand, and the contained environment was thought to eliminate the risk of 
contamination.  Less than 2 % of the fill volume has previously been found to 
evaporate over the entirety of the process and this is not considered to have a 
significant effect (Ferreira, 2008).  The plate was agitated at 37 oC and 1000 rpm 
for 30 minutes to warm the media.  Fifty "L of overnight prepared culture was 
then added to wells and shaken at 37 oC and 1000 rpm for 6 hours.  Automatic 
sampling was done hourly using the sacrificial well approach (Doig et al. 2002) 
and the OD measured using a Tecan microplate reader.  After 6 hours of growth 
aliquots were transferred to new wells or a new plate depending on the number 
of samples required and glycerol added to allow the regeneration of NADPH 
cofactor.  The plate was also cooled to 30 oC at this stage, which reduces 
evaporation of the ketone substrate during bioconversion (Ferreira, 2008).  The 
cells were incubated with glycerol for 15 minutes at 1000 rpm and 30 oC after 
which the ketone substrate (pre-dissolved in 50 mM sodium phosphate buffer) 
was added and bioconversion followed for a total of 1 hour where OD readings 
were taken and 200 "L aliquots transferred to a new 96-DSW plate and frozen to 
stop the reaction.  Following the 1 hour bioconversion the plate containing the 
frozen samples was removed from the freezer and placed back on the deck of the 
robotic platform and left to defrost.  400 "L of ethyl acetate was automatically 
added to all samples in the plate, the plate was sealed using a chemical resistant 
silicone sealing mat (Axygen, California, USA) and automatically transferred to 
the Eppendorf Thermomixer Comfort where it was shaken at 1200 rpm for 3 
minutes.  The plate was then automatically transferred to a Rotanta 46 RSC 
microwell centrifuge (Hettich, Tuttlingen, Germany) and centrifuged for 15 
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minutes at 4000 rpm and 4 oC which was sufficient to separate organic and 
aqueous phases.  The plate was automatically removed from the centrifuge and 
transferred to the platform and the top organic layer from each sample dispensed 
into GC vials for sample analysis. 
 
2.3.1.3 Bioprocess Evaluation using Automated Sequence 
 
The process sequence was adapted accordingly to evaluate different substrates 
and substrate concentrations, growth regimes, well fill volumes and media 
formulations.  The media formulations examined were identical to LB-glycerol 
media, as described in section 2.2.1.1, except for tryptone which was replaced by 
each of the amino acid sources listed in Table 4.2.  The effect of fill volume on 
growth kinetics was investigated by using a range of liquid volumes from 400 "L 
to 1000 "L at a constant agitation and shaking diameter, after 6 hours of growth 
aliquots of culture were transferred to a new plate to achieve a constant fill 
volume of 500 "L for bioconversion.  Volumes lower than 400 "L could have 
resulted in inaccuracies due to an excess of evaporation.  The effect of fill 
volume on bioconversion kinetics was investigated by growing cells at a constant 
fill volume of 1000 "L and then after 6 hours of growth aliquots of culture were 
transferred to a new plate to achieve fill volumes from 200 "L up to 1000 "L for 
bioconversion. 
 
2.3.2 E. coli [pQR367] and E. coli [pQR368] 
 
2.3.2.1 Manual Operations  
 
2.3.2.1.1 Microwell Based Temperature Study 
 
The temperature study was similar to that described in section 2.3.1.1.1 the only 
difference being that wells were filled with TB medium and the temperature of 
incubation tested was 25 oC. 
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2.3.2.1.2 Microwell Based Evaporation study 
 
Wells of a 96-DSW plate were filled with 1 mL sterile TB medium.  The plate 
was left to agitate at 25 oC and 800 rpm for a period of 1 hour, 10 hours and 24 
hours.  After each time period the well contents from each well area was 
removed and weighed and the liquid loss calculated.  The results of this study are 
discussed in section 5.2.2.4. 
 
2.3.2.2 Automated Microscale Linked Process Sequence 
 
A Tecan Genesis platform was used for process automation and setup with all 
required polypropylene 96-DSW culture plates, 96-SRW plates, reagent troughs 
and disposable microconductive tips.  A schematic representation of the process 
is shown in Figure 5.15.  The process begins by addition of 990 "L TB media to 
wells of a 96-DSW plate agitated by an Eppendorf Thermomixer Comfort.  The 
plate was left uncovered during the process due to the high oxygen demand, and 
the contained environment eliminates the risk of contamination.  The plate was 
agitated at 37 oC and 1000 rpm for 30 minutes to warm the media.  Ten "L of 
overnight prepared culture was then added to wells and shaken at 37 oC and 1000 
rpm until the cell OD reached 0.6-0.8.  Automatic sampling was conducted using 
the sacrificial well approach (Doig et al. 2002) and the OD measured using a 
Tecan microplate reader.  The plate was cooled to 25 oC and the agitation 
changed to 800 rpm which were the conditions used for enzyme expression.  
Components found to enhance expression/bioconversion were added at this stage 
including 1 mM ALA and 0.5 mM FeCl3.  The cells were incubated for 20 
minutes with the components at 800 rpm and 25 oC after which enzyme 
expression was induced with 1 mM IPTG.  Following a 10-minute induction 
period, 1 mM 7-ethoxycoumarin (pre-dissolved in ethanol) was added to begin 
bioconversion.  The culture was left to continue for a total of 30 hours where OD 
readings were taken every 5 hours and 200 "L bioconversion samples taken 
every hour during the last 5 hours of culture and transferred to a new 96-DSW 
plate and frozen to stop the reaction.  After a total of 30 hours of culture, final 
samples were taken including a 1 mL aliquot which was dispensed into 
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eppendorfs, centrifuged and the supernatant discarded and frozen in pellets for 
later analysis using a carbon monoxide (CO) based assay.  The plate containing 
the frozen samples was removed from the freezer and placed back on the deck of 
the robotic platform and left to defrost.  400 "L of ethyl acetate was 
automatically added to all samples in the plate, the plate was sealed using a 
chemical resistant silicone sealing mat and automatically transferred to the 
Eppendorf Thermomixer Comfort where it was shaken at 1200 rpm for 3 
minutes.  The plate was then automatically transferred to a Rotanta 46 RSC 
microwell centrifuge and centrifuged for 15 minutes at 4000 rpm and 4 oC which 
was sufficient to separate organic and aqueous phases.  The plate was 
automatically removed from the centrifuge and transferred to the platform, then 
the top organic layer from each sample was dispensed into eppendorfs.  These 
eppendorfs were then transferred to a fume cupboard and left overnight for the 
ethyl acetate to evaporate for at least 12 hours.  The next day 200 µL of 
acentonitrile was added to re-dissolve the bioconversion metabolites and these 
samples analysed by high pressure liquid chromatography (HPLC). 
 
2.3.2.3 Automated Screening Approach 
 
The automated screening approach is similar to that described in section 2.3.2.2.  
Due to the fact that the whole plate was being utilised to test a range of 
components once cells has been induced and the bioconversion substrate added 
no OD readings were taken.  Samples were only taken after 30 hours of growth 
to test the OD, and bioconversion samples transferred to a new 96-DSW plate 
which was processed using the automated liquid-liquid extraction as described in 
section 2.3.2.2.  
 
During the screening studies stocks of %-naphthoflavone and $-naphthoflavone 
were prepared dissolved in DMSO.  Stocks of Hemin were prepared in 50 mM 
sodium hydroxide.  Trace elements were prepared by dissolving 2.7 g 
FeCl36H2O, 0.2 g ZnCl2, 0.2 g CoCl26H2O, 0.2 g Na2MoO42H2O, 0.1 g 
CaCl22H2O, 0.13 g CuCl22H2O and 0.05 g H3BO3 in 100 mL RO water with 10 
% hydrochloric acid. 
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2.4 Parallel Process Sequences at Matched KLa 
 
2.4.1 E. coli TOP10 [pQR210] 
 
2.4.1.1 75 L Operation 
 
For the pilot plant process a 75 L (LH Fermentation, Reading, UK) 0.33 m 
internal diameter bioreactor was used, stirred by three six-bladed Rushton turbine 
impellers attached to a bottom-driven impeller shaft.  The aspect ratio (vessel 
height/ vessel diameter) HV/DV was 2.8 and the impeller diameter to vessel 
diameter ratio Di/DV was 0.3.  The bioreactor was filled with LB-glycerol 
medium (final working volume 45 L) and 0.2 mLL-1 of the antifoam 
polypropylene glycol (PPG) and sterilised in-situ at a temperature of 121 oC for 
20 minutes.  The vessel was inoculated with 5 % of the working volume with 
overnight prepared inoculum and the conditions of the fermenter were set to 37 
oC, 384 rpm, pH 7 and 1 vvm.  The selected operating conditions correspond to a 
Reynolds (Re) number in the turbulent region of 77,440.  pH was monitored but 
not controlled to ensure a realistic comparison to the microwell process to be 
made.  Due to differences in inoculum preparation, media sterilisation and use of 
antifoam agents a sample was taken and used to inoculate a parallel manual 
microwell process, as described in section 2.4.1.2 to ensure both processes would 
begin under identical conditions.  Cells were cultured for 6 hours.  Glycerol was 
then added to a final concentration of 10 gL-1.  The cells were incubated with 
glycerol for 15 minutes after which the ketone substrate was added to a final 
concentration of 0.5 gL-1.  Bioconversion took place for a total of 1 h where 
samples were taken for OD readings and 300 "L aliquots frozen for offline 
analysis. 
 
2.4.1.2 Microwell Linked Process Sequence 
 
This process was conducted manually and in parallel to the 75 L process.  The 
operation was similar to that described in section 2.3.1.2 except that a constant 
fill volume of 500 "L was used for the duration of the process and the inoculum 
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was obtained from the 75 L bioreactor.  In order for the processes to be matched 
the bioconversion stage was carried out at 37 oC and at a substrate concentration 
of 0.5 gL-1.   
 
2.4.2 E. coli [pQR367] and E. coli [pQR368] 
 
2.4.2.1 7.5 L Operation 
 
For the laboratory scale process a 7.5 L (New Brunswick Scientific Co, New 
Jersey, USA) 0.18 m internal diameter bioreactor was used, stirred by two six-
bladed Rushton turbine impellers connected to a top-driven impeller shaft.  The 
aspect ratio HV/DV was 1.6 and the Di/DV was 0.3.  The bioreactor was filled 
with TB medium minus the salts (final working volume 5 L) and 0.2 mLL-1 PPG.  
The pH probes were calibrated using standard buffers at pH 4 and 7.  The 
dissolved oxygen tension (DOT) probe was calibrated at 0 % in nitrogen and 100 
% using gaseous air.  The probes were placed in the holders within the vessel and 
the whole vessel sterilized by autoclaving.  Once sterilisation was complete and 
the vessel had cooled the potassium phosphate salts and 100 mgL-1 ampicillin 
which had been filter sterilized through a 0.2 micron filter were added to the 
vessel aseptically.  An aliquot of 10 mgL-1 chloramphenicol (pre-dissolved in 
ethanol) was also added.  Both probes were finally checked and re-calibrated as 
appropriate if required.  The vessel was inoculated with 1 % of the working 
volume with overnight prepared inoculum (E. coli [pQR367] or E. coli 
[pQR368]) and the conditions of the fermenter were set to 37 oC, 763 rpm, pH 7 
and 1 vvm.  The selected operating conditions correspond to a Re number in the 
turbulent region of 44,278.  pH was monitored but not controlled to ensure a 
realistic comparison with the microwell process.  Due to differences in inoculum 
preparation and use of antifoam agents a sample was taken and used to inoculate 
a parallel manual microwell process, as described in section 2.4.2.2 to ensure 
both processes would begin under identical conditions.  Cells were cultured until 
they reached an OD of 0.6-0.8.  The temperature was dropped to 25 oC and the 
agitation changed to 571 rpm which were the conditions used for enzyme 
expression.  Components found to enhance expression/bioconversion were added 
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at this stage including 5 mM ALA and 20 gL-1 glycerol.  The cells were 
incubated for 20 minutes with the components at 571 rpm and 25 oC after which 
enzyme expression was induced with 1 mM IPTG.  Following a 10-minute 
induction period 1 mM 7-ethoxycoumarin (pre-dissolved in ethanol) was added 
to begin bioconversion.  The culture was left to continue for a total of 30 hours 
where samples were taken for OD readings and 300 "L aliquots frozen for 
offline analysis. 
 
2.4.2.2 Microwell Linked Process Sequence 
 
This process was conducted manually and in parallel to the 7.5 L process.  The 
operation was similar to that described in section 2.3.2.2 except the inoculum 
was obtained from the 7.5 L bioreactor.  
 
2.5 Substrate Solubility Studies 
 
(1R)-(-)-Fenchone, (1R)-(+)-Camphor and (+)-(3R,6RS)-Dihydrocarvone were all 
added pre-dissolved in DMSO rather than 50 mM sodium phosphate buffer 
because they were all poorly water soluble.  A number of other solvents were 
tested including ethanol, methanol, isopropyl alcohol (IPA) and dimethyl 
formamide (DMF) where different concentrations of solvent and buffer were 
made in an attempt to reduce the amount of cosolvent used.  However, in all 
cases 100 % solvent was required to get full solubilisation of the poorly water 
soluble substrates and DMSO was chosen as it was considered to have the least 
damaging effect on the cells and substrates.  7-ethoxycoumarin was also found to 
be poorly water soluble and pre-dissolved in ethanol. 
 
2.6 Analytical Techniques 
 
2.6.1 Optical Density Measurement 
 
The OD of cell samples was measured using an Ultraspec 1100 Pro UV/Visible 
spectrophotometer (Amersham Biosciences, Buckinghamshire, UK) at 600 nm 
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during laboratory and pilot plant scale operations or a Tecan microplate reader 
(Tecan, Reading, UK) at 600 nm during microscale operations.  To enable results 
from a spectrophotometer to be directly compared to those obtained from a 
microplate reader the pathlength of a 200 "L well volume in a 96-SRW 
microplate was calculated and used to obtain a conversion factor of 1.8.  This 
factor was used to convert all microplate readings to standard spectrophotometer 
readings.  Reverse osmosis (RO) water was used as a blank and for sample 
dilution. 
 
2.6.2 Dry Cell Weight Measurement 
 
Cells from a 1 L shake flask culture (working volume 200 mL) were used to 
determine the dry cell weight of E. coli TOP10 [pQR210], E. coli [pQR367] and 
E. coli [pQR368] cells.  Cells of different OD were filtered on pre-weighed glass 
microfiber filter discs grade GF/F with a pore size of 0.7 micron using a vacuum 
pump.  The filter discs were left to dry overnight in an oven at 80 oC and then 
weighed again the next day where the dry cell weight was determined.  The 
results were used to produce dry cell weight calibration curves of OD versus 
biomass concentration as shown in appendix A.  The maximum error of duplicate 
OD readings was ± 4 %. 
 
2.6.3 Automated Robotics 
 
Two robotic arms are utilised by the Tecan automated system.  The first is a 
liquid handling arm (LiHa) with 8 pipetting heads and the ability to do single and 
multipipetting with a maximum pipetting speed of 900 uLs-1.  It can be setup 
with disposable microconductive tips or stainless steel fixed tips and moves on 
the x, y and z planes.  The Tecan Gemini software has a number of pre-set liquid 
classes which are liquid handling parameters specifying speeds, airgaps and 
detection modes for a range of liquids.  Depending on the liquid properties 
specific liquid classes can be developed however the standard water class with 
aspiration and dispense speed of 150 uLs-1 and 600 uLs-1, respectively, were used 
for the majority of liquids unless otherwise stated.  The second is a robotic 
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manipulator arm (RoMa), which can be fitted with a range of grips depending on 
the plates to be processed.  This has planar movements on the x, y and z planes 
with a maximum movement speed of 400 mms-1, and rotational movements on 
the x plane with a rotator speed of 60 o s-1.  
 
The accuracy and precision of pipetting was tested using a method which has 
been described previously (Nealon et al., 2005) with two disposable 
microconductive tips P1000 which can dispense up to 990 µL volumes and P200 
which can dispense up to 190 µL volumes.  The accuracy and precision of all tips 
was confirmed for all working volumes and the coefficient of variance was found 
to be 5 % or below and therefore the liquid handling precision and accuracy was 
considered acceptable (Olsen, 2000). 
 
2.6.4 Gas Chromatography (GC) 
 
2.6.4.1 Sample Preparation for GC 
 
Aqueous samples from the bioconversion were prepared by mixing equal 
volumes of sample and a 1 gL-1 naphthalene and ethyl acetate solution.  
Naphthalene was used as an internal standard.  The sample was vortex mixed for 
30 seconds and centrifuged at 13000 rpm for 2 minutes.  100 µL of the top 
solvent layer was transferred to vials and analysed using GC as described in 
section 2.6.4.2.  The flame ionization detector (FID) response to samples was 
measured as an integrated peak area.  Bicyclo[3.2.0]hept-2-en-6-one, (1R)-(+)-
camphor, norcamphor, cyclohexanone, cycloheptanone, cyclooctanone and (1R)-
(-)-fenchone were used for ketone standards and (1S,5R)-2-oxabicyclo[3.3.0]oct-
6-en-3-one and #-caprolactone was used for the lactone standards.  (+)-(3R,6SR)-
Dihydrocarvone is comprised of two isomers however the combination of both 
isomers was used for the calibration standard.  Lactone products produced from 
norcamphor and cycloheptanone were not commercially available.  Shake flask 
cultures using these substrates were run to completion and the products 2-
oxabicyclo[3.2.1]octan-3-one and oxocan-2-one were extracted into ethyl acetate 
and used to create calibration curves after characterisation by nuclear magnetic 
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resonance spectroscopy, mass spectrometry and infra red spectroscopy.   
 
2.6.4.2 GC Operation and Quantification 
 
A Perkin-Elmer autosystem XL-2 gas chromatograph (Perkin-Elmer, 
Connecticut, USA), fitted with an Heliflex AT-1701 column 30 m x 0.54 mm 
(Alltech Associates Applied Science Ltd, UK) was used to analyse the 
bioconversion substrate and product samples.  One µL samples were injected at a 
temperature of 200 oC by an integrated autosampler and a FID was used to detect 
compounds leaving the column.  The oven temperature and detection 
temperature were set at 100 oC and 280 oC, respectively.  The temperature 
programme used involved a hold for 5 minutes at 100 oC and was then increased 
at 10 oC min-1 to 240 oC.  Both data capture and analysis were conducted using 
the Perkin-Elmer Nelson TurbochromTM software.   
 
For stock solutions the standard deviation for a single peak area measurement 
was determined from triplicate measurements of five sample solutions 
(concentration range 0.2-1 gL-1) in ethyl acetate.  The maximum standard 
deviation of triplicate stock preparations varied between 1.8 % and 10.6 %.  
Sample calibration curves and chromatograms can be found in the appendix A 
and B, respectively.  The ethyl acetate partition coefficients of 
bicyclo[3.2.0]hept-2-en-6-one and (1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one 
have been determined previously as described by Lander (2003) to be tending to 
infinity and 8.17 ± 0.08 respectively, and have been accounted for in all 
calculations.  In the case of all other ketone substrates tested and #-caprolactone 
in this work, the ethyl acetate partition coefficient was found to also be infinity 
while the partition coefficient for lactone products was not determined due to 
limited yields.   
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2.6.5 High Pressure Liquid Chromatography (HPLC) 
 
2.6.5.1 Sample Preparation for HPLC 
 
Aqueous samples from bioconversions were prepared by mixing a 500 "L 
sample with 1 mL ethyl acetate solution.  The sample was vortex mixed for 30 
seconds and centrifuged at 14000 rpm for 2 minutes.  500 µL of the top solvent 
layer was transferred to eppendorfs and left to evaporate overnight for at least 12 
hours.  500 µL of acetonitrile was then added to the eppendorfs and vortex mixed 
for 10 seconds to re-dissolve the metabolite pellets.  Samples were then 
centrifuged for 2 minutes at 14000 rpm and analysed using HPLC as described in 
section 2.6.5.2.  The UV-Vis detector response to samples was measured as an 
integrated peak area.  7-ethoxycoumarin was used for substrate standards and 7-
hydroxycoumarin was used for product standards. 
 
2.6.5.2 HPLC Operation and Quantification 
 
A Agilent 1200 series HPLC (Agilent, West Lothian, UK), fitted with an Packard 
Bell nucleosil 100-5 C18 reverse phase column 4.0 x 125 mm (Agilent, West 
Lothian, UK) was used to analyse the bioconversion substrate and product 
samples.  The mobile phases used were A: water with 0.1 % acetic acid (pH 3.3) 
and B: methanol with 0.1 % acetic acid.  The column was equilibrated for 20-30 
minutes with 2 % mobile phase B and 98 % mobile phase A prior to sample 
analysis.  The column was maintained at a temperature of 40 oC and 5 µL 
samples were injected onto the column at a flow rate of 1 mLmin-1.  A gradient 
programme was used as shown in Table 2.1 and metabolites were detected at a 
wavelength of 320 nm using a UV-Vis detector. 
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Table 2.1 HPLC gradient programme 
 
Time (min) % B % A Stage 
0 2 98 
5 50 50 
Gradient 
10 50 50 Isocratic Hold 
11 2 98 
16 2 98 
Re-equilibration 
 
For stock solutions the standard deviation for a single peak area measurement 
was determined from triplicate measurements of seven sample solutions 
(concentration range 0.0125-1 gL-1) in acetonitrile.  The maximum standard 
deviation of triplicate stock preparations was 0.8 %.  Sample calibration curves 
and chromatograms can be found in the appendix A and B, respectively. 
 
2.6.6 Thin Layer Chromatography (TLC) 
 
TLC was used for quick identification of 7-ethoxycoumarin and 7-
hydroxycoumarin which both fluoresce under UV light.  Cell samples were 
extracted with equal volumes of ethyl acetate for 60 seconds.  The sample was 
centrifuged for 1 min and 13000 rpm and the top organic layer transferred to 
another vial and left to evaporate overnight.  Samples were then concentrated to 
100 mM with the appropriate volume of ethyl acetate.  A solvent system of 
hexane and ethyl acetate in a 3:2 ratio was used and 10 mL of this added to a 50 
mL jar and left closed for a few minutes to saturate the air in the jar with the 
solvents.  Using a glass spotter 1-2 µL of each sample were spotted onto the 
bottom of a silica gel TLC (TLC plate silica gel 60, Merck) sheet.  The TLC 
sheet was then placed in the jar with the solvent just touching the bottom few 
millimeters of the sheet and the lid was placed gently on top.  The TLC sheet was 
left in the jar until the solvent had been draw up the TLC sheet and the substrate 
and products separated.  The TLC sheet was then removed carefully from the jar 
and the spots visualized under UV light in a wavelength of 300-320 nm.  
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2.6.7 Product Identification 
 
New products identified from GC analysis were isolated and purified using silica 
chromatography, then characterised by NMR spectroscopy and mass 
spectrometry and IR spectroscopy to be predominantly 2-oxabicyclo[3.2.1]octan-
3-one from the norcamphor bioconversion and oxocan-2-one (correlated by 
chemical synthesis) from cycloheptanone.  
 
2.6.7.1 Oxocan-2-one 
 
O
O
 
 
Cycloheptanone (1.00 g, 8.93 mmol) and m-chloroperbenzoic acid (0.168 g, 9.74 
mmol) in dichloromethane (10 mL) were stirred for 24 hours at room 
temperature.  The mixture was washed with saturated sodium carbonate solution 
(3 x 10 mL) and saturated sodium chloride solution (10 mL).  The organic layer 
was dried (Na2SO4) and concentrated in vacuo (Harikrishna et al., 2009).  The 
crude product was purified by flash silica chromatography (ethyl acetate:hexane, 
1:1) to give oxocan-2-one as a colourless oil (0.620 g, 54 %). nmax(neat)/cm–1 
2931, 1725; 1H NMR (600 MHz; CDCl3) d 1.58–1.66 (4H, m) 1.74–1.90 (4H, m) 
2.54 (2H, t, J 6.4, CH2CO) 4.34 (2H, t, J 5.7, CH2O); 13C NMR (150 MHz; 
CDCl3) d 24.0, 25.9, 28.4, 31.0, 31.4, 68.0 (CH2O), 176.9 (C=O); m/z (HRCI) 
found [MH]+ 129.09101. C7H13O2 requires 129.09155.  GC retention time: 10.4 
min. 
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2.6.7.2 2-Oxa-bicyclo[3.2.1]octan-3-one 
 
O
O  
 
After baffled shake flask cultures equivalent to that described in section 2.2.1.4 
with racemic norcamphor as a substrate, a whole cell solution (200 mL) was 
centrifuged and the supernatant was extracted with ethyl acetate (200 mL).  The 
organic layer was dried (Na2SO4) and concentrated in vacuo.  The crude product 
was purified by flash silica chromatography (ethyl acetate:hexane, 1:1) to give 
the major isomer 2-oxa-bicyclo[3.2.1]octan-3-one and minor isomer 3-
oxabicyclo[3.2.1]octan-2-one in a ratio of 15:1, as a colourless oil in 43 % 
isolated yield (50 mg).  nmax(neat)/cm–1 2950, 1730; 1H NMR (600 MHz; CDCl3) 
(major isomer) d 1.61–1.75 (2H, m) 1.88–2.00 (3H, m) 2.08–2.20 (1H, m) 2.42–
2.52 (1H, m) 2.52–2.57 (1H, m) 2.68–2.74 (1H, m) 4.86 (1H, m, CHOCO); 13C 
NMR (150 MHz; CDCl3) (major isomer) d 29.4, 31.9, 32.6, 36.0, 40.8, 81.1 
(CHO), 171.0 (C=O); m/z (HREI) found [M]+ 126.06814.  C7H10O2 requires 
126.06808.  GC retention time (major isomer): 14.62 min. 
 
2.6.8 NADPH Consumption Microscale Assay 
 
2.6.8.1 Sample Preparation 
 
1 mL samples from cultures were centrifuged at 4 oC for 2 minutes at 13000 rpm.  
The supernatant was discarded and the cell pellet re-suspended in 50 mM TRIS-
HCL pH 9.  The sample was sonicated (Soniprep 150) on ice for 5*10s on and 
5*10s off at 8 µm.  The sample was centrifuged to remove the cell debris at 4 oC 
for 2 minutes and 13000 rpm and the supernatant kept on ice or frozen at – 20 oC 
until used in the assay.   
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2.6.8.2 NADPH Consumption Assay 
 
The intracellular CHMO activity can be quantified by following the substrate 
induced consumption of NADPH.  Donoghue and Trudgill (1975) previously 
reported that the oxidation of 1 µmol of cyclohexanone by CHMO is 
accompanied by the consumption of 1 µmol of NADPH and 0.84 µmol of O2.  
Therefore the consumption of NADPH is stoichiometrically linked to product 
formation in CHMO catalysed reactions.  NADPH absorbs strongly at 340 nm 
whereas NADP does not and this can therefore be used in a spectrophotometric 
assay.  The method used is based on that previously reported by Donoghue and 
Trudgill (1975) however has been adapted to a microscale approach. 
 
A Tecan microplate reader was used for sample analysis.  The microplate reader 
was set to 30 oC.  100 µL of 50mM TRIS-HCL pH 9, 20 µL of 1.6 mM NADPH 
and 60 µL of sample prepared as described in section 2.6.8.1 were added to wells 
of a 96-SRW plate and left to warm to 30 oC for 10 minutes.  20 µL of 20 mM 
cyclohexanone (or substrate of interest) was added to three wells containing 
sample and 20 µL water was added to another three wells containing sample to 
monitor the background rate and the decrease in absorbance at 340 nm was 
monitored for a total of 30 minutes or until NADPH has been fully consumed.  
The activity of the enzyme was expressed in Units (U) where one unit is 
equivalent to the number of µmoles of NADPH consumed per minute.  Sample 
calculations are shown in the appendix C. 
 
This assay was adapted depending on the substrates tested.  If substrates were 
dissolved in a alternative buffer or DMSO (for those with poor solubility) then 
control experiments were also conducted where cyclohexanone was also 
dissolved in buffer or DMSO. 
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2.6.9 Carbon Monoxide (CO) Assay 
 
2.6.9.1 Sample Preparation 
 
All buffers and reagents used for this assay were made fresh on the day of the 
assay.  Samples from cytochrome P450 cultivations were centrifuged for 1 
minute at 14000 rpm at 4 oC.  The supernatant was discarded and resuspended in 
1 mL buffer (80 % 100 mM potassium phosphate buffer pH 7.5, 20 % glycerol, 2 
mM EDTA, 1.5 mM DTT and 0.4 % Triton X-100).  The sample was left on ice 
for 30 minutes as PMSF is unstable at room temperature and after 30 minutes of 
cooling 1 mM PMSF was added to the sample.  The sample was sonicated on ice 
for 10*10s on and 10*10s off at 8 "m.  The sample was then centrifuged for 1 
hour at 14000 rpm and 4 oC and the pellet discarded.  The supernatant was used 
in the CO assay and stored on ice when not in use or frozen at – 20 oC until 
needed. 
 
2.6.9.2 CO Assay 
 
Omura and Sato (1964) first reported the presence of distinct soret peaks at 420 
nm and 450 nm when cytochrome P450s are bound with CO.  This observation is 
now used to assay for the presence and quantification of active cytochrome P450. 
During the development of this assay a few experiments were conducted to get 
the best possible spectrum.  It has been found that incubation time with CO can 
effect the results (Phillips and Shephard, 2006) therefore CO was incubated with 
the sample for various time periods and it was found that 5 minutes was 
appropriate to ensure full CO binding and no change in spectrum results as 
shown in the appendix C.  The majority of works previously reported also use 
substrate free samples when this assay is conducted as the presence of substrates 
can cause spectral changes (McLean et al., 1996).  This was tested and it was 
found that the assay should only be conducted with substrate free samples as 
when substrates is present a poor spectrum is produced making cytochrome P450 
quantification difficult as shown in the appendix C. 
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Prior to running the assay samples were left to reach room temperature.  All 
samples were run in UV-transparent cuvettes.  The Cecil Aquarius 190-1100 nm 
UV-Vis spectrophotometer (Cecil Instruments LTD, Cambridge, UK) was 
blanked using buffer (80 % 100 mM potassium phosphate buffer pH 7.5, 20 % 
glycerol, 2 mM EDTA, 1.5 mM DTT and 0.4 % Triton X-100) and the baseline 
run between 400 and 500 nm.  The sample was reduced by adding 25 mM (final 
concentration) sodium hydrosulphite (dissolved in 80 % 100 mM potassium 
phosphate buffer pH 7.5, 20 % glycerol, 2 mM EDTA and 1.5 mM DTT) was 
mixed gently and left for 1 minute.  The sample was then scanned between 400 
to 500 nm.  CO was bubbled through the sample at a rate of 1 bubble per second 
(achieved using a needle valve for fine control) for 30 seconds and the sample 
left for 5 minutes to allow the CO to bind and then the sample was scanned again 
between 400 to 500 nm.  The CO difference spectrum was calculated by 
subtracting the reduced spectrum from that achieved when CO was bubbled and 
an extinction coefficient of 91 mM-1cm-1 was used.  Protein content was 
estimated by using the Bradford assay as described in section 2.6.10.  P450 
expression in nmolg-1 represents the nmol of active P450 detected from the CO 
assay per gram of soluble protein.  Sample calculations and CO difference 
spectrums are shown in the appendix C. 
 
2.6.10 Bradford Assay 
 
1 mL cell samples were centrifuged for 2 minutes at 13000 rpm and 4 oC.  The 
supernatant was discarded and the pellet resuspended in 50 mM sodium 
phosphate buffer pH 7 (or 50 mM TRIS buffer pH 7 for P450 samples).  The 
sample was sonicated on ice for 5*10s on and 5*10s off at 8 µm and then 
centrifuged for 2 minutes at 13000 rpm and 4 oC to remove the cell debris.  BSA 
standards from 0.1 gL-1 up to 1.4 gL-1 were made in appropriate buffer in 
triplicate to allow quantification of protein samples.  The Bradford reagent was 
removed from the fridge and allowed to come to room temperature.  5 µL of 
samples, 5 µL of each BSA standard and 5 µL of buffer (blanks) were added to 
wells in triplicate of a 96-SRW plate.  250 µL of bradford reagent was added to 
all wells and the plate was immediately placed in a Tecan microplate reader for 
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analysis.  The plate was mixed for 30 seconds and left to incubate for 5 minutes 
and the absorbance was measured at 595 nm.  Using the BSA standard curve the 
protein concentration of each sample was determined.  In the case of 
concentrated samples these were diluted appropriately with buffer and the assay 
repeated.   
 
2.6.11 KLa Measurements 
 
2.6.11.1 Microscale Measurements 
 
In order to measure the KLa at a range of operating conditions at the microscale a 
96-DSW plate was adapted to enable DOT measurements.  A diagram of the 
adapted plate which was based on previously reported designs (Ferreira-Torres, 
2008; Islam, 2007) and was constructed by the Biochemical Engineering 
Workshop in UCL is shown in Figure 2.1 A and B.  A 3 mm diameter hole was 
drilled into the side of one well of the plate and a non-invasive oxygen sensing 
spot (Precision Sensing) was mounted flush to the inside wall of the plate via a 
Perspex transparent support.  This would enable the liquid to be in contact with 
the spot while preventing any leakage from the plate.  A miniature polymer 
optical fibre (POF) (Precision Sensing) was then mounted inline with the spot via 
a PVC mounting screw.  The spot and fibre were both light sensitive and thus 
were stored in the dark when not in use.  During measurements the POF 
illuminates the sensing spot with a blue LED exciting it to emit fluorescent 
pulses.  The principle of the oxygen sensing involves quenching of these 
fluorescence pulses when oxygen molecules are detected.  These signals are 
transferred via the POF to a transmitter box (Precision Sensing OXY-4 4 channel 
oxygen meter) and then a computer which records the signals and converts them 
to DOT values.  Sterile medium containing 0.2 mLL-1 PPG was added to the well 
with the oxygen sensing spot and used for all KLa measurement studies.  The 
POF was first calibrated at 100 % by first sparging air into the headspace of the 
well and then calibrated at 0 % by sparging a stream of nitrogen into the 
headspace of the well.  The probe response time (prt) was then determined.  The 
plate was shaken until the DOT reached 100 %.  According to Van’t Riet (1979) 
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the prt is the time needed to record a percentage change in DOT of 63 % (for 
example 100 % down to 37 %).  Nitrogen was then sparged into the headspace of 
the well until 37 % was reached.  This was done in triplicate and the mean prt 
was calculated to be 3 s.  This was a very fast response time and thus was 
considered negligible.  According to Tribe et al. (1994) prts greater than 10 s can 
cause considerable errors in KLa quantification and thus must be accounted for in 
these instances. 
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Figure 2.1 (A) Front view of a single well with oxygen sensing spot and (B) 
cross-sectional view of a single well with oxygen sensing spot and adjacent 
miniature polymer optical fibre for fluorescent signal transmission. 
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Dynamic gassing out studies (Van’t Riet, 1979) were conducted at a range of fill 
volumes (500 µL – 1000 µL), shaker speeds (400 – 1000 rpm), temperatures and 
mediums depending on the conditions required and results are presented in 
Chapter 6.  The modified plate was shaken using an Eppendorf Thermomixer 
Comfort.  Each condition was setup and the plate agitated at the required shaker 
speed and nitrogen sparged into the well until the DOT reached 0 %, at this point 
the nitrogen was removed and the rate at which DOT increased up to 100 % was 
recorded.  Each measurement was conducted in triplicate.  The prt was found to 
be negligible, therefore Equation 2.1 (Garcia-Ochoa and Gomez, 2009) can be 
used to determine the KLa, where 
! 
"CL
"t  (mmolesdm
-3h-1) is the change in oxygen 
concentration with time, CL* (mmolesdm-3) is the saturated dissolved oxygen 
concentration, and CL (mmolesdm-3) is the concentration of oxygen in the broth. 
 
! 
"CL
"t = KLa CL
* #CL( )          (Eq. 2.1) 
 
Intergrating Equation 2.1 gives Equation 2.3. 
 
! 
CL = (CL* "CL )e"KL a( t )         (Eq. 2.3) 
 
Taking the natural log and rearranging gives Equation 2.4. 
 
! 
In(CL* "CL ) = KLa(t) + InCL        (Eq. 2.4) 
 
Using the DOT measurements CL* = 100 % and CL = DOT at each time point 
and if the 
! 
ln CL* "CL( )  is plotted versus time the KLa can be determined from the 
gradient of the linear part of the graph. 
 
2.6.11.2 Laboratory Scale Measurements 
 
For the laboratory scale measurements a 7.5 L (New Brunswick Scientific Co, 
New Jersey, USA) stirred tank fermenter was used.  The vessel was filled with 
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4.5 L TB medium excluding the salts and 0.2 mLL-1 PPG.  The DOT probe was 
calibrated at 0 % in nitrogen and 100 % using gaseous air.  The probes were 
placed in the holders within the vessel and the whole vessel sterilised by 
autoclaving.  Once sterilisation was complete and the vessel had cooled the 
potassium phosphate salts which had been filter sterilised through a 0.2 µm filter 
were added to the vessel aseptically.  Both probes were finally checked and re-
calibrated as appropriate.  The probe response time was determined by agitating 
the medium until the DOT reached 100 %.  Nitrogen was then sparged into the 
vessel through sterile filters and the time taken for the oxygen concentration to 
reach 37 % was recorded.  This was done in triplicate and the mean prt was 
calculated to be 20 s. 
 
Dynamic gassing out studies were conducted at a range of shaker speeds (400 – 
800 rpm) and temperatures depending on the conditions required and results are 
presented in Chapter 6.  Each condition was setup such as 200 rpm, 37 oC and 1 
vvm and nitrogen was sparged into the vessel through sterile filters until the 
DOT reached 0 %.  The nitrogen was then switched off and rate at which DOT 
increased up to 100 % was recorded.  Each measurement was conducted in 
triplicate.  Due to the extended prt it was required to consider this in the KLa 
calculation.  This was achieved by using a correlation developed by Lamping et 
al. (2003) as shown in Equation 2.5, where Cp  is the undissolved 
fraction of oxygen at time t, tp is the probe response time and .  An 
iterative approach was used to solve this equation for KLa at each time point 
between 20 % and 80 % saturation.  These results were used to calculate the 
mean KLa at each condition tested. 
 
      (Eq. 2.5) 
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2.6.11.3 Pilot Plant Scale Measurements 
 
For the pilot plant scale measurements a 75 L (LH Fermentation, Reading, UK) 
stirred tank fermenter was used.  The vessel was filled with 45 L LB-glycerol 
medium and 0.2 mLL-1 PPG.  The DOT probe was calibrated at 0 % in nitrogen 
and 100 % using gaseous air.  The probes were placed in the holders within the 
vessel and the whole vessel sterilised in situ.  Once sterilisation was complete 
and the vessel had cooled probes were finally checked and re-calibrated as 
appropriate.  The probe response time was determined by agitating the medium 
until the DOT reached 100 %.  Nitrogen was then sparged into the vessel through 
sterile filters and the time taken for the oxygen concentration to reach 37 % was 
recorded.  This was done in triplicate and the mean prt was calculated to be 15 s. 
 
Dynamic gassing out studies were conducted at a range of shaker speeds (200 – 
800 rpm) depending on the conditions required and results are presented in 
Chapter 6.  Each condition was setup such as 200 rpm, 37 oC and 1 vvm and 
nitrogen was sparged into the vessel through sterile filters until the DOT reached 
0 %.  The nitrogen was then switched off and rate at which DOT increased up to 
100 % was recorded.  Each measurement was conducted in triplicate.  KLa was 
calculated as described for laboratory scale measurements in section 2.6.11.2. 
 
2.6.12 Enzyme Units 
 
A Unit (U) is defined as "mol of product formed/minute. 
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3 Design and Development of a Automated Microscale 
Platform for Investigation of Whole Cell Oxidative 
Biocatalytic Processes" 
 
3.1 Introduction 
 
A unique feature of automated microscale approaches is the potential to establish 
whole process sequences which would allow a more rapid investigation into 
novel oxidative biocatalytic processes.  The environmental impact of chemical 
oxidations requiring highly reactive and/or toxic reagents makes the 
identification of sustainable biocatalytic alternatives for industrial 
pharmaceutical synthesis a useful application of microscale automation (Baboo 
et al., 2012).  Incentives such as reduced developmental costs and accelerated 
process development have thus prompted continual progress in this area of 
research.  A preliminary demonstration of process automation using E. coli 
TOP10 [pQR239] was achieved with the Multiprobe II EX liquid handling robot 
(Ferreira-Torres et al., 2005).  The developed sequence was successful in 
evaluating oxidative biocatalysts libraries however, had a limited level of 
automation and lacked an aseptic processing environment, making it less 
applicable to extended culture times.  Reproducibility of data collection is 
crucially important during parallel cultivations at the microscale.  Studies have 
been done using robotic liquid handling to ensure liquid phase homogeneity by 
jet macro-mixing (Nealon et al., 2006) and a greater throughput and higher 
sensitivity when using reduced sample and reagent volumes compared to manual 
alternatives (Nealon et al., 2005).  The Tecan automated robot has also 
previously been used for the automated culture of E. coli JM107:pQR706 
overexpressing transketolase (Micheletti et al., 2006).  This is a sophisticated 
platform with increased functionality, particularly suited for process automation 
for a range of unit operations and was used in the present work.  Successful %%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
"%Some of the results presented in this chapter are included in Baboo et al (2012), ‘An automated 
microscale platform for evaluation and optimization of oxidative bioconversion processes’, 
Biotechnology Progress, 28, 392-405, DOI: 10.1002/btpr.1500. 
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integration of the miniature bioreactor system BioLector within an automated 
platform has resulted in the development of Robo-Lector.  The system enabled 
the collection of kinetic data on biomass and fluorescent protein formation 
during microbial cultivation (Huber et al., 2009).  A number of important 
advancements have already been made however continual efforts are required in 
this area if there is to be a greater uptake for characterisation and optimisation 
studies and a move away from traditional shake flask experimentation.   
 
In view of this objective, the focus of this chapter was to design a generic 
microscale automated platform which was robust, allowed increased throughput 
and saved time and effort compared to manual operations without compromising 
precision and accuracy of data collection.  To achieve this goal the oxidative 
biocatalyst cyclohexanone monooxygenase (CHMO) was used as a model 
system for process development.  E. coli TOP10 [pQR210] is a recombinant 
whole cell biocatalyst expressing CHMO from Acinetobacter calcoaceticus 
NCIMB 9871.  CHMO was used to catalyse the reaction of the ketone 
bicyclo[3.2.0]hept-2-en-6-one to two regioisomeric lactones (-)-(1S,5R)-2-
oxabicyclo[3.3.0]oct-6-en-3-one and (-)-(1R,5S)-3-oxabicyclo[3.3.0]oct-6-en-2-
one as shown in reaction Scheme 1.2 in section 1.2.3.1.1.1.  Due to the 
stereoselective Baeyer-Villiger oxidation of numerous ketones (Alphand et al., 
2003), CHMO is an industrially attractive biocatalyst as discussed in section 
1.2.3.1.1.1.  The production of this biocatalyst will be described in section 3.2 to 
demonstrate its similarity to E. coli TOP10 [pQR239] (Doig et al., 2001), which 
shares the host strain and CHMO enzyme.  The main difference is that L-
arabinose is required for E. coli TOP10 [pQR239] induction, whereas CHMO 
has been found to be constitutively expressed from E. coli TOP10 [pQR210], 
thus was used in this work.   
 
Factors influencing microwell microbial cultivation and bioconversion have been 
investigated previously including microwell geometry, inoculum concentration, 
evaporation effects and temperature (Ferreira-Torres, 2008).  In Chapter 1 the 
need for optimisation early during process development and high-throughput 
methods useful to achieving such needs were discussed.  Nevertheless, being 
able to deal with the data generated by high-throughput techniques is still a 
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challenge.  It was therefore of interest to develop an improved approach with a 
higher degree of automation of multiple processing steps to enable ‘walk away 
operation’.  In this approach operator dependent tasks are focused on data 
analysis and process improvement rather than sampling, culture maintenance and 
data collection.  By utilising the Tecan automated robot this study will examine 
the capability of the robotic platform and how it can be applied to achieve a fully 
automated approach for whole cell CHMO production and evaluation.  
 
3.2 Results and Discussion 
 
3.2.1 Production of Cyclohexanone Monooxygenase 
 
Limited research has been conducted using E. coli TOP10 [pQR210], it was 
therefore of interest to initially determine the growth and bioconversion kinetics 
of CHMO using the model substrate bicyclo[3.2.0]hept-2-en-6-one using 
conventional shake flask culture.  Previous work has focused on the strain E. coli 
TOP10 [pQR239] (Doig et al., 2001, Ferreira-Torres, 2008) which is a derivative 
construct of E.  coli TOP10 [pQR210] (Doig et al., 2001).  Due to the similarities 
between the strains established conditions from previous work were used as a 
starting point for these studies and as a reference data set with which to compare 
the present results against.  E. coli TOP10 [pQR210] seed stocks were created 
and confirmed by sequence analysis to carry the correct plasmid as described in 
section 2.2.1.1.  100 mL of LB-glycerol media was inoculated with 5 % 
inoculum prepared as described in section 2.2.1.4 in a 500 mL baffled shake 
flask and incubated at 200 rpm and 37 oC.  The growth kinetic data of a typical 
shake flask culture is shown in Figure 3.1 A.  The specific growth rate was 
calculated from the first three hours of growth to be 0.86 h-1 and the final 
biomass concentration achieved was 4.91 gDCWL-1.  These values compare well 
with results obtained using a similar E. coli TOP10 [pQR239] shake flask culture 
by Ferreira-Torres (2008) and using a 1.5 L stirred tank reactor culture by Doig 
et al. (2001).  Table 3.1 shows a summary of the results obtained in these studies.  
The only difference in the culture conditions used in this work was that no 
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inducer addition was required as cells were found to express CHMO 
constitutively.   
 
Whole cells have the ability to recycle NADPH intracellularly making them 
more attractive than isolated systems if the correct reductant and reductant 
concentration are used prior to bioconversion.  Doig et al. (2003) found that 10 
gL-1 glycerol allowed for optimum cofactor regeneration and thus this amount of 
glycerol was added after 6 hours of growth.  Following a 15 minute incubation 
period, 1 gL-1 ketone substrate was added and the bioconversion kinetics 
monitored for an hour.  Figure 3.1 B shows the bioconversion kinetics data in 
terms of bicyclo[3.2.0]hept-2-en-6-one consumption and lactone formation.  The 
chromatograms obtained for ketone and lactone at three time points are shown in 
Figure 3.2.  The lactone refers to the combination of the two regioisomers 
produced (-)-(1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one and (-)-(1R,5S)-3-
oxabicyclo[3.3.0]oct-6-en-2-one as it was not possible to separate them by the 
GC method adopted for quantification as shown in Figure 3.2 C.  Complete 
conversion was achieved in 1 hour where final values of 0.06 ± 0.01 gL-1 and 
1.13 ± 0.01 gL-1 were obtained for the final ketone and lactone concentrations 
respectively.  These findings are consistent with those obtained by Ferreira-
Torres (2008).  A CHMO specific activity of 34.0 UgDCW-1 was calculated from 
the initial rate of lactone formation. 
 
Table 3.1 Comparison of E. coli TOP10 [pQR210] culture to E. coli TOP10 
[pQR239]. 
 
Reference Culture  
Format 
Specific Growth 
Rate (h-1) 
Final Biomass 
Concentration 
(gDCWL-1) 
This work 500 mL shake flask 0.86 4.9 
Ferreira-Torres (2008) 500 mL shake flask 0.69 4.5 
Doig et al. (2001) 1.5 L bioreactor 0.90 5.5 
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Figure 3.1 Growth (A) and bioconversion kinetics (B) of E. coli TOP10 
[pQR210] biocatalyst catalysing bicyclo[3.2.0]hept-2-en-6-one (filled symbols) 
to lactone product (unfilled symbols) collected during a typical shake flask 
culture. Error bars indicate the range of measured values about the mean.  
 
 
 
B 
A 
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Figure 3.2 Chromatograms displaying the conversion of 1 gL-1 
bicyclo[3.2.0]hept-2-en-6-one (retention time: 6.7 min) to (-)-(1S,5R)-2-
oxabicyclo[3.3.0]oct-6-en-3-one and (-)-(1R,5S)-3-oxabicyclo[3.3.0]oct-6-en-2-
one (retention times: 13.7 min and 13.8 min) at (A) 0 minutes, (B) 15 minutes 
and (C) 60 minutes of bioconversion. Peak present at 11 minutes corresponds to 
naphthalene which was used as an internal standard and added to all samples.   
A 
C 
B 
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The similarity in terms of growth and bioconversion kinetics of E. coli TOP10 
[pQR210] to E. coli TOP10 [pQR239] was confirmed from these initial shake 
flask studies.  This system was therefore used to test the design of the newly 
developed automated microscale platform.  
 
3.2.2 A Robotic Platform for Microscale Process Development 
 
The Tecan Genesis automated liquid handling platform equipped with Gemini 
software was used to develop a fully automated microscale process using the E. 
coli TOP10 [pQR210] strain.  The system is completely contained within a 
Bigneat class 2 biosafety cabinet equipped with a laminar airflow system and 
HEPA filtration making it ideal for aseptic processing.  Two robotic arms that 
can move over the entire workstation with an approximate footprint of 1.3 m2 
and access all ancillary devices on the platform were utilised for process 
automation.  The platform has 69 grid locations and can be setup with a range of 
carriers for multiple plates, tips racks and devices.  This platform is equipped 
with a Tecan microplate reader, a Tecan microplate centrifuge with 4 plate 
locations, an Agilent 1200 series HPLC, a Tecan vacuum separator and an 
Eppendorf thermomixer enabling a high degree of process automation and 
analysis.  Figure 3.3 shows the external and internal view of the platform along 
with ancillary equipment. 
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Figure 3.3 Tecan Genesis automated platform. (A) Front view of enclosed 
platform within Bigneat Biosafety Cabinet with (a) HPLC. (B) Internal view of 
robotic platform with ancillaries including (a) pipette waste station (b) plate 
carrier and plates, (c) disposable tip racks, (d) reagent reservoirs, (e) eppendorf 
and vial carriers, (f) microplate reader, (g) access hole for centrifuge. (C) LiHa. 
(D) RoMa. (E) Thermomixer. (F) Centrifuge. 
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To build confidence in the data collected using the automated approach, the 
accuracy and precision of the LiHa pipetting was tested by applying a method 
which has been described previously using two disposable microconductive tips 
(Nealon et al., 2005).  The precision and accuracy of the automated pipetting 
system were calculated from three individual dispenses of the same volume for a 
range of volumes using Equations 3.1 and 3.2, respectively.  Figure 3.4 and 3.5 
show the results from the volumes tested with P1000 and P200 tips respectively.  
For all working volumes the coefficient of variance was found to be 5 % or 
below, therefore the liquid handling precision and accuracy was considered 
acceptable (Olsen, 2000).  The pipetting accuracy was regularly checked after 
process runs to enable any pipetting problems to be rectified.    
 
Precision % CV = [(mean – target) / mean] * 100    (Eq. 3.1) 
 
Accuracy % CV = [standard deviation /mean] * 100   (Eq. 3.2) 
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Figure 3.4 P1000 single dispense accuracy (A) and precision (B). Accuracy and 
precision calculated over three separate dispenses. Tip 1 (!), tip 2 (!), tip 3 
(!), tip 4 ("), tip 5 (#), tip 6 ($), tip 7 (+) and tip 8 (-). The dashed line 
displays 5 % coefficient of variance for precise and accurate liquid handling. 
A 
B 
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Figure 3.5 P200 single dispense accuracy (A) and precision (B). Accuracy and 
precision calculated over three separate dispenses. Tip 1 (!), tip 2 (!), tip 3 
(!), tip 4 ("), tip 5 (#), tip 6 ($), tip 7 (+) and tip 8 (-). The dashed line 
displays 5 % coefficient of variance for precise and accurate liquid handling. For 
20 µL and 10 µL a wash was used between each dispense. 
 
 
A 
 B 
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3.2.3 Automated Microwell Cultivation 
 
96-Deep square well (96-DSW) plates have been found to be a suitable culture 
format for aerobic microbes (Micheletti et al., 2006; Ferreira-Torres, 2008).  
Firstly, the square geometry has been found to ensure the best condition for 
oxygen transfer (Duetz and Witholt, 2001) by promoting gas-liquid mass transfer 
where the corners of the wells act as baffles would in a fermenter (Doig et al., 
2002).  The deep well format is better suited to sampling over extended periods, 
without the early onset of evaporation or cell settling effects which have been 
observed when using standard round well (SRW) plates (Ferreira-Torres, 2008).  
In addition, the use of 96 wells increases the throughput, enabling increased data 
collection from a single experiment which is of particular interest in this study.  
However, a common problem associated with microwells is the phenomenon of 
“edge effects”.  “Edge effects” occur when results obtained from wells at the 
peripheries of a plate are different from those obtained from wells located in the 
centre of the plate.  This effect may be due to temperature differences, compound 
photosensitivity or evaporation (Girard et al., 2001).  The optimal growth 
temperature for E. coli TOP10 [pQR239] was reported to be 37 oC (Doig et al., 
2001, 2002; Ferreira-Torres, 2008) and a temperature study was designed to 
ensure edge effects were not occurring in the chosen well plate format.  A 
temperature study was conducted as described in section 2.3.1.1.1 where the 
temperature of wells containing 1 mL LB-glycerol media in five areas of the 
plate was monitored over a seven-hour period and results are shown in Figure 
3.6.  Figure 3.6 demonstrates that after approximately 30 minutes at 1000 rpm a 
temperature of 37 oC is reached in all wells and it then remains constant for the 
remaining 6.5 hours.  Results do indicate slight differences in temperatures 
between well positions in the plate, where wells in the top left corner are the 
coolest and those in the top right are the hottest.  However, the difference is at 
most ± 2 oC and this is not considered to cause a significant effect on the growth 
of E. coli TOP10 [pQR210].   
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Figure 3.6 The effect of well position on well temperature. Top left (dark blue), 
top right (pink), bottom left (light blue), bottom right (purple), middle (green). 
Error bars indicate the range of measured values about the mean.  
 
Figure 3.7 Reproducibility of growth kinetics of E. coli TOP10 [pQR210] across 
a 96-DSW plate collected during an automated culture. Columns 1-2 (!), 
columns 3-4 (!), columns 5-6 ("), columns 7-8 ($), columns 9-10 (#), 
columns 11-12 (!). Error bars indicate the range of measured values about the 
mean.  
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The first stage of process automation was to develop an effective method of 
monitoring the growth of E. coli TOP10 [pQR210] cells.  It was important to 
ensure that growth was reproducible across the plate.  A 96-DSW plate was first 
automatically filled with 1 mL LB-glycerol media and heated until a temperature 
of 37 oC was reached.  This volume ensured no spillage from the wells which 
could result in well-to-well contamination at an agitation of 1000 rpm.  
Automatic addition of 5 % v/v overnight prepared inoculum of E. coli TOP10 
[pQR210] followed and the growth monitored using the sacrificial well approach 
(Doig et al., 2002) for six hours.  Samples were diluted accordingly into 96-SRW 
plates and these transferred via the RoMa to a Tecan microplate reader for 
analysis at hourly intervals.  Culture sterility was tested previously (Ferreira-
Torres, 2008) and found to not be compromised due to the use of antibiotic.  The 
same antibiotic along with the contained environment, as described in section 
3.2.2, ensured that no culture contamination was observed in the present work.  
Figure 3.7 displays the growth kinetics across a 96-DSW plate demonstrating 
that the well position has no effect on the growth of cells allowing the entire 
plate to be used for analysis. 
 
The reproducibility of data collected on different days is an important issue to 
consider to ensure repeated walk-away operation was possible.  The growth 
kinetic data were obtained in triplicate on three separate days as described in 
section 2.3.1.2 and results are shown in Figure 3.8.  Similar growth profiles were 
observed for each of the three runs.  From the three runs, an average of 0.72 h-1 
and 4.04 gDCWL-1 were calculated for the mean specific growth rate (µ) and the 
mean final biomass concentration respectively, and are similar to those reported 
previously (Ferreira-Torres et al, 2005).  Using data from these runs the 
calculated average and maximum error were 5 % and 12 % respectively and are 
representative of the day-to-day variations attributing to differences in media and 
inoculum preparations.  In section 3.2.2 the error of robotic dispenses was 
established to be less than 5 %.  Day-to-day robotic performance should be 
consistent and significant changes from the average error would indicate a fault.  
The preparatory manual steps conducted prior to automated processing are thus a 
likely source of error.  For example, slight differences in cell maturity, due to 
differences in overnight inoculum preparation could be responsible for the error.  
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A potential solution to reduce the variation observed would be to automate the 
overnight culture. 
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Figure 3.8 Growth kinetics of E. coli TOP10 [pQR210] biocatalyst collected 
using the automated process sequence from three separate runs (run 1 (square), 
run 2 (circle) and run 3 (triangle)). Error bars indicate the range of measured 
values about the mean.  
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3.2.4 Automated Microwell Bioconversion 
 
Once the cultivation stage had been developed the second objective was to fully 
automate the bioconversion of bicyclo[3.2.0]hept-2-en-6-one.  In preparation for 
this step, cell aliquots were automatically transferred to new wells as described in 
section 2.3.1.2 and incubated with glycerol at 30 oC.  A similar temperature study 
to that described in section 3.2.3 was conducted to confirm that 30 oC was 
reached at the end of the incubation period.  Glycerol is more viscous than water 
and thus a different liquid class was used where the aspiration and dispense 
speed of the LiHa were set to ensure adequate dispensing performance.  1 gL-1 
bicyclo[3.2.0]hept-2-en-6-one was added to the wells and Figure 3.9 shows the 
bioconversion kinetics data in terms of ketone consumption and lactone 
formation using cells obtained after six hours of growth.  Both substrate 
consumption and product formation follow a linear behaviour (potentially due to 
mass transport issues into the cell) and similar final concentrations were achieved 
for the three runs after 1 hour of bioconversion.  The impact of changing 
variables could be assessed from the data collected on the initial bioconversion 
kinetics within this timeframe.  Mean final values of 0.27 ± 0.04 gL-1 and 0.47 ± 
0.06 gL-1 were obtained for the ketone and lactone respectively, corresponding to 
a final product yield of 47 %.  Using the mean initial lactone formation rate 
obtained from the three runs the calculated mean CHMO specific activity was 
15.0 UgDCW-1.  The sum of the experimental errors in sample preparation and GC 
analysis are believed to be responsible for the increased error observed for the 
bioconversion stage in comparison to the cultivation step.  Inaccuracies are likely 
to derive from the ethyl acetate extraction due to the volatility of the solvent used 
causing a change in sample concentrations.  In order to avoid such inaccuracies 
an automated ethyl acetate extraction step was developed and it will be discussed 
in section 3.2.5.   
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Figure 3.9 Bioconversion kinetics of E. coli TOP10 [pQR210] biocatalyst 
catalysing bicyclo[3.2.0]hept-2-en-6-one (filled symbols) to lactone product 
(unfilled symbols) collected using the automated process sequence from three 
separate runs (run 1 (square), run 2 (circle) and run 3 (triangle)). Error bars 
indicate the range of measured values about the mean.  
 
 
 
 
 
 
 
 
 
 
 
 124 
3.2.5 Automated Liquid-liquid Extraction  
 
The method employed to manually extract the bioconversion metabolites is 
described in section 2.6.4.1 and involves vortex mixing of individual cell 
samples with ethyl acetate.  Automated microscale approaches can generate large 
sample numbers, which need to be processed in a short timeframe if they are to 
generate reliable results.  In order to prevent this step from becoming the process 
bottleneck it was of interest to develop an automated alternative step.  It was also 
desirable to increase the consistency and accuracy of data collection, as the 
manual processing may have been responsible for the increased error reported in 
section 3.2.4. 
 
Ethyl acetate is a volatile solvent, consequently, a liquid class was developed so 
that this solvent could be aspirated and dispensed with appropriate 
accuracy/precision.  The LiHa works with microconductive tips.  While such tips 
are appropriate for most of the fluids used in this work, for ethyl acetate it was 
necessary to remove the conductivity sensing.  The aspiration of a set volume of 
ethyl acetate was conducted in triplicate.  Results were compared with those 
obtained from the same experiment conducted manually and the percentage 
difference was found to be 1 %, confirming that the developed liquid class 
properties were suitable for the liquid handling of ethyl acetate. 
 
Figure 3.10 shows a comparison of results obtained using a manual procedure 
with those obtained as described in section 2.3.1.2 using a 96-DSW plate agitated 
at 1200 rpm on an Eppendorf thermomixer for 0.5 up to 3 minutes.  Following 
extraction the plate was transferred via the RoMa to a microplate centrifuge and 
centrifuged for 15 minutes at 4000 rpm and 4 oC.  This was found to separate 
organic and aqueous phases.  A total of 3 minutes was the time required to fully 
extract both ketone and lactone using the thermomixer.  Ketone concentration 
remains approximately constant from 1 minute up to 3 minutes whereas there is a 
greater degree of variation when using the manual vortex extraction.  This new 
extraction method was also tested throughout the plate in different well locations 
and an average error of less than 5 % was calculated between the target and 
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extracted ketone concentration.  The thermomixer method was therefore used for 
the further processing of all samples with the added benefit of being able to 
process up to 96 samples in one extraction.  An alternative method to combat the 
error arising from the volatility of the ethyl acetate would be to adjust metabolite 
concentrations in relation to changes in the concentration of internal standard 
added to each sample detected by GC.  Therefore deviations in the concentration 
of the internal standard would give a quick indication on how much a sample 
may have been concentrated by due to solvent evaporation and this could be 
considered to calculate the true concentration of ketone and lactone. 
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Figure 3.10 The effect of agitation time on the concentration of ketone (A) and 
lactone (B) extracted into ethyl acetate using a vortex mixer (!) and a Eppendorf 
thermomixer ($). For each data point the same sample was extracted with both 
devices. Error bars indicate the range of values about the mean of duplicate well 
measurements for the thermomixer results and duplicate samples for the vortex 
mixer results. 
 
A 
B 
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3.2.6 Automated Linked Process of Cultivation, Bioconversion 
and Liquid-liquid Extraction 
 
The complete automated approach for evaluation of E. coli TOP10 [pQR210] 
using each of the steps described in sections 3.2.3 to 3.2.5 is shown in Figure 
3.11.  ‘Walk away operation’ was achieved once the Tecan platform had been 
setup and prepared for aseptic processing as described in section 2.3.1.2.  The 
preparation of culture plates (96-DSW) and analysis plates (96-SRW), reagent 
addition including inoculum, glycerol, substrate and ethyl acetate as well as 
sampling and OD measurements were all automated.  Data was automatically 
collected throughout the culture and bioconversion samples were frozen every 15 
minutes.  The frozen bioconversion samples were defrosted and an automated 
liquid-liquid extraction followed.  At the end of the process GC vials containing 
ethyl acetate with the extracted metabolites were collected from the platform, 
capped and loaded onto the GC instrument for analysis.   
 
The automated microwell approach has been confirmed to rapidly collect 
reproducible data on different days as described in sections 3.3 to 3.6.  A 
manually run experiment conducted within the Tecan enclosed environment was 
also found to be in good agreement with the automatically collected data.  From 
three manually conducted runs an average error of 21 % and maximum error of 
27 % was calculated which represents the error arising from the inconsistency in 
plate preparation and sampling, and inaccuracies in manual pipetting.  The day-
to-day deviations are greater during manual operations thus the reliability of the 
automated approach makes it a superior method for process investigation.   
 
There are notable benefits from using this approach over the traditional shake 
flask experimentation.  The effects of six parameters can be tested 
simultaneously in duplicates in 8 hours with minimal error, low chance of 
contamination and significantly reduced manual operations.  The traditional 
manual approach would require twelve shake flasks cultures, which, due to 
manual processing would cause a larger error and risk of contamination.  
Additionally, keeping the culture mixing and at constant growth conditions 
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prevents cellular stresses whereby during the automated approach no 
interruptions in shaking are required.  It has been reported when shaking is 
stopped during sample collection there can be a reduction in oxygen uptake rate 
due to oxygen limitation which can become quite significant when screening 
multiple vessels (Büchs, 2001; Wittmann et al., 2003; Fernandes and Cabral, 
2006).  Automation reduces these risks where operators are only required for 
preparation, setup and monitoring.  The seven-hour processing time conducted 
by the robot can be spent in analysing results and carrying out analytical 
measurements such as GC and preparation for other experiments.  Moreover, 
system downtime is decreased where automated sequences can be run almost 
back-to-back after platform setup and sterilisation and overnight processing is 
possible, thus maximising system productivity.  Furthermore, working at the 
microscale reduces raw material requirements and multiple plates can be 
processed in parallel increasing throughput within the same process time.   
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Figure 3.11 Schematic representation of the fully automated linked process sequence using E. coli TOP10 [pQR210] expressing 
cyclohexanone monooxygenase. Coloured wells represent filled wells as an example (yellow: media and culture, blue: RO water).   
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3.3 Concluding Remarks 
 
The commercialisation of biologics is a long process.  Hence the biotechnology 
industry is under constant pressure to reduce developmental timelines and cut 
costs if they are to meet market demands and gain competitive advantage.  One 
strategy is to use a combination of miniaturisation to cut costs and automation to 
speed processing consistency and reduce downtime.  In line with this approach, 
the objective of this work was to design and develop a generic microscale 
automated platform for bioprocess investigation.  The key achievements included 
a demonstration of robustness, increased throughput and accuracy of data 
collection on multiple upstream process steps.  
 
E. coli TOP10 [pQR210] was found to be a suitable system for the production of 
CHMO.  The Tecan automated liquid handling platform was chosen due to its 
applicability to process automation and high degree of functionality.  The LiHa 
liquid dispense was established to have an error below 5 % and thus was an 
acceptable system (Olsen, 2000) to begin process automation for the microscale 
production of CHMO using E. coli TOP10 [pQR210].  Working from established 
microscale microbial culture, 96-DSW plates were found to allow reproducible 
culture conditions across the plate with no adverse “edge effects”.  The 
automated approach was further found to rapidly collect data on different days 
reproducibly in spite of differences in media and overnight inoculum 
preparations.  Moreover, when compared to manual runs the error between 
triplicates was reduced from an average of 21 % down to 5 %.  The collection of 
reproducible bioconversion kinetics was established.  However, the error 
observed between triplicate bioconversion data sets prompted the development of 
an automated liquid-liquid extraction allowing 96 samples to be processed in one 
run of the automated method.  From automated data collection cells of E. coli 
TOP10 [pQR210] grew at a specific rate of 0.72 h-1 to a final biomass 
concentration of 4.04 gDCWL-1 and were found to metabolise 1 gL-1 
bicyclo[3.2.0]hept-2-en-6-one to the respective lactone in a yield of 47 % and 
with a specific activity of 15 UgDCW-1. 
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The developed platform has the potential to be applied to multiple microbial and 
oxidative biocatalytic systems.  Whole cell recombinant proteins are used for the 
production of fine chemicals, drug synthesis and bioremediation to name a few 
applications (Duetz et al., 2001).  The majority of production processes involve a 
growth, expression and bioconversion phase all of which have been automated in 
this study and can be rapidly assessed.  Depending on the process requirements 
this generic approach could be used in its current state or adjusted to suite the 
requirements of each individual system.  In particular, novel strains which have 
yet to be fully investigated would clearly benefit from rapid evaluation using this 
automated approach and as such this will be covered in Chapter 5.  It can 
therefore be used to test the constraints and limitations of a system to enable full 
process optimisation. 
 
Using the Tecan robotic system fully automated microbial culture, bioconversion 
and metabolite liquid-liquid extraction has been achieved.  This allows the rapid 
collection of process data with increased throughput, accuracy and 
reproducibility making it superior to traditional approaches reliant on manual 
operations prone to error and contamination.  More importantly, this approach 
enables the majority of the process time to be used for data analysis, further 
experimentation or analytics.  Once the automated microscale platform was in 
place, it was of interest to apply it for whole bioprocess evaluation.  The initial 
microwell results collected in this study will form the basis for strain growth and 
bioconversion kinetics.  These will be used for further studies covered in Chapter 
4 where the optimised process conditions for the oxidative biocatalyst CHMO 
will be defined.   
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4 Whole Bioprocess Evaluation Using an Automated  
Microscale Platform!  
 
4.1 Introduction 
 
The development of a high-throughput robust automated microscale platform for 
rapid data collection on upstream unit operations was described in Chapter 3.  
Preliminary microwell based results were collected, forming a basis for growth 
and bioconversion kinetics on a CHMO-expressing system.  Whole bioprocess 
evaluation is important to test system constraints and limitations to enable 
optimal process conditions to be identified.  In particular, the selected conditions 
can then be tested in large-scale conventional bioreactors to ensure the 
reproduction of kinetic results in geometrically different formats.  This aspect 
will be covered in Chapter 6.  This illustrates the benefits of microscale 
automation where time consuming developmental stages can be accelerated at 
reduced cost and large-scale cultivations focussed on production. 
 
In the last few years there has been significant interest in CHMO from A. 
calcoaceticus NCIMB 9871 resulting in CHMO becoming the best characterised 
BVMO to date (Alphand et al., 2003).  This is predominantly because it can 
catalyse the Baeyer-Villiger oxidation without conventional toxic and/or unstable 
oxidants in an enantioselective manner.  Due to intrinsic limitations, namely a 
pathogenic nature and requirement of the toxic carbon source cyclohexanol 
(Trudgill, 1990), use of the wild type organism is avoided while recombinant 
systems have enabled considerable progress since the 1990s (Stewart et al., 1998; 
Mihovilovic et al., 2001; Doig et al., 2001).  E. coli expression systems have 
been studied to determine conditions for biocatalyst expression, activity and 
bioconversion.  In the case of E. coli TOP10 [pQR239] a number of factors have 
been investigated using the model substrate bicyclo[3.2.0]hept-2-en-6-one.  
Firstly, culture conditions will have an impact on whole cell CHMO specific !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!!Some of the results presented in this chapter are included in Baboo et al (2012), ‘An automated 
microscale platform for evaluation and optimization of oxidative bioconversion processes’, 
Biotechnology Progress, 28, 392-405, DOI: 10.1002/btpr.1500. 
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activity.  This has been found to reach a maximum at pH 7 with a broad pH 
optimum range between 6 and 8 (Doig et al., 2003).  Similarly, while a 
temperature of 37 oC yields the highest activity, temperatures ranging from 30 oC 
to 40 oC will promote activity (Doig et al., 2003).  In the case of microscale 
studies, due to the requirement of an open system, 30 oC is the best temperature 
to overcome the effects of substrate evaporation (Ferreira-Torres, 2008).  The 
source of amino acid used in media formulations can also improve CHMO 
specific activity which was the case when soyabean peptone was used (Baldwin 
and Woodley, 2006; Berezina et al., 2007).  Finally, monitoring cellular growth 
can often be crucial is determining the point of cell harvest as CHMO specific 
activity expressed from E. coli TOP10 [pQR239] will increase with biocatalyst 
concentration but only up to 2 gDCWL-1. 
 
Bioconversion conditions should also be considered, such as reactant 
concentration, where bicyclo[3.2.0]hept-2-en-6-one has been reported to have a 
inhibitory limit.  Doig et al. (2003) reported substrate inhibition to take place at 
concentrations above 0.2 - 0.4 gL-1 using resuspended whole cells, whereas Shitu 
et al. (2009) found a greater tolerance using the same strain and substrate 
concentration was found to be detrimental above 2 gL-1.  Furthermore, the 
lactone product concentration can limit the reaction where specific 
biotransformation activity will reduce as soon as it is produced (Doig et al., 
2003; Shitu et al., 2009) and the highest reaction rate has been determined in the 
absence of product.  Whole cells can recycle NADPH intracellularly in the 
presence of an appropriate carbon source where Doig et al. (2003) found both the 
choice and concentration of reductant to influence specific activity.  Both cellular 
growth and CHMO bioconversion are oxygen dependent, hence DOT and 
oxygen transfer rates play a crucial role in achieving the maximum enzymatic 
performance (Doig et al., 2001).  Consequently, at the microscale the volumetric 
CHMO activity has been found to increase when increasing the surface area to 
volume ratio of a 96-DSW plate (Doig et al., 2002; Ferreira-Torres, 2008). 
 
Identifying industrially relevant reactions is an area of significant interest.  
Moreover, there is a sustained focus in examining the substrate specificity of 
CHMO.  Due to the fact that ketones and lactones can be applied in flavour and 
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fragrance production such as !-decalactone which is used to create a peach-like 
flavour.  In fact, CHMO can metabolise numerous substrates (Roberts and Wan, 
1998).  Cyclic ketones such as cyclohexanone and cyclopentanone (Doig et al., 
2003; Ferreira-Torres et al., 2005), the bicyclic ketone bicyclo[3.2.0]hept-2-en-6-
one (Alphand, 2003), racemic bicyclic diketones (Ottolina et al., 2005), 1,3-
diathiane (Zambianchi et al., 2004) and "-substituted cyanocylohexanones 
(Berezina et al., 2007) have all been tested with E. coli TOP10 [pQR239].  Other 
E. coli-expressed CHMO have also been reported to metabolise terpenones such 
as cis-dihydrocarvone, carvomenthone and methone (Cernuchova and 
Mihovilovic, 2007), 4-substituted-3,5-dimethylcyclohexanones (Mihovilovic et 
al., 2005) and racemic benzylketones (Geitner et al., 2007) to name a few.   
 
Accordingly, few previous works have been conducted to gain a greater 
understanding of the CHMO system, substrate specificity and its respective 
constraints and limitations.  The ability to complete such studies in a reduced 
time frame and with minimal raw materials is therefore of great importance.  A 
robust automated microscale platform for the investigation of CHMO was 
developed as described in Chapter 3.  In order to demonstrate the platform utility 
for whole bioprocess sequence evaluation, build on current research and further 
investigate areas which have yet to be extensively studied, a range of operating 
conditions and substrates were tested with E. coli TOP10 [pQR210] and the 
results are presented in this chapter.  
 
4.2 Results and Discussion 
 
4.2.1 Automated Investigation of CHMO Specific Activity 
 
4.2.1.1 Impact of Oxygen Transfer Rate on Bioprocess 
Performance 
 
CHMO is an oxidative biocatalyst and is expressed from an aerobic 
microorganism thus oxygen supply is critical.  The rate at which oxygen is 
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supplied to a microwell system can therefore be varied to determine the extent of 
oxygen dependency.  This was assessed by investigating the effect of well fill 
volume on growth kinetics as it is an important parameter shown to affect air-
liquid mass transfer in microwell geometries (John et al., 2003; Kensy et al., 
2005; Funke et al., 2009).  The growth curves obtained from an automated run at 
varying fill volumes as described in section 2.3.1.3 are shown in Figure 4.1 A.  
Similar growth is observed at all conditions for the first 4 hours after which a 
clear distinction between the curves at different fill volumes can be observed.  
Biomass concentrations of 5.59 gDCWL-1 and 4.23 gDCWL-1 were achieved at fill 
volumes of 500 !L and 1000 !L, respectively.  Reducing the fill volume to 600 
!L caused the growth to increase, while further volume reductions have no 
significant effect.  Oxygen therefore becomes the limiting growth factor above a 
600 !L fill volume. 
 
Decreasing the fill volume creates a larger specific interfacial area thus 
improving the gas liquid mass transfer coefficient (KLa).  KLa (s-1) can be 
estimated using Equation 4.1 (Doig et al., 2005) for each of the operating fill 
volumes.  The equation was developed for a range of plate geometries using a 
dimensionless group approach. 
 
! 
KLa = 31.35DaiRe0.68 Sc 0.36FrxBoy     (Eq. 4.1) 
 
Where x = 0.64, y = 0.15, (Doig et al., 2005) for 96-SRW microplates and are 
geometry dependant coefficients, D (m2s-1) is the oxygen diffusion coefficient 
(Perry and Green, 1997), ai (m-1) is the initial specific surface area and Re, Sc, Fr 
and Bo are dimensionless numbers which have been defined for the microwell 
geometry adapting their definition for conventional stirred bioreactors. 
 
Predicted KLa values, computed using Equation 4.1 at each fill volume, are 
shown in Table 4.1 at 1000 rpm shaker speed and 3 mm shaking diameter.  A 
square geometry was used in this work and, as Equation 4.1 was developed for 
round wells, a 30 % increase in KLa was added to take into account the geometry 
difference (Micheletti et al., 2006).  From the predicted values a 50 % decrease 
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in the fill volume causes the surface area to volume ratio to double, resulting in 
an approximately double value of KLa.  However, it is important to note that this 
improvement can only be achieved with appropriate agitation to ensure 
significant surface disruption.  This finding confirms that an improved KLa is 
responsible for improved growth.  KLa value predictions help in the evaluation of 
fill volume impact on final reaction yield and provide an initial indication of how 
the rate of oxygen transfer will vary. 
 
Following the growth at varying fill volumes 500 µL cell aliquots were 
transferred from each well to a new plate and the bioconversion results are 
shown in Figure 4.1 B.  In Figure 4.1 B the fastest rate of substrate consumption 
and highest specific activity (16.7 UgDCW-1) were achieved at a 600 !L fill 
volume.  This is 36 % higher than the corresponding value achieved at 1000 !L 
(12.3 UgDCW-1).  A higher enzyme yield, resulting from the improved growth is 
responsible for this finding.  Evaporation effects during the culture are thought to 
be responsible for the higher than expected initial substrate concentration (1.2 
gL-1) at a 500 !L fill volume.  This reaction suffers from substrate inhibition 
(Doig et al., 2003) which will be discussed in detail in section 4.2.2.1 and is 
responsible for the results observed in this work.  In this work by improving the 
oxygen supply through the increase in the surface to volume ratio both cell 
growth and bioconversion yield were considerably improved. 
 
Adopting the same methodology as in the previous experiment the impact of fill 
volume on the bioconversion step was examined.  Figure 4.2 A shows the rate of 
substrate consumption obtained where cells were initially grown at a constant fill 
volume of 1000 !L for the first 6 hours and then the volume varied from 200 !L 
up to 1000 !L during the bioconversion.  The CHMO specific activities were 
calculated from initial rates of product formation and are shown along with the 
mass balance analysis in Figure 4.2 B.  Predictions of KLa values using Equation 
4.1 have confirmed that reducing the fill volume improves the gas liquid transfer 
rate, therefore it is expected that it will also increase the rate at which substrate 
can be oxidised and converted to product. 
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Figure 4.1 (A) Growth kinetics of E. coli TOP10 [pQR210] at varying fill 
volumes of 400 !L (!), 500 !L ("), 600 !L (!), 800 !L (#) and 1000 !L (!) 
for 6 hours of growth and (B) bioconversion kinetics at each of the volumes 
tested with 1 gL-1 bicyclo[3.2.0]hept-2-en-6-one (filled symbols) to lactone 
product (unfilled symbols). All well volumes changed to 500 !L at 6 h time point 
except for 400 !L volume where well transfer was not carried out due to 
insufficient volume. Error bars indicate the range of measured values about the 
mean. 
!"
#"
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Table 4.1 Summary of calculated values for prediction of KLa at different well 
fill volumes. 
 
Fill volume (!L) ai (m-1) Re Sc Fr Bo KLa (s-1) 
1000 64     0.085 
800 80     0.107 
600 107 0.142 
500 128 0.171 
400 160 
1067 400 161 0.011 
0.213 
 
In this study, once the fill volumes were adjusted and the bioconversion initiated, 
oxygen was required for two competing processes, cell maintenance and 
bioconversion.  As the fill volume reduced the rate of substrate consumption 
increased where at 200 !L substrate was consumed at the fastest rate.  This may 
imply lower fill volumes enable both cell maintenance and bioconversion to 
occur without limitation whereas at well volumes of 400 !L and above 
bioconversion is compromised as oxygen is more readily used for cell 
maintenance.  Baldwin and Woodley (2006) have also reported previously that 
oxygen is preferentially used for cellular maintenace and once this requirement is 
fulfilled oxygen will then be used for the Baeyer-Villiger oxidation. 
 
From the mass balance results the extent of evaporation could be evaluated.  A 
slight increase in ketone/lactone evaporation can be observed at decreasing fill 
volumes.  This finding was not observed when a 200 !L fill volume was used as 
the highest specific activity was achieved at this volume. 
 
A useful approach to control the level of oxygen transfer for both growth and 
bioconversion operations has been shown to be the well fill volume.  The results 
of this work have shown that only under oxygen limited conditions a change in 
fill volume is required where reduced fill volumes increase KLa but have no 
further benefit on cell growth.  Moreover, under non-oxygen limited conditions, 
further fill volume reductions could be detrimental to this particular process 
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where DOT above 10 % has previously be found damaging to enzyme activity 
(Doig et al., 2001). 
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Figure 4.2 (A) Bioconversion kinetics of E. coli TOP10 [pQR210] with 1 gL-1 
bicyclo[3.2.0]hept-2-en-6-one using a well fill volume of 200 !L (!), 400 !L 
("), 500 !L (#), 600 !L (!), 800 !L ($) and 1000 !L (%). Error bars indicate 
the range of measured values about the mean. (B) Effect of bioconversion fill 
volume on specific activity (!) and % mass balance (&) at different fill volumes 
after a 1 hour bioconversion defined as [(mass of ketone in well + mass of 
lactone in well) / (total ketone added to well)] * 100. 
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4.2.1.2 Impact of Biomass Concentration on Biocatalyst Activity 
 
The use of whole cell systems are, in some cases, preferred to isolated enzymes 
because biocatalysts are believed to be in a stable environment, do not require 
additional cofactor regeneration systems and further costly steps (enzyme 
isolation and purification) can be avoided (Duetz et al., 2001).  Nevertheless, 
maintenance of growing cells can cause challenges similar to those found in this 
work where oxygen limitation hindered growth above biomass concentrations of 
2 gDCWL-1 and inevitably impacted biocatalysts activity.   
 
One possible solution could be an increase in the oxygen supply, or alternatively, 
identifying when biocatalyst is most active.  The later was therefore examined 
whereby the automated process was used to culture cells from 1 hour up to 6 
hours as shown in Figure 4.3 A.  Biomass concentrations were varied from 0.60 
gDCWL-1 to 3.50 gDCWL-1 and cells were then used for a 1 hour bioconversion as 
shown in Figure 4.3 B.  The slowest rate of product formation was observed at 
the lowest biomass concentration when cells were grown for just 1 hour and 
converted 25 % of the substrate.  Full conversion of substrate to product was 
only achieved when cells were cultured for 3 hours to a biomass concentration of 
1.85 gDCWL-1 prior to bioconversion.  Below this concentration, down to 1 
gDCWL-1, cells had a higher specific activity as shown in Figure 4.3 C, although 
the bioconversion rate was still lower due to insufficient enzyme present.  
However, when the biomass concentration obtained was higher than 1.85 gDCWL-
1, both the specific activity and the reaction rate began to decrease.  This 
reduction became quite significant for cells grown for 4 hours to 2.55 gDCWL-1 
and above.  In this case the specific activity fell to 23 UgDCW-1 from the highest 
specific activity of 65 UgDCW-1 and only 55 % of the substrate was successfully 
converted to product.  From these results it may be concluded that the reason for 
a drop in specific activity at biomass concentrations above 2 gDCWL-1 is oxygen 
limitation as found in section 4.2.1.1.  
 
In order to confirm the finding, samples from the automated run were removed 
after each designated culture time prior to bioconversion and used in a separate 
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NADPH consumption assay.  Full details are described in section 2.6.8.  Each 
sample was re-suspended in 50 mM TRIS-HCL buffer at pH 9, sonicated and 
then centrifuged to remove the cell debris.  The cell lysate was incubated with 
0.16 mM NADPH and, after addition of 2 mM of the natural substrate 
cyclohexanone, the consumption of NADPH monitored spectroscopically by 
following the depletion of absorbance at 340 nm.  It has been found previously 
that the consumption of 1 !mol of NADPH is stoichiometrically linked to the 
oxidation of 1 !mol of cyclohexanone (Trudgill, 1975).  From Figure 4.4 A a 
similar trend to that obtained in Figure 4.3 B can be noted where the rate at 
which NADPH is consumed increases with biomass concentration from 0.5 
gDCWL-1 (obtained after 1 hour of culture) up to 1.6 gDCWL-1 (obtained after 3 
hours of culture).  At biomass concentrations higher than 1.6 gDCWL-1 the 
consumption rate gradually decreases.  Hence, the specific activity was found to 
increase with biomass concentration and reduce significantly above 2 gDCWL-1, as 
shown in Figure 4.4 B.  As the described experiments use cell-free samples, 
results indicate that, in addition to oxygen limitation, reduced CHMO titre at 
increased biomass concentrations is also responsible for the reduction in 
bioconversion rate.  It has been reported previously that a reduction in enzyme 
synthesis with increased yield is a common feature of overexpresed enzymes 
(Micheletti et al., 2006).  
 
The results obtained in this work suggest that extended culture reduces the level 
and effectiveness of the biocatalyst.  It is true, as shown in section 4.2.1.1, that 
increasing the oxygen transfer rate can improve the bioconversion by preventing 
oxygen limitation conditions.  However specific activities, achieved from 
operating at a lower biomass concentration, are significantly higher (65.0 UgDCW-
1 at 1.04 gDCWL-1) than those achieved when operating at reduced fill volumes 
(23.0 UgDCW-1 at a 200 !L bioconversion fill volume).  In this work, growing 
cells for a maximum of 3 hours ensures the biomass concentration remains below 
2 gDCWL-1 and allows an adequate supply of highly active biocatalyst for 
bioconversion.   
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Figure 4.3 (A) Growth kinetics of E. coli TOP10 [pQR210] grown for a period 
of 1 hour (!), 2 hours (!), 3 hours ("), 4 hours (!), 5 hours (#) and 6 hours 
($) to a biomass concentration of 0.60 gDCWL-1, 1.04 gDCWL-1, 1.85 gDCWL-1, 
2.55 gDCWL-1, 3.06 gDCWL-1, and 3.50 gDCWL-1 respectively. (B) Bioconversion 
kinetics of bicyclo[3.2.0]hept-2-en-6-one (filled symbols) to lactone product 
(unfilled symbols) collected using cells from each culture. 
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Figure 4.3 (C) Specific activity at each biomass concentration tested. Error bars 
indicate the range of measured values about the mean. 
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Figure 4.4 (A) The change in absorbance due to NADPH consumption by 
isolated CHMO samples incubated with cyclohexanone prepared as described in 
section 2.6.8.1 from cultures grown for 1 hour (!), 2 hours (!), 3 hours ("), 4 
hours (!), 5 hours (#) and 6 hours ($) to a biomass concentration of 0.46 
gDCWL-1, 0.88 gDCWL-1, 1.57 gDCWL-1, 2.42 gDCWL-1, 2.98 gDCWL-1, and 3.52 
gDCWL-1 respectively. (B) Specific activity at each biomass concentration tested. 
Error bars indicate the range of measured values about the mean. 
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4.2.1.3 Evaluation of Media Composition 
 
The amino acid source used in media formulation has been found to impact 
cellular growth and CHMO specific activity (Baldwin and Woodley, 2006; 
Berezina et al., 2007) but has not been fully investigated.  Common amino acid 
sources found in growth media supplying nitrogen, carbon and sulfur include 
peptones, derived from the digestion of animal or plant proteins, and tryptones, 
derived from the milk protein casein.  The impact of amino acid source using the 
automated process was investigated.  E. coli TOP10 [pQR210] was cultured in 
eight media identical in composition to LB-glycerol differing only by the 
tryptone component which was replaced by each amino acid source listed in 
Table 4.2. 
 
Table 4.2 Amino acid sources tested using automated sequence. 
 
Amino Acid Source Source Preparation 
Soyabean Peptone Soyabean Papaic digestion of Soya flour  
Broadbean peptone Broadbean Enzymatic hydrolysis of broadbean protein 
concentrates 
Bacteriological peptone Animal Enzymatic digestion of animal protein 
sources 
Peptone N/A Enzymatic digest of protein 
Tryptone Casein (Milk protein) Pancreatic digest of casein 
Peptone from casein 
pancreatic digest 
Casein (Milk protein) Enzymatic digest of casein 
Peptone from casein 
tryptic digest 
Casein (Milk protein) Enzymatic digest of casein 
Tryptone pancreatic 
digest from casein 
Casein (Milk protein) Enzymatic digest of casein 
Tryptone enzymatic 
digest from casein 
Casein (Milk protein) Enzymatic digest of casein 
 
Figure 4.5 A shows the growth profiles obtained with each media formulation.  
After 3 hours of growth, once the biomass concentration reached 1.5 gDCWL-1 a 
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distinct change in growth with different media formulations can be observed.  
The reason for this finding can be attributed to a nutrient specific effect 
associated with each amino acid source tested.  Growth was enhanced in the 
presence of soyabean peptone where the highest biomass concentration of 4.58 
gDCWL-1 was observed, while a nutritional limitation in tryptone enzymatic digest 
from casein limited growth when this media formulation was used to a final 
biomass concentration of 2.47 gDCWL-1.  Generally, casein-derived sources 
produced the poorest growth while those from a vegetable origin resulted in cell 
growth improvement.  The original media formulation LB-glycerol (media 
composition described in section 2.2.1.1) containing tryptone constituted an 
exception and the growth kinetics can be found in Figure 3.8 in section 3.  In line 
with the results presented in this work peptones derived from casein were also 
reported to slow E. coli growth by Berezina et al. (2007).  Soyabean peptone has 
also been found to improve cell growth for Claviceps fusiformis, a type of 
fungus, and thus it can be speculated that it is beneficial for a range of organisms 
(Rozman et al., 1985). 
 
The influence of each media formulation on CHMO bioconversion kinetics and 
specific activity, respectively, is presented in Figures 4.5 B and C.  Cells cultured 
with tryptone pancreatic digest grew to a low biomass concentration but still 
produced the highest specific activity of 33.3 UgDCW-1 and product yield of 0.79 
gL-1.  The activity was 1.7 times the activity achieved using soyabean peptone 
(18.7 UgDCW-1) while the product yield (0.66 gL-1) was 20 % higher.  This 
activity was twice the activity achieved using the original LB-glycerol 
formulation containing tryptone (15 UgDCW-1).  The impact of biomass 
concentration on biocatalyst activity has already been discussed and could be 
contributing to the results observed in this work where slow growth prevents the 
onset of early oxygen limitation.  In fact, specific activities over 30.0 UgDCW-1 
were only measured from casein-derived amino acid sources.  For media 
containing soyabean or broadbean biomass concentrations exceeded 3 gDCWL-1 
hence the bioconversion step yielded specific activities that were less than 20 
UgDCW-1.   
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Figure 4.5 (A) Growth kinetics and (B) bioconversion kinetics of E. coli TOP10 
[pQR210] grown in soyabean peptone (!), broadbean peptone ("), 
bacteriological peptone (!), peptone (#), peptone from casein pancreatic digest 
(!), peptone from casein tryptic digest ($), tryptone pancreatic digest from 
casein (") and tryptone enzymatic digest from casein (%) as the amino acid 
source. Error bars indicate the range of measured values about the mean. 
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Figure 4.5 (C) Specific activities achieved using cells grown in the eight media 
formulations tested. 
 
 
 
 
 
 
 
 
Figure 4.6 Specific activities achieved using cells grown to a similar biomass 
concentration in the eight media formulations tested. 
!"
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In order to determine the effects of the amino acid source on bioconversion 
without the detrimental impact of oxygen limitation, cells were grown in each 
media for a period of 3 hours.  At this stage of the culture (Figure 4.5 A) it is 
shown that there is no significant difference in biomass concentration and values 
remain below 2 gDCWL-1.  Figure 4.6 shows the specific activity achieved in the 
eight media formulations when cells were grown to a similar biomass 
concentration.  For all media tested there was an improvement in specific 
activity.  This is expected as, by limiting the growth to a point where there is no 
oxygen limitation, both cell maintenance and bioconversion requirements can be 
easily met.  The bioconversion is only limited by the level of biocatalyst and/or 
mass transfer to the active site.  In the initial study bacteriological peptone only 
produced moderate specific activities but, if tested after 3 hours of growth it was 
the best performing media with a specific activity of 67.0 UgDCW-1.  Soyabean 
peptone at this condition is the poorest media with a specific activity of 30.0 
UgDCW-1, however, this is not significantly different from what was presented in 
Figure 4.5 C.  In general, while five of the media exhibit quite similar specific 
activities, the source of amino acid does play a role in determining how well 
CHMO will perform.  One potential explanation is an improvement in substrate 
mixing associated with the amino acid source.  This could be due to the broth 
viscosity being affected by the choice of peptone or tryptone and thus affecting 
fluid hydrodynamic properties and the substrate transport to the cell.   
 
The results presented in this section have important implications with regards to 
media recipe selection but they also highlight the need to study process 
interactions and quantify the impact of each unit operation on the final product 
yield.  While only one media component was tested in this work the automated 
approach could be readily applied to test multiple formulations and media 
supplements for the rapid assessment of an organism’s nutritional requirements.  
This approach could be crucial in early process design. 
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4.2.2 Automated Investigation of Alternative CHMO Reactions 
 
4.2.2.1 The Impact of Substrate Concentration 
 
In a bioprocess deterioration of whole cell biocatalysts is a potential problem due 
to cell damage, natural cell death and substrate inhibition/toxicity (Shitu et al., 
2009).  Bicyclo[3.2.0]hept-2-en-6-one has been found previously to have 
inhibitory effects over a threshold concentration, however, different sources 
report a range of upper limits of inhibition effects even when the same strain was 
used (Doig et al., 2003; Shitu et al., 2009).  This is potentially due to differences 
in bioconversion conditions between the work of Shitu et al. (2009), where a 
greater substrate tolerance up to 2 gL-1 was reported before a drop in the initial 
product formation rate, and the work of Doig et al. (2003), who found a 
reduction in specific activity once the substrate concentration increased above 
0.4 gL-1.  For this reason it was of interest to ascertain the inhibitory limit of 
CHMO expressed from whole cells of E. coli TOP10 [pQR210] in order to 
maintain the optimum biocatalysts efficiency for the present microscale 
approach. 
 
Using the automated approach, after a 6-hour growth, bioconversion was 
initiated by addition of substrate concentrations ranging from 0.2 gL-1 to 6 gL-1.  
Differences in substrate concentrations had a distinct effect on the growth during 
the 1-hour bioconversion as shown in Figure 4.7 A.  At increasing substrate 
concentration the growth rate was found to decrease.  Cellular growth continued 
at the lowest substrate concentration tested (0.2 gL-1) reaching the highest 
biomass concentration of 4.42 gDCWL-1, while at the highest substrate 
concentration growth stopped and cell death was observed.  It can therefore be 
concluded that bicyclo[3.2.0]hept-2-en-6-one is damaging to the cell.  It was 
previously found, by using flow cytometry, that substrate addition caused 
changes in both cell physiology and metabolism (Shitu et al., 2009).  In 
particular, a 20-fold increase in substrate concentration from 0.5 gL-1 up to 10 
gL-1 resulted in over a 2-fold drop in cell viability (Shitu et al., 2009).   
 
 152 
The effect of substrate concentration on bioconversion rates is shown in Figure 
4.7 B.  Full conversion of substrate to product was only achieved at substrate 
concentrations from 0.2 gL-1 to 0.5 gL-1.  Above this limit the final product 
concentration gradually decreased and the lowest final product concentration of 
0.16 gL-1 was reached after a 1-hour bioconversion at the highest substrate 
concentration tested (6 gL-1).  The maximum specific activity of 25 UgDCW-1 was 
measured at a 0.5 gL-1 substrate concentration and it was found to decrease to 
just 4 UgDCW-1 at 6 gL-1 substrate as shown in Figure 4.7 C.  Two contributory 
factors have been reported as being responsible for the findings observed, 
including the reduced cell viability and a compromised cofactor (NADPH) 
regeneration ability due to a poorly functioning cell membrane caused by 
substrate toxicity (Shitu et al., 2009).  This effect is not exclusive to 
bicyclo[3.2.0]hept-2-en-6-one where 1,3-dithiane has also been found to have 
inhibitory effects (Zambianchi et al., 2004).  In order to maintain the maximum 
productivity of the CHMO system using whole cells at the microscale the 
substrate concentration should be operated at 0.5 gL-1. 
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Figure 4.7 (A) Growth and (B) Bioconversion kinetics of E. coli TOP10 
[pQR210] at varying substrate (bicyclo[3.2.0]hept-2-en-6-one) concentrations of 
0.2 gL-1 (!), 0.4 gL-1 ("), 0.5 gL-1 (!), 2 gL-1 (!), 4 gL-1 (#), and 6 gL-1 ($). 
Substrate addition was at the 6.25 h time point. Error bars indicate the range of 
measured values about the mean. 
 
 
 
!"
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Figure 4.7 (C) The effect of substrate concentration on specific activity. 
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4.2.2.2 High-throughput Screening of Baeyer-Villiger Substrates 
 
Identification of enzyme substrates is an industrially relevant application of 
automated microwell based techniques.  Over 100 CHMO substrate candidates 
have previously been identified (Kamerbeek et al., 2003) and, from these, those 
yet to be tested with CHMO expressed by E. coli TOP10 [pQR210] were 
investigated.  Chemical structures of the selected ketone substrates as well as 
reported or resulting products are shown in Table 4.3, together with the model 
substrate bicyclo[3.2.0]hept-2-en-6-one and the natural substrate cyclohexanone.  
These include (1R)-(+)-camphor, (1R)-(-)-fenchone and (+)-dihydrocarvone 
which have applications in the food and cosmetic industry as the CHMO 
catalysed products are flavour active lactones (Gatfield, 1997).  For instance, 
when treated under acidic conditions in the presence of alcohol, pleasant scents 
are produced from (1R)-(+)-camphor and (1R)-(-)-fenchone.  2-
oxabicyclo[3.2.1]octan-3-one the product of CHMO-catalysed racemic 
norcamphor has also been reported in the synthesis of prostaglandins (Newton 
and Roberts, 1980) and nucleosides (Levitt et al., 1990).  Additionally 
cycloheptanone and cyclooctanone were also selected for testing and, while the 
respective products do not have direct applications, many can be further 
metabolised to useful products.  For example the metabolism of oxocan-2-one 
from cycloheptanone can produce pimelic acid whose derivatives are used in the 
biosynthesis of amino acids (Hasegawa et al., 1982). 
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Table 4.3 Selected ketone substrates oxidised by CHMO. 
 
Substrate Products* 
(Doig et al., 2003) 
 
bicyclo[3.2.0]hept-2-en-6-one 
 
O
 
 
(1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one 
O
H
H
O
 
(1R,5S)-3-oxabicyclo[3.3.0]oct-6-en-2-one 
O
H
H O
 
(Abril et al., 1989) 
 
(1R)-(+)-camphor 
 
O
 
 
2-oxabicyclo[3.2.1]1,7,7-trimethyloctan-3-one  
O
O  
(Abril et al., 1989; Mihovilovic et al., 2008) 
 
racemic norcamphor 
 
O
 
 
2-oxabicyclo[3.2.1]octan-3-one 
O
O  
 
3-oxabicyclo[3.2.1]octan-2-one 
O
O
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(Abril et al., 1989) 
 
(1R)-(-)-fenchone 
 
O  
 
1,2-fencholide 
O O  
2,3-fencholide 
O
O  
(Abril et al., 1989; Cernuchova and Mihovilovic, 2007) 
 
(+)-(3R,6RS)-dihydrocarvone 
O
 
 
6-isopropenyl-3-methyl-2-oxacycloheptanone 
O
O
 
(Kim et al., 2008) 
 
cyclohexanone 
 
O
 
 
!-caprolactone 
 
O O
 
(Hasegawa et al., 1982; Kim et al., 2008) 
 
cycloheptanone 
 
O
 
 
oxocan-2-one 
 
O O
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(Kim et al., 2008) 
 
cyclooctanone 
 
O
 
 
1-oxa-2-oxo-cyclononane 
 
O
O
 
* Indicates products produced only when oxidised by CHMO. 
 
Six new substrates were tested using the automated approach and, along with 
cyclohexanone, the growth kinetic results are shown in Figure 4.8 A.  It is 
important to note that substrates were only added after 6.25 hours of growth.  
The final biomass concentrations obtained from all substrates were similar, 
ranging from 4.06 gDCWL-1 in the presence of norcamphor to 3.49 gDCWL-1 in the 
presence of (1R)-fenchone.  In agreement with the established protocol described 
in Chapter 3, the slightly higher biomass concentration obtained with 
cyclohexanone can be attributed to differences in inoculum and media 
preparations as experiments were run on different days.  Due to poor water 
solubility the substrates (1R)-fenchone, (1R)-camphor and (+)-dihydrocarvone 
had to be added pre-dissolved in DMSO.  To identify any possible inhibitory 
effects of DMSO on growth and bioconversion a control experiment was carried 
out.  DMSO was found to have no significant effect on growth, however, it 
caused a reduction in enzyme specific activity.  As dissolving substrates in 
DMSO was the only suitable method of adding them to the culture such method 
was adopted in this work.  The progress of substrate consumption and product 
formation of the six new substrates and cyclohexanone are shown in Figure 4.8 
B.   
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Figure 4.8 (A) Growth and (B) bioconversion kinetics of E. coli TOP10 
[pQR210] with substrates (1R)-camphor (+), (1R)-fenchone (!), (+)-
dihydrocarvone (!), cyclooctanone ("), norcamphor (#) to 2-
oxabicyclo[3.2.1]octan-3-one ($), cycloheptanone (%) to oxocan-2-one (&) and 
cyclohexanone (!) to !-caprolactone ('). The results of cylohexanone 
presented here were collected in a separate automated run to that of the other six 
substrates. Substrate addition was at the 6.25 h time point. Error bars indicate the 
range of measured values about the mean. 
!"
#"
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Together with the natural substrate cyclohexanone, products were only observed 
from norcamphor and cycloheptanone catalysis.  Single product peaks were 
observed in the GC chromatograms for these two substrates (see appendix B for 
sample chromatograms) and, by analogy with previously reported work, these 
were identified as 2-oxabicyclo[3.2.1]octan-3-one (Abril et al., 1989) and 
oxocan-2-one (Hasegawa et al., 1982), respectively.  The nature and chemical 
structures of the two products obtained were confirmed by Mass Spectroscopy 
(MS), Nuclear Magnetic Resonance (NMR) and Infrared Spectroscopy (IR) 
analysis or by correlation to a chemically synthesised standard.  The final 
product yield achieved from microscale experiments was too low to produce 
sufficient material for MS and NMR analysis, thus shake flask bioconversions 
were conducted and the resulting products purified by flash silica 
chromatography and used as described in section 2.6.7.2.  NMR, MS, and IR 
spectrums of purified norcamphor products can be found in appendix D.  
Mihovilovic et al. (2008) reported the formation of two regioisomers which they 
termed “normal” (the major isomer 2-oxabicyclo[3.2.1]octan-3-one) and 
“abnormal” (3-oxabicyclo[3.2.1]octan-2-one) lactones using CHMO from a 
range of sources including Acinetobacter NCIMB 9871 expressed in a 
recombinant E. coli strain.  The major product detected by GC and NMR 
analysis in this work was confirmed to be the “normal” lactone observed by 
Mihovilovic et al. (2008), which was produced in a ratio of approximately 15:1 
(“normal” : “abnormal”) from a 2-hour shake flask bioconversion.  This is 
consistent with the work of Mihovilovic et al. (2008) where a ratio of 97:3 was 
achieved using CHMO from Acinetobacter NCIMB 9871.  The theoretical mass 
of 2-oxabicyclo[3.2.1]octan-3-one and 3-oxabicyclo[3.2.1]octan-2-one 
(C7H10O2) is 126.06808 gmol-1 and from the MS analysis it was measured to be 
126.06814 gmol-1. 
 
In the case of cycloheptanone, the yield of product achieved from a 100 mL 
initial shake flask culture was insufficient to produce a NMR spectra confirming 
the presence of oxocan-2-one.  Therefore oxocan-2-one was chemically 
synthesised from pure cycloheptanone as described in section 2.6.7.1.  NMR and 
MS spectrums of the chemically synthesised oxocan-2-one can be found in 
appendix D.  The theoretical mass of oxocan-2-one (C7H13O2) was 129.09155 
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gmol-1 and from the MS analysis it was measured to be 129.09101 gmol-1 for the 
chemically synthesised product.  Once a chemical standard was available, 
biologically synthesised oxocan-2-one could be directly compared to it.  Four 
100 mL shake flask bioconversions were conducted with cycloheptanone to 
produce a maximum final oxocan-2-one yield of 0.2 g.  A sample of chemically 
and biologically-synthesised oxocan-2-one were mixed in ethyl acetate and run 
on the GC and, as shown in Figure 4.9, only one peak was visualised at 10.04 
minutes, confirming both products had identical retention times.  NMR, MS, and 
IR spectrums of purified oxocan-2-one from CHMO catalysed cycloheptanone 
can be found in appendix D.  From the MS analysis the mass of biologically 
produced oxocan-2-one was measured to be 129.09101 gmol-1.  MS and proton 
NMR compared well to the chemically synthesised standard confirming that 
oxocan-2-one can be produced from cycloheptanone using CHMO. 
 
From the initial rate of product formation specific activities of 17.3 UgDCW-1 and 
10.9 UgDCW-1 were calculated from the bioconversion of norcamphor and 
cycloheptanone, respectively, producing final concentrations of 0.56 gL-1 and 
0.35 gL-1 of the respective lactones.  There are similarities in terms of yield and 
specific activity between the norcamphor and bicyclo[3.2.0]hept-2-en-6-one 
bioconversions.  Additionally, norcamphor results were in good agreement with 
CHMO-catalysed cyclohexanone results which produced a specific activity of 
16.2 UgDCW-1 and final !-caprolactone yield of 0.57 gL-1.  Similarities between 
the norcamphor and cyclohexanone bioconversion data may be due to the fact 
that they both possess six-membered-ring ketone moieties, despite the bridged 
bicyclic functionality in norcamphor restricting conformational flexibility.  
Bicyclo[3.2.0]hept-2-en-6-one and norcamphor are able to adopt similar 
orientations within the active site as both are bicyclic ketones with no methyl 
side groups.  The relationship between ketone structure and substrate specificity 
has been previously observed (Trower et al., 1989; Kostichka et al., 2001).  Some 
monooxygenases can show substrate specificity for those compounds which are 
cyclic (Trower et al., 1989) rather than straight chained, have a specific carbon 
chain length or ring size (Kostichka et al., 2001), while the size of the enzyme 
has also been proposed to play a role in substrate specificity. 
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Figure 4.9 GC chromatogram of mixed chemically synthesised and biologically 
produced oxocan-2-one (retention time: 10.04 minutes) from cycloheptanone 
(retention time: 8.12 minutes). Naphthalene was used as an internal standard 
(retention time: 11.23 minutes).   
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The substrates tested in this work have been tested before using alternative 
microorganisms.  Whole cells of the strain KUC-7N of the Norcadia genus 
completely converted 2 gL-1 cycloheptanone to 1-oxa-2-oxo-cyclooctane in two 
days of growth (Hasegawa et al., 1982).  Compared to the present study the 
conversion rate is eight times slower and is likely to be due to the strain and 
growth conditions used.  From the results of this study it was assumed that full 
conversion would have been possible if the reaction had been operated below the 
inhibitory limit and the reaction conducted for just over 2 hours.  This 
presumption was tested and will be discussed in section 4.2.3.  In the case of 
isolated enzyme CHMO expressed from Acinetobacter NCIB 9871 was 
immobilised and reported to catalyse 11 gL-1 norcamphor over a five-day period 
to 2-oxabicyclo[3.2.1]octan-3-one in a 81 % yield (Abril et al., 1989).  The 
slower conversion rates achieved by Abril et al. (1989) may be due to the use of 
purified enzyme which requires the use of a NADPH regeneration system for 
cofactor recycling, the activity of immoblised enzyme and the rate of NADPH 
regeneration. 
 
No products were detected from bioconversions with (1R)-fenchone, (1R)-
camphor, (+)-dihydrocarvone or cyclooctanone after GC analysis.  To elucidate 
the reason for this the percentage evaporation of each of the substrates was 
measured from evaporation studies and is shown in Table 4.4.  It was confirmed 
that out of the four substrates which failed to react, all evaporated with time and 
only the results from (1R)-fenchone indicated cell metabolism.  CHMO is able to 
bioconvert (+)-dihydrocarvone, (1R)-fenchone, (1R)-camphor and cyclooctanone 
as shown by Abril et al. (1989), Kim et al. (2008) and Donoghue et al. (1976).  
Therefore there are a number of explanations why no conversion was observed in 
this work.  Firstly, the expression host has been reported to alter specific activity 
(Kim et al., 2008) and these substrates have not been previously tested with E. 
coli TOP10 [pQR210].  Many of these substrates are hydrophobic in nature, 
making them less accessible to the cell, and more vigorous mixing may be 
required to ensure effective substrate mixing (Marques et al., 2007).  CHMO has 
been found to have the lowest affinity for cyclooctanone and successful 
bioconversion has also been reported when using purified enzyme (Donoghue et 
al., 1976).  This implies mass transfer limitations may be preventing the uptake 
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of cyclooctanone, thus a longer reaction time or specific reaction conditions may 
be required to promote conversion of this substrate.  One (or a combination) of 
these factors may be responsible for the lack of conversion observed.  The setup 
of the automated platform means it can now be routinely used to further 
investigate the exact cause and identify conditions to promote product formation.   
 
Table 4.4 Percentage evaporation of substrates tested. 
 
Substrate % Evaporation 
Bicyclo[3.2.0]hept-2-en-6-one 10 
(1R)-(+)-camphor 29 
Norcamphor 2 
(1R)-(-)-fenchone 51 
(+)-dihydrocarvone 31 
Cyclohexanone 6 
Cycloheptanone 26 
Cyclooctanone 8 
Substrates were added to LB-glycerol media and shaken for 1 hour at 30 oC and 1000 
rpm. Percentage Evaporation is the percentage difference between the initial 
concentration and final concentration of substrate after 1 hour of incubation. 
 
The identification of new substrates for whole cell biotransformations capable of 
undergoing the Baeyer-Villiger oxidation represents a major finding of this work.  
In addition, the use of whole cells is an important advantage whereby the need 
for expensive NADPH regeneration systems is eliminated.  The automated 
approach can be used to systematically evaluate a range of conditions to optimise 
conversion with norcamphor and cycloheptanone, identify those needed to 
achieve conversion from (+)-dihydrocarvone, (1R)-fenchone, (+)-camphor and 
cyclooctanone and test more reaction substrates or CHMO expressing systems.  
 
 
 
 
 165 
4.2.3 Automated Process Optimisation 
 
It has been established that the automated process can effectively collect data on 
a range of parameters influencing CHMO expression and on CHMO-mediated 
reactions.  From such data the impact on growth and bioconversion stages can be 
rapidly assessed.  The final aim in this work was to demonstrate automated 
process optimisation by selecting the best conditions from each of the studies 
with the view to scale-up those conditions.  Therefore the optimised process 
involved a 3-hour growth at a 500 !L fill volume to ensure the highest CHMO 
activity and no oxygen limitation.  In view of process scale-up at matched KLa 
conditions, it was also of interest to keep a constant fill volume for both growth 
and bioconversion steps.  This is why 500 !L was preferred to 600 !L for the 
growth fill volume as studies have shown there is no significant difference 
between the results achieved at these volumes.  Following growth, a 1-hour 
bioconversion was carried out at a bicyclo[3.2.0]hept-2-en-6-one concentration 
of 0.5 gL-1, which is the highest working substrate concentration before 
inhibition effects occur and substrate toxicity become detrimental to the process.  
A range of amino acid formulations were tested in section 4.2.1.3.  However, 
although bacteriological peptone was found to be the best medium, LB-glycerol 
was used for all other experiments and in order to avoid unexpected effects 
resulting from interactions between the parameters, as already observed in 
section 4.2.1.3, it was decided to select LB-glycerol media for the scale-up study.  
In Figure 4.10 A and B the results of the optimised automated run are shown 
alongside the original non-optimised process.  By adopting the best conditions 
found in this study, full conversion was achieved in just over 24 minutes within a 
1-hour bioconversion time and the process time was almost halved.  This was not 
possible originally due to a combination of substrate and product inhibition.  The 
specific CHMO activity also increased to 78.6 UgDCW-1 from 15 UgDCW-1 (over a 
400 % increase) achieved in the original process which was due to the 
improvement in biocatalysts activity and prevention of oxygen limitation.  
Following on from the success of the automated approach for process 
optimisation in this study it was of interest to apply it to the substrates tested in 
section 4.2.2.2. 
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Figure 4.10 Growth (A) and bioconversion kinetics (B) of E. coli TOP10 
[pQR210] biocatalyst catalysing bicyclo[3.2.0]hept-2-en-6-one (unfilled 
symbols) to lactone product (filled symbols) collected from a optimised (!) and 
non-optimised run ("). Error bars indicate the range of measured values about 
the mean. 
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An adapted automated run was conducted with the six new substrates.  In line 
with the findings of section 4.2.1.2 and 4.2.2.1, the effect of a longer 
bioconversion time, reduced substrate concentration and increased biocatalyst 
activity were investigated.  The growth was allowed to continue for only three 
hours at a fill volume of 1000 µL.  The effect of substrate concentration was not 
tested with all the substrates, however, initial studies with cycloheptanone 
indicated substrate inhibition effects.  For this reason after the growth stage, 0.5 
gL-1 of each substrate was added to cells and the bioconversion conducted at a 
500 µL fill volume and left to run for a total of 4 hours.  This approach was 
adopted to determine if a longer bioconversion time would promote conversion 
from the unproductive substrates.  In Figure 4.11 A the growth kinetics during 
the 3-hours of growth and 4-hours of bioconversion are shown.  In the original 
experiment, as shown in Figure 4.8 A, only minor changes in growth were 
observed during the 1-hour bioconversion whereas in the newly obtained results 
the difference is more significant.  Growth continues in the presence of both 
norcamphor and cycloheptanone, both of which have already been successfully 
bioconverted in the original study in section 4.2.2.2.  In the case of all the other 
substrates growth was found to be reduced and the lowest biomass concentration 
of 2.02 gDCWL-1 is observed from (+)-dihydrocarvone.  Results indicate that 
because the least amount of growth is observed from substrates that are not 
readily metabolised they may be damaging to the cell, preventing cell uptake.  In 
fact (+)-dihydrocarvone has been shown to have antimicrobial activity and is a 
common constituent of mint essential oils found in herbs which were 
traditionally used in food preservation (Sivropoulou et al., 1995). 
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Figure 4.11 (A) Growth and (B) bioconversion kinetics of E. coli TOP10 
[pQR210] with substrates (1R)-camphor (!), (1R)-fenchone (!), (+)-
dihydrocarvone ("), cyclooctanone (!), norcamphor (#) to 2-
oxabicyclo[3.2.1]octan-3-one ($) and cycloheptanone (%) to oxocan-2-one (&). 
Substrate addition was at the 3 h time point. Error bars indicate the range of 
measured values about the mean. 
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The substrate consumption and product formation profiles for each substrate are 
shown in Figure 4.11 B.  Norcamphor and cycloheptanone were metabolised at 
the fastest rate and full conversion of both was observed in just over an hour.  
The specific activities calculated from the initial rate of 2-
oxabicyclo[3.2.1]octan-3-one and oxocan-2-one formation were 61.2 UgDCW-1 
and 56.0 UgDCW-1, 3 and 5 times higher respectively, if compared to activity 
values typical of the original process.  From Figure 4.11 B results show that the 
improved conditions have resulted in an improvement in substrate depletion.  For 
cyclooctanone the reduction was found to be due to evaporation.  In the case of 
(1R)-camphor, (1R)-fenchone and (+)-dihydrocarvone after evaporation losses, 
results did indicate that substrate was being consumed.  In fact a potential 
product peak was visualised in the GC chromatograms from (1R)-camphor as 
shown in Figure 4.12 at a retention time of 9.23 minutes.  NMR and MS analysis 
would be required to determine if this was in fact a true product, namely 2-
oxabicyclo[3.2.1]1,7,7-trimethyloctan-3-one as observed previously (Abril et al., 
1989).  However, because the level produced was very low and could not be 
quantified without a product standard these studies were not conducted as part of 
this work.   
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Figure 4.12 GC chromatogram of (1R)-camphor (retention time: 10.76 minutes) 
bioconversion after (A) 0 hours and (B) 4 hours. Peak at a retention time of 9.23 
minutes is a potential camphor product and peak at 6.34 minutes is DMSO used 
to solubilise camphor during the bioconversion. 
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Successful bioconversion of (1R)-camphor, (1R)-fenchone, (+)-dihydrocarvone 
and cyclooctanone have been reported using purified enzyme.  It was therefore of 
interest to determine if the lack of bioconversion observed in this work was due 
to mass transfer limitations to the cell.  The NADPH consumption assay, 
conducted as described in section 2.6.8, was used to assess this effect.  Cell 
samples taken from the automated run after 3 hours of growth, and prior to 
bioconversion, were prepared accordingly, as described in section 2.6.8.1, and 
the cell lysate containing CHMO was used in the assay.  Due to solubility issues 
two experiments where done.  Norcamphor, cycloheptanone and cyclooctanone 
were all dissolved in 50 mM TRIS-HCL pH 9 when added to the assay and 
compared to the natural substrate cyclohexanone also dissolved in buffer.  (1R)-
Camphor, (1R)-fenchone and (+)-dihydrocarvone were all poorly water soluble 
and were dissolved in DMSO.  In order to consider any effects of DMSO, 
cyclohexanone was also dissolved in this solvent and used for comparison 
purposes.  Once substrate was added to the assay, NADPH consumption was 
monitored and the specific activity calculated as shown in Table 4.5.  Figure 4.13 
shows the percentage relative activity of each substrate compared to 
cyclohexanone which was set to 100 %.  Similar to the bioconversion results 
norcamphor was found to be the best substrate out of the six tested, followed by 
cycloheptanone in terms of specific activity.  Interestingly, (1R)-camphor, (1R)-
fenchone and (+)-dihydrocarvone also had specific activities which were not far 
from that achieved with cycloheptanone.  Cyclooctanone produced the lowest 
observed specific activity and was just 9 % of that achieved with cyclohexanone.  
Product formation was not tested however a measurable specific activity implies 
the enzyme is oxidising the substrate and CHMO does show activity to all the 
substrates tested in this work.  These results confirm that mass transfer limitation 
into the cell is a contributory factor in preventing successful metabolism as 
reported previously with bicyclo[3.2.0]hept-2-en-6-one (Doig et al., 2002).  
Furthermore, the hydrophobic nature of certain substrates is potentially hindering 
the reaction by preventing effective dispersion and thus contact with the cell 
(Marques et al., 2007). 
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Table 4.5 CHMO specific activity in the presence of substrates. 
 
Substrate Specific Activity* (UgDCW-1) 
Dissolved in Buffer 
Cyclohexanone 22.0 
Norcamphor 18.6 
Cycloheptanone 14.8 
Cyclooctanone 2.1 
Dissolved in DMSO 
Cyclohexanone 26.1 
(1R)-(-)-fenchone 17 
(+)-dihydrocarvone 15.6 
(1R)-(+)-camphor 17.7 
* Calculated from CHMO assay results. 
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Figure 4.13 Percentage relative activity of CHMO in the presence of each 
substrate compared to the natural substrate cyclohexanone. 
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4.3 Concluding Remarks 
 
An automated platform for rapid microscale data collection was established in 
Chapter 3.  This was shown to generate reproducible results on multiple days 
with a higher degree of consistency and accuracy if compared to manual 
alternatives.  In line with reducing production costs, a current challenge is the 
development of more efficient bioprocesses and the automated platform could be 
an ideal tool for achieving this goal.  In order to demonstrate its potential, the 
approach was used for whole bioprocess evaluation in view of defining 
optimised process conditions for the CHMO-based system. 
 
Three factors influencing CHMO specific activity were chosen including oxygen 
transfer rate, biomass concentration and amino acid source.  The dependence on 
oxygen was found to be critical where, in the event of oxygen limitation, both 
growth and biocatalyst activity were compromised.  It was found that reducing 
the microwell fill volume could overcome this issue due to an increase in oxygen 
transfer rate.  However, this was only effective for volumes as low as 600 µL fill 
volume while further volume reductions had no significant improvement.  The 
biomass concentration was also found to be a rate-limiting step where once 2 
gDCWL-1 had been exceeded the decrease in specific activity was considerable.  
This was partly due to oxygen limitation, where oxygen is supplied in preference 
for growth rather than biocatalysis, but also because the CHMO titre was found 
to decrease at increasing biomass concentrations.  Improving the oxygen supply 
was a reasonable solution, although a more effective approach was to reduce the 
level of growth before oxygen limitation became detrimental.  Finally, the 
performance of CHMO was affected by the media formulation where a change in 
amino acid source from the original tryptone to bacteriological peptone caused a 
17 % improvement in specific activity.  Once the CHMO specific activity had 
been optimised it was important to consider a wide range of reactions.  Substrate 
inhibition is a common problem and in this work it was found to limit the 
reaction above 0.5 gL-1 of bicyclo[3.2.0]hept-2-en-6-one due to detrimental 
effects on cell viability.  Due to the industrial interest a clear use of the 
automated approach is to screen for new CHMO substrates and six substrates, 
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previously untested with this strain, were investigated.  Two out of the six were 
successfully metabolised and the respective products confirmed by NMR, MS 
and IR analysis to be consistent with those reported from other CHMO 
expressing systems.   
 
By combining the best conditions from each of the studies the ultimate aim was 
to develop an optimised bioprocess for eventual scale-up.  The growth was 
carried out for 3 hours at a 500 µL fill volume to prevent the onset of oxygen 
limitation and to produce highly active CHMO for a bioconversion operated at 
0.5 gL-1, below the substrate inhibitory limit.  A almost 2-fold drop in processing 
time and over a 5-fold increase in CHMO specific activity was observed where 
full conversion of bicyclo[3.2.0]hept-2-en-6-one to the respective lactones was 
achieved in under 25 minutes.  This represented a considerable improvement on 
the original process.  Optimised conditions were also found to benefit the 
conversion of norcamphor and cycloheptanone while mass transfer limitations 
were identified as being responsible for the lack of product formation from (1R)-
camphor, (1R)-fenchone, (+)-dihydrocarvone and cyclooctanone.   
 
In conclusion, automated microscale approaches have proved effective for media 
recipe selection, substrate specificity studies and most importantly process 
optimisation.  However, the development of novel oxidative systems presents an 
important challenge where there is limited research and would clearly benefit 
from rapid evaluation.  In Chapter 5 the automated platform will be applied to 
two novel cytochrome P450 biocatalysts illustrating its potential for a range of 
systems.  Chapter 6 includes results focussing on the scale-up of the optimised 
microscale work presented in this chapter. 
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5 Microscale Process Development of Novel Cytochrome 
P450 Biocatalysts 
 
5.1 Introduction 
 
The ability to rapidly generate data on whole bioprocesses using automated 
microscale technologies was presented in Chapters 3 to 4.  The approach could 
be applied to a range of biocatalytic systems to allow quicker identification of 
optimised process conditions, making them more applicable for large-scale 
development.  One group of enzymes that could particularly benefit from the 
approach are cytochrome P450s.  
 
Cytochrome P450s are a superfamily of haemoprotein monooxygenases which 
have been studied for over 50 years due to their vast reaction ability which 
includes hydroxylations, isomerisations, dehydrogenations and carbon-carbon 
bond cleavage (Klingenberg, 1958; Garfinkel, 1958; Werck-Reichhart and 
Feyereisen, 2000).  However, as discussed in section 1.2.3.1.2.1, exploiting the 
reaction ability can be a challenging task.  Specific P450s biocatalysts are 
membrane bound and the requirement for complex electron transport systems 
makes heterologous expression difficult.  In addition, isolated enzymes require 
efficient NAD(P)H regeneration systems.  The use of whole cell systems can 
overcome some of these issues while physiological problems concerning 
substrate uptake, product/substrate toxicity, product degradation and poor 
substrate solubility may arise (van Beilen et al., 2003).  The original expression 
system may not be the optimal producer of the target P450 biocatalyst.  For 
example, mammalian cytochrome P450s can metabolise drugs (Parikh et al., 
1997), steroids (Williams et al., 2000) and herbicides (Inui et al., 2000), however 
their expression yields can be limited (Fischer et al., 1992; Jansson et al., 2000).  
The discovery of novel self-sufficient P450s which have been cloned into E. coli 
expression systems makes them attractive for further research (Roberts et al., 
2002; Liu et al., 2006; Zhang et al., 2010).  Hussain and Ward (2003 b) 
developed two such systems where the cytochrome P450 and adjacent ferredoxin 
from Streptomyces griseolus were combined with the ferredoxin reductase from 
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Streptomyces coelicolor and successfully expressed in E. coli.  It was found that 
the inclusion of the ferredoxin reductase along with the choice of E. coli host 
strain enabled high level expression of the two P450s, cytochrome P450SU1 and 
cytochrome P450SU2.  In addition, both were found to catalyse the O-
dealkylation of 7-ethoxycoumarin, a xenobiotic compound, to the fluorescent 7-
hydroxycoumarin as shown in reaction scheme 5.1.  There are a number of 
beneficial reactions associated with dealkylations including drug metabolism (La 
et al., 1955).  In particular, 7-ethoxycoumarin has typically been used to monitor 
P450 activity in hepatic and extrahepatic tissues (Phillips and Shephard, 2006).  
In the original host strain P450SU1 and P450SU2 were able to metabolise 
sulfonylurea herbicides to compounds less poisonous to plants, thus highlighting 
them as potential bioremediation biocatalysts (O’keefe et al., 1991).  
 
 
 
Reaction Scheme 5.1 P450 catalysed O-dealkylation of 7-ethoxycoumarin to 7-
hydroxycoumarin. 
 
The number of industrial processes utilising P450s is limited.  Traditionally, 
P450 monooxygenases have been utilised in toxicity determination or to 
elucidate the effects of xenobiotic compounds in vivo (Urlacher and Sabine, 
2006).  Commercial examples include the biotransformation of the steroid 
hydrocortisone produced at 100 ton/yr by Bayer Pharmaceuticals using P450 
monooxygenases to conduct 11!-hydroxylation (Sonomoto et al., 1983), the 
production of cortisone from progesterone by Pfizer (Peterson, 1952), and 
production of Pravastatin by microbial oxidation of compactin by Bristol-Myers 
Squibb Company.  Considering the P450 reaction repertoire as addressed in 
section 1.2.3.1.2.1 there is great potential for increased industrial uptake.  Future 
applications could include antibiotic synthesis (Andersen et al., 1993), anticancer 
drug synthesis (Jennewein et al., 2005), bioremediation (Guengerich, 1995; 
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Kellner et al., 1997), polymer (Picataggio et al., 1992) and flavour (Wust and 
Croteau, 2002) production where P450s have been found to catalyse useful steps 
in these areas.  Further research in this area is needed to develop strategies aimed 
at optimising yields and overcoming the shortcomings.   
 
The aim of this chapter is to adapt the established automated approach developed 
in Chapter 3 for the investigation of cytochrome P450s.  In this study the 
recombinant strains developed by Hussain and Ward (2003 b), E. coli BL21 Star 
(DE3)pLysS [pQR367] (referred to here on as E. coli [pQR367]) expressing 
P450SU1 its ferredoxin from Streptomyces griseolus and the ferredoxin 
reductase SCF15a from Streptomyces coelicolor, and E. coli BL21 Star 
(DE3)pLysS [pQR368] (referred to here on as E. coli [pQR368]) expressing 
P450SU2 its ferredoxin from Streptomyces griseolus and the ferredoxin 
reductase SCF15a from Streptomyces coelicolor, were used.  The bioconversion 
of 7-ethoxycoumarin was only touched upon in previous work.  Hence, strategies 
to improve this bioconversion were employed to demonstrate the utility of the 
adapted automated process.  The experimental approach and methodology used 
in this work have been described in Chapter 3.  The results are presented and 
discussed in section 5.2 and the chapter closes with a summary of findings in 
section 5.3. 
 
5.2 Results and Discussion 
 
5.2.1 Production of Cytochrome P450SU1 and P450SU2 
 
Prior to the development of microscale cultivations it was important to test the 
growth and bioconversion of E. coli [pQR367] and E. coli [pQR368] following 
the established culture and expression protocols reported by Hussain and Ward 
(2003 b).  The presence of the correct P450 and ferredoxin reductase genes were 
confirmed by sequence analysis (as described in section 2.2.2.3) after 
transformation of the plasmid into E. coli BL21 Star (DE3)pLysS for both 
strains.  Figure 5.1 shows an example of the shake flask growth kinetics results 
of induced and non-induced cultures of E. coli [pQR367] and E. coli [pQR368] 
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along with an induced negative control culture of E. coli BL21 Star (DE3)pLysS.  
100 mL Terrific broth (TB) was inoculated with 1 % inoculum (as described in 
section 2.2.2.4) in 500 mL shake flasks and incubated at 250 rpm and 37 oC.  
Similar growth profiles were observed from all cultures, characterised by a one 
hour lag phase potentially due to different inoculum and culture medium (LB and 
TB, respectively).  Cells were grown until an OD of 0.6-0.8 (typically after 2.7-3 
hours of growth).  Specific growth rates for induced cultures of 1.18 h-1, 1.21 h-1 
and 1.22 h-1 were calculated for E. coli [pQR367], E. coli [pQR368] and E. coli 
BL21 Star (DE3)pLysS, respectively.  
 
At an OD of 0.6-0.8 conditions were changed to promote expression.  
Cytochrome P450s have a haem prosthetic group, which is the essential active-
oxygen carrying group of these P450s, and haem precursors such as !-
aminolevulinic acid (ALA) and ferric chloride (FeCl3) supplementation have 
been found to increase the level of spectrally measurable P450 (Imai and Sato, 
1993; Jansson et al., 2000; Hussain and Ward, 2003 b).  Hence, both ALA and 
FeCl3 were added to the culture 20 minutes prior to IPTG induction of the 
respective P450s and incubated at 25 oC and 180 rpm for the remainder of the 
culture.  This change in culture condition is responsible for the slight reduction in 
growth present in Figure 5.1 from the third hour of growth onwards.  The time of 
ITPG addition was previously found to have no effect on biocatalyst expression 
(Hussain and Ward, 2003 b).  However, the optimal expression of P450SU2 was 
measured between 24 and 35 hours of induction (Hussain and Ward, 2003 b) 
therefore in the present work cultures were run for a total of 30 hours.  A 
significant decrease in growth is observed after 25 hours of culture due to a 
increased dead cell population.  Cells were harvested after 30 hours of growth 
where induced cultures of E. coli [pQR367], E. coli [pQR368] and E. coli BL21 
Star (DE3)pLysS reached a final biomass concentration of  3.16 gDCWL-1, 3.41 
gDCWL-1 and 2.91 gDCWL-1, respectively.  Figure 5.1 shows little difference 
between induced and non-induced culture indicating that enzymatic expression 
has no effect on the growth of these strains.     
 
In order to quantify the level of active P450 expression, samples were analysed 
spectroscopically using a carbon monoxide (CO) based assay as described in 
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section 2.6.9 and the amount of active P450SU1 and P450SU2 was calculated 
from the CO difference spectrums shown in Figure 5.2 A and B respectively.  
Cytochrome P450s can exist in two states, an active high spin state termed 
‘cytochrome P450’ and an inactive low spin state termed ‘cytochrome P420’.  
This terminology originates from the presence of soret peaks at wavelengths of 
450 nm and 420 nm in CO difference spectra as described by Omura and Sato 
(1964).  Both forms can be observed in the spectrum for P450SU1 with 25 ± 1.1 
nmol of active P450 per gram of soluble protein (nmolg-1) whereas only the 
active form is visible in the P450SU2 spectrum with 391 ± 1.6 nmol of active 
P450 per gram of soluble protein.  Values achieved in this work are lower than 
those reported previously and are summarised in Table 5.1, however this may be 
attributed to differences in sample harvest time.  While this effect was observed 
on P450SU2 expression, P450SU1 expression was found to be less than half the 
value achieved previously.  P450SU1 is the less productive biocatalysts and, as 
shown in Figure 5.2 A, susceptible to forming the inactive P420.  Hence, a longer 
expression time was considered to be beneficial for this biocatalyst.  
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Figure 5.1 Growth kinetics of E. coli [pQR367] (!), E. coli [pQR368] (") and 
E. coli BL21 Star (DE3)pLysS (control) (!) during a induced (closed symbol) 
and non-induced (open symbol) shake flask culture catalysing 7-ethoxycoumarin 
to 7-hydroxycoumarin. Error bars indicate the range of measured values about 
the mean. 
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Figure 5.2 Representative CO difference spectra of (A) P450SU1 expressed in 
E. coli [pQR367] and (B) P450SU2 expressed in E. coli [pQR368]. Samples 
were from cultures where no 7-ethoxycoumarin was added. 
 
 
 
 
 
!"
#"
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Table 5.1 Summary of P450 expression from shake flask cultures. 
 
Strain P450 Expression (nmolg-1) 
pQR368 391 ± 1.6 
pQR367 25 ± 1.1 
pQR368* 413 
pQR367* 55 
* Represents results from Hussain and Ward, (2003 b). 
 
The bioconversion was initiated by the addition of 1 mM of 7-ethoxycoumarin to 
cultures 10 minutes after induction.  In Figure 5.1 7-ethoxycoumarin was present 
in all cultures from the third hour of growth onwards.  TLC analysis of culture 
samples (prepared as described in section 2.6.6) was used as a quick test for the 
production of 7-hydroxycoumarin, more commonly known as Umbelliferone, as 
shown in Figure 5.3 prior to HPLC.  Using standards of 7-hydroxycoumarin 
(column P), product spots were only detected in induced cultures.  TLC sheets 
were stained with permanganate for better visualisation of the substrate which, as 
shown in Figure 5.3 B, was present in all samples.  HPLC analysis (as described 
in section 2.6.5) was used to quantify the final product yield after 30 hours of 
culture as shown in Figure 5.4 (sample HPLC chromatograms of shake flask 
bioconversions can be found in appendix B).  No product was detected in non-
induced or control cultures in agreement with results obtained from TLC.  A total 
of 1.6 mgL-1 and 4.3 mgL-1 was produced from induced cultures of E. coli 
[pQR367] and E. coli [pQR368] respectively. 
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Figure 5.3 TLC analysis showing the bioconversion of 7-ethoxycoumarin to 7-
hydroxycoumarin. (A) Shows compounds under UV light. Column S and P 
contain standards of 7-ethoxycoumarin and 7-hydroxycoumarin in ethyl acetate. 
(B) Shows compounds stained with permanganate and visualised under UV light. 
Columns 2, 4 and 5 are from induced cultures of E. coli [pQR368], E. coli 
[pQR367] and E. coli BL21 Star (DE3)pLysS (control). Columns 1 and 3 are 
from non-induced cultures of E. coli [pQR368] and E. coli [pQR367].  
 
Figure 5.4 7-hydroxycoumarin concentration after 30 hours of induced and non-
induced culture of E. coli [pQR368], E. coli [pQR367] and induced culture of E. 
coli BL21 Star (DE3)pLysS (control). Error bars indicate the range of measured 
values about the mean. 
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Hussain and Ward (2003 b) reported the successful O-dealkylation of 7-
ethoxycoumarin to 7-hydroxycoumarin, however they did not report the yield 
obtained.  Results from a group using the same strains with 7-ethoxycoumarin 
were also reported by the University of Edinburgh (unpublished data), where low 
7-hydroxycoumarin yields between 2 and 5 % from E. coli [pQR368] and no 
conversion from E. coli [pQR367] were achieved.  This is in agreement with the 
results presented in Figure 5.4 whereby P450SU2 was found to be a better 
biocatalyst than P450SU1.  The results can be explained by the associated 
ferredoxin as it has been reported that Fd-2, which is adjacent to P450SU2, is 
more effective at restoring monooxygenase activity to mixtures of purified P450 
(O’keefe et al., 1991).  In addition, the low level expression of P450SU1 
compared to P450SU2 has been attributed to rare codons present in the P450SU1 
gene which may not be provided for by the expression strain (Hussain and Ward, 
2003 b). 
 
The high level expression of P450SU1 and P450SU2 as shown here has been 
reported previously and yet the biotransformation ability of 7-ethoxycoumarin is 
poor.  Increasing biotransformation efficiency is important if environmentally 
compatible alternatives to chemical synthesis are to be exploited for industrial 
application.  Poor bioconversion can inevitably be due to poor substrate 
specificity.  However, it was of interest to investigate if the O-dealkylation could 
be improved considering the benefits of this reaction.  This includes increasing 
molecule hydrophilicity, improving their pharmaceutical activities and increasing 
the industrial applicability (Niraula et al., 2001).  Section 5.2.2 will outline the 
methodology used to develop the automated approach for the investigation of 
P450SU1 and P450SU2 in view of applying it for biotransformation 
improvement as addressed in section 5.2.3.   
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5.2.2 Automated Microscale Production of Cytochrome P450s 
 
5.2.2.1 The Effect of Temperature During Expression  
 
The automated process described in section 3.2.6 was used as an initial platform 
to develop the process automation of cytochrome P450s.  96-DSW plates were 
selected among other microwell formats as found suitable for both aerobic 
culture and bioconversion demands.  It was considered appropriate to use similar 
microwell culture conditions to those established in Chapter 3 due to host 
similarties.  In particular, as described in section 2.3.2.2, wells were 
automatically filled with 1 mL TB and inoculated with 1 % v/v E. coli [pQR368] 
and/or E. coli [pQR367].  Cells were incubated at 1000 rpm and 37 oC until an 
OD of 0.6-0.8 was reached.  The conditions under which biocatalyst expression 
can be initiated are important, temperature in particular.  The expression 
temperature of 25 oC was used in shake flask cultures and it has been reported 
that culture temperature must be returned to 30 oC prior to induction with IPTG 
(Phillips and Shephard, 2006).  This is because recombinant E. coli protein 
expression at 37 oC can often lead to inactive protein aggregates, known as 
inclusion bodies, and a decrease in temperature has been found to prevent 
inclusion body formation (Schein, 1989; Vasina and Baneyx, 1996; Delcarte et 
al., 2003).  Furthermore, Lu and Mei (2007) found that the optimum induction 
temperature for the expression of P450 BM3 was 30 oC.  When a temperature of 
37 oC was used a significant decrease in specific activity was observed.  
However, Taylor et al. (1999) reported the presence of P420 (inactive P450) in 
inclusion bodies formed after induction.  Additionally, it is recommended by the 
manufacturer of the pET vector system as used in this work that the temperature 
is lowered during expression to ensure production of soluble enzyme and 25 oC 
was found by Zhang et al. (2010) to be optimum for P450SMO expression who 
also used the pET vector system.  A temperature study as described in section 
2.3.2.1.1 was conducted to ensure the correct expression incubation temperature 
was reached prior to induction.  Figure 5.5 shows that after an initial incubation 
at 37 oC it took approximately 20 minutes for a temperature of 25 oC to be 
reached in all wells which then remained constant.  A 20 minute incubation 
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period with ALA and FeCl3 was required before induction which was also 
sufficient time for the correct induction temperature to be reached.   
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Figure 5.5 Cooling time required to achieve the correct induction temperature of 
25 oC.  
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5.2.2.2 The Effect of Agitation Speed 
 
The agitation speed used during expression is cytochrome P450 dependant where 
both gentle and fast shaker speeds have been found beneficial for expression.  
For example with P450c17 (a microsomal steroidogenic P450) low shaking 
speeds of 150 rpm were found optimal for expression whereas higher shaking 
speeds of 210 rpm were found optimal for P450scc (a mitochondrial 
steroidogenic P450) (Phillips and Shephard, 2006).  Similarly, Jansson et al. 
(2000) found the best shaker speed for CYP1B1 (a human heamoprotein) was 
150 rpm whereas CYP101 (cytochrome P450cam) expression was poor at this 
shaker speed and required higher rates from 175 rpm to 200 rpm.  In the case of 
P450SU1 and P450SU2 expression following the original protocol (Hussain and 
Ward, 2003 b) which was replicated in section 5.2.1 demonstrated a gentle 
shaking speed was required.  In Figure 5.6 and Figure 5.7 the effect of agitation 
speed during expression on the growth and bioconversion using both strains is 
presented.   
 
Three agitation speeds were tested.  At 600 rpm a clear reduction in growth can 
be observed compared to results obtained at 800 rpm and at 1000 rpm.  This is 
probably due to an oxygen limitation as insufficient agitation results in 
inefficient gas-liquid mass transfer (Duetz and Witholt, 2004).  When the 
agitation speed is reduced an increase in cell sedimentation in wells was also 
observed in some cases.  This is probably due to the extended culture times of 
over 30 hours required for P450 expression.  Additionally, as cell numbers 
increase low agitation rates are unable to keep all cells in suspension.  This effect 
was described by Marques et al. (2007) who observed that reducing agitation 
rates resulted in cell cluster formation and accumulation on the well bottom.  At 
800 rpm there is no oxygen limitation, while further increases in agitation up to 
1000 rpm had no further improvement in growth.   
 
The formation of 7-hydroxycoumarin was next assessed at each agitation speed 
tested.  Figure 5.7 shows that increasing the agitation rate from 600 rpm to 800 
rpm causes a 65 % increase in product concentration expressed from P450SU2, 
 190 
whereas there is little change from P450SU1.  However, further agitation 
increases up to 1000 rpm caused a drop in product concentration from P450SU2, 
lower than that achieved at the lowest agitation rate tested of 600 rpm.  
Moreover, no product was detected from P450SU1, at least at levels that could 
be detected by the HPLC assay.  This result demonstrates the importance of 
agitation rate selection in P450 bioconversion.  Jansson et al. (2000) described 
that high agitation rates inhibited expression of human P450 CYP1B1 expressed 
in E. coli and suggested that cell integrity was damaged due to incorporation of 
haemoprotein in the cytoplasmic membrane.  In this work low agitation rates can 
lead to non-homogenous mixtures, cell settling and oxygen limitation.  Hence, 
800 rpm was chosen for microwell expression as it promoted good mixing, 
oxygen limitation did not occur and the yield of 7-hydroxycoumarin was 
improved. 
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Figure 5.6 The effect of microwell agitation rate on growth of E. coli [pQR367] 
(!) and E. coli [pQR368] ("). 600 rpm (unfilled symbols), 800 rpm (grey filled 
symbols), 1000 rpm (black filled symbols). Error bars indicate the range of 
measured values about the mean. 
 
 
Figure 5.7 The effect of microwell agitation rate on 7-hydroxycoumarin 
production from E. coli [pQR367] expressing P450SU1 (grey bars) and E. coli 
[pQR368] expressing P450SU2 (white bars). Error bars indicate the range of 
measured values about the mean. 
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5.2.2.3 The Influence of Microwell Fill Volume 
 
In Chapter 4 microwell fill volume was found to be an important parameter in 
controlling oxygen levels.  The effect of microwell fill volume was thus 
investigated in this work to determine the optimal working volume for the 
system.  In the study initial fill volumes ranged from 400 !L up to 1000 !L and 
cells were cultured at 1000 rpm and 37 oC until an OD of 0.6-0.8.  The agitation 
and temperature was dropped to 800 rpm and 25 oC for expression and incubated 
with ALA and FeCL3 which was followed by induction and then bioconversion.  
Figure 5.8 shows the effect of fill volume on E. coli growth kinetics.  Results do 
not show a significant effect of fill volume, however the highest and lowest 
biomass concentrations were achieved at the highest and lowest fill volume, 
respectively.  In Chapter 4 it was found that decreasing the fill volume increased 
the oxygen transfer rate resulting in an increase in growth.  This effect was not 
observed with E. coli BL21 Star (DE3)pLysS where the effect of evaporation on 
larger volumes is reduced and can sustain higher cell concentrations.  Whereas, 
the effect of evaporation on low volumes is pronounced due to increased 
gas/liquid interfacial area (Marques et al., 2007) and the concentrating effect on 
media components such as salts may be detrimental to growth.  The increased 
headspace as a result of reduced volumes in microwells has also been reported to 
cause void formation where the centrifugal force will project liquid towards the 
walls (Marques et al., 2007) this may also be responsible for the reduced growth.   
 
Figure 5.9 shows increased well volumes have a beneficial effect on product 
yields.  The concentration of solutes which may be detrimental for growth may 
also be responsible for the reduction in bioconversion where a 40 % reduction in 
fill volume causes a 42 % decrease in product concentration.  Due to the 
beneficial effects of reduced fill volumes observed during the CHMO studies 
these results are difficult to elucidate without further investigations.  It is 
speculated that high oxygen transfer rates may be damaging to the P450 
biocatalysts.  In section 5.2.2.2 (Figure 5.7) increasing the agitation rate to 1000 
rpm resulted in no product formation from E. coli [pQR367] and in the present 
study reductions in fill volume also reduced the product level.  Increasing 
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agitaiton and reducing the fill volume should both result in increased oxygen 
transfer however in these studies particular conditions (above 800 rpm and below 
1000 !L) are deterimental to product formation.  Further studies need to be done 
to measure the DOT at each condition and also the activity of the biocatalyst to 
confirm if high DOT is responsible for a reduction in bioconversion 
performance.  From these findings 1000 !L was used as the culture working 
volume due to increased product concentrations and the reduced impact of 
evaporation over extended culture times.   
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Figure 5.8 The effect of microwell fill volume on growth E. coli [pQR367]. 
1000 !L (!), 800 !L (!), 700 !L (!), 600 !L ("), 500 !L (#), 400 !L ($). 
Error bars indicate the range of measured values about the mean. 
   
 
Figure 5.9 The effect of microwell fill volume on 7-hydroxycoumarin 
production from E. coli [pQR367] expressing P450SU1. Error bars indicate the 
range of measured values about the mean. 
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5.2.2.4 The Effect of Microwell Evaporation 
 
Considering the extended culture times involved in the production of the 
cytochrome P450s it was considered important to quantify the effects of 
evaporation.  Wells of a 96-DSW plate were filled with 1000 !L TB and shaken 
at 25 oC and 800 rpm for a total period of 24 hours as described in section 
2.3.2.1.2.  The well content was weighed after 1, 10 and 24 hours and the liquid 
loss calculated.  Figure 5.10 shows the effect of evaporation in different wells of 
the plate over the 24 hour time period.  A difference in evaporation associated 
with the well position can be observed.  The highest evaporation rate of 5 uLh-1 
was calculated for wells located at the top left of the plate and the lowest 
evaporation rate of 4 uLh-1 for wells located in the middle right section of the 
plate.  On average a rate of evaporation of 5 uLh-1 can be calculated from all 
wells.  This value amounts to 15 % of the wells contents in a total of 30 hours of 
culture.  Duetz and Witholt (2001) reported after 20 days of culture a total loss of 
27 % of the well contents whilst using an appropriate cover to prevent excessive 
evaporation and humidified conditions.  A maximum liquid loss of 15 % was 
considered acceptable for this work however cultures should not be run for 
considerably longer than 30 hours.  Nevertheless, it is important to quantify the 
level of evaporation and to evaluate methods to reduce it.   
 
A potential solution to excessive evaporation in microwell format could be the 
use of a membrane.  A gas permeable membrane (Breath-easy) was selected 
which allows the diffusion of oxygen and reduces evaporation.  A culture was 
carried out in a 96-DSW plate where half of the plate was covered with a Breath-
easy membrane and the other half was left open.  The results of the study are 
shown in Figure 5.11.  The use of a permeable membrane has a significant effect 
on the cell growth of both strains causing a reduction by nearly 50 % when the 
membrane is used.  Similarly Marques et al. (2009) reported a 50 % reduction in 
oxygen transfer rates when using a sealing tape on microwell plates to prevent 
evaporation.  
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Figure 5.10 The effect of well position on the amount of liquid evaporated from 
a 96-DSW plate at 25 oC and 800 rpm. Plate locations: top left (!), top right 
(!), middle left (!), middle ("), middle right (+), bottom left (#), bottom right 
($). Error bars indicate the range of measured values about the mean. 
 
 
Figure 5.11 The effect of covering wells with a gas permeable membrane (open 
symbols) on the culture of E. coli [pQR367] (#) and E. coli [pQR368] (!) 
compared to uncovered wells (closed symbols). Error bars indicate the range of 
measured values about the mean. 
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Zimmermman et al. (2003) tested a range of plastic seals and concluded that 
none of the products tested could provide both high oxygen permeability and 
high water vapour retention.  Using an open system enables overnight sampling 
which would have been otherwise impossible using the robotic disposable tips 
with a sealed plate.  Fixed tips can be installed, however, there is a risk of well-
to-well contamination due to sample carry over thus reducing the number of 
samples that can be withdrawn.  Continual piercing of membranes may also 
result in damage over time.  Overcoming problems such as evaporation is an 
important practical issue and an interesting solution would be the development of 
an automated plate opening/closing system with an appropriate gas permeable 
lid.  A lid similar to that developed by Duetz et al. (2000), who reported 
evaporation rates of 20 !L per well per day and has been widely employed for 
mammalian and bacterial culture would be worth investigating.  It is important to 
note that these rates were achieved at a humidity of 50 % and accurate control of 
humidity was not available in the system used in this work.  For this reason it 
was decided to conduct the experiments with no permeable membrane which 
would significantly alter the oxygen transfer rate and consequently impact the 
cell growth and biocatalyst productivity. 
 
5.2.2.5 Automated Data Collection on Cytochrome P450s 
 
From the studies already discussed in sections 5.2.2.1 to 5.2.2.4 the automated 
run used in this work involved a microwell growth phase at 1 mL, 37 oC and 
1000 rpm until an OD of 0.6-0.8 then a expression phase at 1 mL, 25 oC and 800 
rpm followed by induction and substrate bioconversion.  Considering the 
extended culture time it was important to develop a sampling strategy which 
would allow data to be collected on both growth and bioconversion during a 30 
hour culture for bioprocess evaluation.  The first strategy was to sample every 5 
hours of culture using a sacrificial well approach.  This would allow the impact 
of three factors on two strains or six factors on one strain to be tested in a single 
plate/automated run.  Figure 5.12 shows the product formation results obtained 
during 30 hours of culture.  No product was detected prior to 20 hours of culture. 
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A likely reason for this finding could be due to the product levels being too low 
to be detected.  Alternatively, product may have only been produced after 20 
hours of culture due to very slow metabolism or reduced enzyme titre.  To 
investigate this further the initial protocol was altered.  Rather than adding the 
substrate after 3 hours of culture it was added after 25 hours of culture which is 
the point of optimal enzyme expression as reported previously (Hussain and 
Ward, 2003 b).  An additional benefit of this approach is that as 7-
ethoxycoumarin is poorly water soluble, it had to be added dissolved in 100 % 
ethanol thus adding the substrate at a higher cell biomass would alleviate any 
adverse effects caused by the ethanol.   
 
Figure 5.13 shows the results of this study.  Product was only detected when 
substrate addition took place after 3 hours of culture, when substrate was added 
at the 25th hour nothing was detected.  This indicated that not only was the 
biocatalyst expression important but the substrate incubation time was also a 
crucial factor in bioconversion.  It has been reported that certain P450s are 
induced by xenobiotic compounds (Bolwell et al., 1994), particularly plant 
P450s, as expression is initiated as a means of protection to metabolise 
environmental pollutants.  In fact, the wild type organism Streptomyces griseolus 
expresses P450SU1 and P450SU2 when induced with sulfonylurea herbicides.  
Uno et al. (2008) also reported that the P450 1A expression increased when 
exposed to environmental pollutants.  However, in the E. coli expression system 
the P450 genes were separated from the native transcription control sequences 
and replaced with the artificial T7 promoter sequence thus 7-ethoxycoumarin is 
unlikely to induce P450SU1 and P450SU2 in this work.  The increased 
incubation time is most likely responsible for the increased bioconversion.  
Additionally, other factors including poor substrate solubility, inefficient 
transport into cells (Urlacher and Girhard, 2012) and slow dealkylation are likely 
explanations for the observed behaviour.  
 
 
 
 
 
 199 
 
Figure 5.12 7-hydroxycoumarin production from E. coli [pQR367] (grey bars) 
and E. coli [pQR368] (white bars). Substrate addition took place after 3 hours of 
culture. No product detected prior to 20 hours of culture. Error bars indicate the 
range of measured values about the mean. 
 
 
Figure 5.13 The effect of substrate addition time on 7-hydroxycoumarin 
production from E. coli [pQR367] (grey bars) and E. coli [pQR368] (white bars). 
Error bars indicate the range of measured values about the mean. 
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It was therefore decided that the sampling strategy would involve OD samples to 
be taken every 5 hour interval until the 25th hour and then every 1 hour for the 
remaining culture.  Bioconversion samples would only be taken at 0 hours and 
hourly during the last 5 hours of culture when there was a sufficient level of 
product to be detected by HPLC.  A schematic representation of the adapted 
automated approach for the evaluation of E. coli [pQR367] expressing P450SU1 
and E. coli [pQR368] expressing P450SU2 is shown in Figure 5.14.  
 
Similar to what was achieved for the CHMO process ‘walk away operation’ was 
developed in this work for cytochrome P450 studies.  Initially the platform is 
setup with the required plates and reagent reservoirs and an aseptic processing 
environment is prepared as described in section 2.3.2.2.  Samples are 
automatically collected throughout the culture and OD measured using the plate 
reader to obtain kinetic cell growth data.  User prompts are used to enable the 
operator to initiate the expression phase once the cells have reached a preset OD 
of 0.6.  Figure 5.15 shows an example of the user prompt used.  The prompt will 
appear at stage two in Figure 5.14.  Inserting a value lower than 0.6 will result in 
OD sampling to continue, while inserting a value greater than or equal to 0.6 will 
initiate the expression phase.  Due the nature of certain reagents the operator is 
required to add reagent reservoirs when they are needed to avoid likely 
degradation at room temperature.  However, apart from reagent addition, an 
operator is only needed for regular monitoring.  The system works independently 
for 30 hours and at the end of the process the operator will collect and freeze 
bioconversion samples at designated time points as shown in Figure 5.14.  At 30 
hours of culture the final OD and bioconversion samples are taken and a 1 mL 
aliquot frozen for analysis of CO reduced spectra as described in section 2.6.9.  
The process continues with an automated liquid-liquid extraction on samples 
collected during the bioconversion as described in section 2.3.2.2 for metabolite 
extraction and the organic layer automatically dispensed into eppendorfs after 
centrifugation.  These are then transferred to a fume cupboard for overnight 
evaporation and re-dissolved in acetonitrile for HPLC analysis.  Upstream and 
downstream process steps and analytical measurements (which include plate 
preparation, reagent addition, sampling) are all fully automated.  
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Figure 5.14 Schematic representation of the fully automated linked process sequence using E. coli [pQR367] and E. coli [pQR368] 
expressing cytochrome P450SU1 and P450SU2 respectively. Coloured wells represent filled wells as an example (orange: media and 
culture, blue: RO water).   
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Figure 5.15 User prompt to initiate expression phase. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 203 
The time required to obtain a sufficient number of cells for biocatalyst 
production and detectable bioconversion is 30 hours and this extended time 
period causes several challenges when working with microlitre amounts of 
material.  The reproducibility of data collection was assessed to ensure the data 
collected was not adversely affected by evaporation.  In particular, it was 
important to test both the reproducibility of growth and bioconversion on 
different days and from different areas of the plate to evaluate any “edge effects”.  
From Figures 5.16 A and B the growth of both E. coli [pQR367] and E. coli 
[pQR368] is very similar between triplicate data sets collected on three separate 
days in three separate areas of the plate using the automated approach shown in 
Figure 5.14.  A mean specific growth rate of 1.56 h-1 and 1.84 h-1 and final 
biomass concentration of 9.33 gDCWL-1 and 9.01 gDCWL-1 were obtained from the 
cultures of E. coli [pQR367] and E. coli [pQR368] respectively.  The calculated 
average and maximum errors were 5 % and 13 % for E. coli [pQR367] and 6 % 
and 13 % for E. coli [pQR368] between triplicate runs. 
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Figure 5.16 Reproducibility of growth kinetic data collected from three separate 
runs on the culture of (A) E. coli [pQR367] in different areas of a 96-DSW plate 
(!) columns 3-4, (") columns 7-8 and (!) columns 11-12 and (B) of E. coli 
[pQR368] in different areas of a 96-DSW plate (#) columns 1-2, ($) columns 5-
6 and (") columns 9-10. Error bars indicate the range of measured values about 
the mean. 
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The reproducibility of bioconversion kinetic data is shown in Figure 5.17.  The 
rate of product formation is quite slow and there is a very slow increase in 
product yield during the last 5 hours of growth.  The mean final concentration of 
7-hydroxycoumarin produced from P450SU1 and P450SU2 was 0.98 ± 0.06 
mgL-1 and 3.55 ± 0.17 mgL-1 representing product yields of 0.5 % and 1.9 % 
respectively.  The calculated average and maximum errors were 5 % and 10 % 
for E. coli [pQR367] and 4 % and 5 % for E. coli [pQR368] between triplicate 
runs. 
 
The samples collected after 30 hours of growth were analysed using a CO assay 
and the expression of P450SU1 and P450SU2 are shown in Figure 5.18 A and B.  
Similar to the spectrums achieved from shake flask cultures, P450SU1 displays 
the presence of soret peaks at 420 nm and 450 nm whereas P450SU2 only has a 
distinct peak at 450 nm.  The calculated level of active P450 was 29 nmolg-1 
from P450SU1 and 53 nmolg-1 from P450SU2.  
 
The results collected using the automated microwell platform confirmed that 
reproducible growth and bioconversion kinetic data can be collected on two P450 
biocatalysts.  The automated approach could also be used to produce samples for 
CO difference spectrum analysis.  A number of parameters could potentially be 
investigated using the automated sequence however it was decided to use the 
approach to improve the product yield at the bioconversion stage.  Investigation 
of enzyme expression has been looked at (Hussain and Ward, 2003 b).  A 
microscale CO assay was not developed in this work thus samples had to be 
processed manually using the original spectrophotometric approach.  Due to the 
number of sample preparation steps required for this assay including sonication 
and sparging CO into every sample this can become the limiting step in sample 
analysis.  Thus at present the automated approach is more suitable for assessment 
of bioconversion effectiveness using HPLC which is dependant on enzymatic 
expression and activity.  However, research into microscale sonication 
techniques is in progress (Ordidge, 2012) and a microscale CO assay has been 
reported (Choi et al., 2003).  It would therefore be worthwhile to develop 
microscale approaches for additional processing steps which could be included in 
this automated sequence to enable a more efficient analysis of samples for CO 
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difference spectrum analysis, the ‘gold standard’ for assessing the level of active 
P450.   
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Figure 5.17 Reproducibility of bioconversion kinetic data collected on the 
culture of E. coli [pQR367] in different areas of a 96-DSW plate (!) columns 3-
4, (") columns 7-8 and (!) columns 11-12 and the culture of E. coli [pQR368] 
(#) columns 1-2, ($) columns 5-6 and (") columns 9-10. Error bars indicate 
the range of measured values about the mean. 
 
 
 
 
 
 
 
 
 
 
!"#$! !%#&! !'#(! !)#*! !+#",! !""#"$!!
!! !#! !"! !$! !!! !"!!
!! !#! !"! !$! !!! !"!!
!! !#! !"! !$! !!! !"!!
 208 
 
 
Figure 5.18 Representative CO difference spectra of (A) P450SU1 expressed in 
E. coli [pQR367] and (B) P450SU2 expressed in E. coli [pQR368] during 
automated process sequence. Samples were from cultures where no 7-
ethoxycoumarin was added. 
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5.2.3 Applying the Automated Approach for Bioconversion 
Improvement  
 
There has been limited research on methods aimed to improve the O-dealkylation 
activity and bioconversion efficiency was found to be poor in section 5.2.2.5.  
Bioconversion effectiveness is inevitably linked to enzymatic expression and 
activity thus factors associated with improved expression were used as a starting 
point in an attempt to improve O-dealkylation activity where the conversion of 7-
ethoxycoumarin to 7-hydroxycoumarin was used as a model system.   
 
From a review of published findings particular media additions were found to be 
successful in promoting improved enzymatic expression as discussed in Chapter 
1.  Firstly, components termed as P450 activators including !-benzoflavone and 
!-benzoflavone were reported by Taylor et al. (1999) to stimulate the activity of 
P450 SOY from Streptomyces griseus.  Haem precursors such as ALA (Taylor et 
al., 1999, Richardson et al., 1995), and the iron containing media supplements 
hemin (Chen et al., 1996) and FeCl3 (Jansson et al., 2000; Hussain and Ward, 
2003 b; Zhang et al., 2010) are well documented at improving P450 yields.  In 
fact up to a 20-fold improvement in expression levels has been reported when 
using ALA (Jansson et al., 2000) and it has been termed essential for 
heamoprotein production (Gillam et al., 1995).  Thirdly, trace elements and 
thiamine are often added in the culture medium (Shimada et al., 1998; Gillam et 
al., 1995; Fischer et al., 1992).  However, some sources do claim these 
components may not be essential for expression (Phillips and Shephard, 2006; 
Jansson et al., 2000).  Finally, glycerol and sugar supplementation have been 
found to enhance P450 gene expression (Kagawa and Cao, 2001).  In particular 
arabinose was found to enhance the expression of a microsomal P450 by 
inducing an osmotic stress response and was reported to play a crucial part in 
formation of functional proteins (Kagawa and Cao, 2001). 
 
Therefore, a number of factors have been found to be beneficial in the expression 
of active P450 however the aim in this study was to assess if they could improve 
the bioconversion ability of P450SU1 and P450SU2.  It was first of interest to 
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conduct an initial screen where an increased number of factors could be tested 
simultaneously for their bioconversion ability.  The automated approach 
developed in section 5.2.2.5 was purposefully modified and the method used for 
the automated screens is described in section 2.3.2.3.  Once cells had reached an 
OD of 0.6-0.8 (corresponding to stage 3 in Figure 5.14) each of the factors 
shown on the x-axis in Figure 5.19 A and B and Figure 5.20 A and B were added 
to wells in duplicate.  However, in the case of trace elements and thiamine these 
were added to the TB medium during preparation as thus were present in the 
medium from the start of the process.   
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Figure 5.19 The effect of !-benzoflavone (!-B), !-benzoflavone (b-B), ALA, 
hemin, FeCl3, thiamine, and trace elements on 7-hydroxycourmarin production 
from (A) E. coli [pQR367] expressing P450SU1 and (B) E. coli [pQR368] 
expressing P450SU2. Error bars indicate the range of measured values about the 
mean. 
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Figure 5.20 The effect of the sugars D-fructose, D-glucose, maltose, L-
arabinose, D-ribose and glycerol on 7-hydroxycourmarin production from (A) E. 
coli [pQR367] expressing P450SU1 and (B) E. coli [pQR368] expressing 
P450SU2. Error bars indicate the range of measured values about the mean. 
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Factors were tested alongside control cultures of E. coli [pQR367] and E. coli 
[pQR368] grown following the original protocol but with no haem precursor 
addition.  The factors thiamine, trace elements, hemin and FeCl3 were found to 
have little or no significant effect on 7-hydroxycoumarin production from both 
strains.  The result with FeCl3 was unexpected as studies with E. coli [pQR368] 
have shown an improved yield of active P450 (Hussain and Ward, 2003 b).  This 
result seems to imply that FeCl3 is only beneficial when added with ALA where 
improvements have been reported previously (Jansson et al., 2000; Hussain and 
Ward, 2003 b).  P450 activators were found to result in a significant decrease in 
7-hydroxycoumarin production from E. coli [pQR368].  The opposite was 
observed with E. coli [pQR367] where increases in both !-benzoflavone and !-
benzoflavone caused an increase in product concentrations.  
 
Among all factors tested ALA was found to be the most effective at improving 
the production of 7-hydroxycoumarin from both P450SU1 and P450SU2.  ALA 
has a crucial role in haem production where it is one of the first components in a 
series of events for the final formation of haem.  Supplementation of this acid is 
an efficient method to increase the yield especially if intracellular production 
becomes a limiting factor.   
 
Figure 5.20 shows the effect of a range of sugars and glycerol.  Glycerol and D-
ribose were both found to improve product formation from P450SU1 while only 
glycerol had a significant effect on P450SU2 product formation.  The addition of 
10 gL-1 glycerol resulted in over a 2-fold and a 1.4-fold increase from P450SU1 
and P450SU2, respectively, while the addition of 10 gL-1 D-ribose caused over a 
2-fold increase from P450SU1.  The additions of D-glucose, D-fructose and 
maltose caused minimal improvements of P450SU1 bioconversion and a 
reduction in product formation from P450SU2.  The result with D-glucose is 
expected as it indirectly represses the transcription of the lac operon by reducing 
the catabolite activator protein level which is required to assist RNA polymerase 
binding during protein synthesis.  Therefore a reduced biocatalyst titre could be 
responsible for the significant drop in bioconversion from P450SU2.   
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Kagawa and Cao (2001) suggest that sugar addition increases P450 expression 
by two possible mechanisms.  Firstly, they provide an effective carbon source 
and secondly they can induce an osmotic stress response which has been linked 
to the formation of functional proteins.  Table 5.2 shows a summary of the final 
biomass concentration reached after 30 hours of culture in the presence of each 
carbon source.  The lowest biomass concentrations were achieved in the presence 
of D-glucose and D-fructose and as a result significant reductions in product 
concentration were obtained with P450SU2.  In the case of glycerol increased 
biomass concentrations were observed and glycerol was also found to promote 
product formation from both strains.  It is important to note that this is not a 
absolute trend and a increase in biomass concentration does not mean a direct 
increase in product formation.  This is seen from maltose experiments which 
resulted in one of the highest biomass concentrations but had no significant effect 
on final product concentration. 
 
Table 5.2 Summary of the effect of carbon source on growth. 
 
Carbon Source Final Biomass 
Concentration (gDCWL-1) 
E. coli [pQR368] 
Final Biomass  
Concentration (gDCWL-1) 
E. coli [pQR367] 
No additional carbon source 9.07 7.84 
Maltose 10.11 9.86 
Glycerol 11.28 8.82 
L-arabinose 11.48 8.55 
D-ribose 9.45 7.92 
D-fructose 3.00 3.17 
D-glucose 2.87 2.91 
 
From the results of these preliminary experiments, described in Figures 5.19 and 
5.20, it was decided to further investigate those which showed the greatest 
improvement in bioconversion.  These included ALA and glycerol additions.  !-
benzoflavone was found to be beneficial for P450SU1 bioconversion however 
due to solubility issues this was not investigated further.  A study on the effects 
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of varying concentrations of ALA and glycerol as well as a glycerol feeding 
regime on growth, bioconversion and active P450 expression using the 
automated sequence shown in Figure 5.14 will be discussed in section 5.2.3.1.   
 
5.2.3.1 The Effect of !-aminolevulinic Acid (ALA)  
 
P450SU1 and P450SU2 biocatalysts are both heamoproteins and will only 
actively function with a haem prosthetic group.  Haem synthesis begins with the 
synthesis of ALA from glutamic acid via the C-5 pathway in E. coli (Woodard 
and Dailey 1995; Delcarte et al., 2000).  Shin et al. (2007) suggested that the 
rate-limiting step in this process is the formation of ALA where ALA 
supplementation to the cell culture has been used to by-pass this issue.  Therefore 
this factor was selected for further studies. 
 
A range of ALA concentrations from 1 mM up to 5 mM were investigated and 
the growth kinetics are shown in Figure 5.21 A and B.  Increasing ALA 
concentrations from 1 mM up to 5 mM had little effect and similar growth 
profiles were obtained at each condition tested for both strains where cells grew 
linearly to a maximum biomass concentration at the 25th hour, after which cell 
death began.   
 
The effect on bioconversion during the last 5 hours of growth is shown in Figure 
5.22 A and B.  There is a clear trend where increases in ALA concentration result 
in increases in product concentration and 5 mM ALA generates the highest 
product levels.  At 5 mM ALA a 63 % and 26 % improvement in 7-
hydroxycoumarin concentration was achieved, respectively, after 30 hours of 
culture compared to when no ALA addition was made.  
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Figure 5.21 The effect of ALA concentration on the culture of (A) E. coli 
[pQR367] and (B) E. coli [pQR368]. 0 mM (!), 1 mM (!), 2 mM ("), 3 mM 
(#), 4 mM (!), 5 mM ($). Error bars indicate the range of measured values 
about the mean. 
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Figure 5.22 The effect of ALA concentration on 7-hydroxycoumarin production 
from (A) E. coli [pQR367] and (B) E. coli [pQR368]. 0 mM (!), 1 mM (!), 2 
mM ("), 3 mM (#), 4 mM (!), 5 mM ($). Error bars indicate the range of 
measured values about the mean. 
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Samples collected after 30 hours of growth were analysed using the CO assay at 
each of the ALA concentrations tested and results are shown in Figure 5.23 A 
and B.  The calculated level of active P450 expression is shown in Table 5.3 for 
ALA concentrations from 0 to 5 mM.  The yield of active P450SU1 and 
P450SU2 biocatalysts increases at increasing ALA concentration.  This result is 
not in agreement with previous work where ALA was found to have no impact 
on P450SU1 expression (Hussain and Ward, 2003 b).  This finding can be 
explained by the fact that a low concentration of ALA (1 mM) was previously 
used whereas significant improvements were observed in this work when ALA 
concentrations above 2 mM were used.  In this study 5 mM ALA was found to 
be the best concentration for active expression of P450SU2 resulting in a 3-fold 
improvement.  4 mM ALA was found to be the best concentration for P450SU1 
displaying a 3.2-fold improvement over conditions when ALA was not added.   
 
A similar trend was reported by Jansson et al. (2000) but a smaller concentration 
range was studied from 0.5 mM to 2.5 mM.  In their work a 20-fold increase in 
the expression of the human P450 CYP1B1 was observed at 2.5 mM ALA 
compared to no ALA addition.  Richardson et al. (1995) stated that the influence 
of ALA may be bigger or smaller depending on the form of cytochrome P450 
expressed as observed in this work where a larger improvement was found with 
P450SU1 compared to P450SU2.  Jansson et al. (2000) also found that out of the 
two cytochrome P450s they investigated human P450 CYP1B1 and cytochrome 
P450cam (CYP101), there was a more significant improvement on CYP1B1 
expression from ALA addition.  It has been speculated by Richardson et al. 
(1995) that poorly expressed enzymes are more prone to degradation.  Therefore 
ALA addition increases haem concentration which promotes protein folding, thus 
reducing the susceptibility to protease degradation.  Due to the fact that ALA is 
the first committed intermediate in the haem biosynthesis pathway (Lu et al., 
2010) it is reasonable to presume that the rate-limiting step in the production of 
correctly folded active P450 is the synthesis of the haem prosthetic group 
(Hussain and Ward, 2003 b).  Furthermore, Hussain and Ward (2003 b) report 
that ALA addition causes a combined increase in protein expression and 
correctly folded holoenzyme with haem in its correct protein environment.  
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Results obtained in this work confirm that ALA has a positive effect on the level 
of active holoenzyme which is then utilised for improved bioconversion.   
 
Cornelissen et al. (2011) reported previously that the P450 concentration of 
CYP153A6 did not directly correspond to specific hydroxylation activity.  The 
authors postulated this to be due to physiological parameters such as substrate 
mass transfer into the cell or cofactor regeneration limiting the hydroxylation 
rather than cytochrome gene expression.  This could also explain why in this 
study, even though ALA increases both the expression and bioconversion, a 2-
fold increase in expression yield does not result in a 2-fold increase in product 
formation. 
 
Table 5.3 P450 expression a varying ALA concentrations. 
 
ALA Concentration 
(mM) 
P450SU1 Expression 
(nmolg-1) 
P450SU2 Expression 
(nmolg-1) 
0 27 57 
1 34 64 
2 49 74 
3 58 93 
4 88 156 
5 87 173 
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Figure 5.23 Representative CO difference spectra of (A) P450SU1 expressed in 
E. coli [pQR367] and (B) P450SU2 expressed in E. coli [pQR368] cultured at 
varying ALA concentrations. Samples were from cultures where no 7-
ethoxycoumarin was added. 
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5.2.3.2 The Effect of Glycerol 
 
From the study discussed in section 5.2.3 glycerol was highlighted as a factor 
beneficial for 7-hydroxycoumarin production.  For this reason different glycerol 
concentrations were tested varying from 2.5 gL-1 to 20 gL-1.  In addition a 10 gL-
1 glycerol feeding strategy was also evaluated.   
 
Growth kinetics achieved at each of the concentrations tested are shown in 
Figure 5.24 A and B.  Glycerol concentration does not seem to have a significant 
effect during the main growth phase however there are some differences 
observed during the last 5 hours of growth.  Glycerol might provide an energy 
source and sustain cell growth for a longer period of time.  In the case of E. coli 
[pQR367] cells continue to grow at 2.5 gL-1 and 5 gL-1 glycerol up until the 30th 
hour whereas typically cell death would begin from the 25th hour onwards.  The 
lower glycerol concentrations tested also seem to promote higher final biomass 
concentrations.  For instance, 5 gL-1 glycerol enabled a final biomass 
concentration of 10 gDCWL-1 from E. coli [pQR367] to be reached compared to 
only 6.54 gDCWL-1 at 20 gL-1 glycerol concentration.  A similar result was 
achieved with E. coli [pQR368] only that 2.5 gL-1 glycerol resulted in the highest 
final biomass concentration.  
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Figure 5.24 The effect of glycerol concentration on the culture of (A) E. coli 
[pQR367] and (B) E. coli [pQR368]. 2.5 gL-1 (!), 5 gL-1 ("), 10 gL-1 (!), 20 
gL-1 (#), fed 10 gL-1 every 5 hours (!). Error bars indicate the range of 
measured values about the mean. 
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From assessing the bioconversion kinetic data shown in Figure 5.25 A and B 
glycerol feeding and adding 20 gL-l glycerol to the culture produced the highest 
levels of 7-hydroxycoumarin from both strains.  Glycerol enhances the 
bioconversion with P450SU2 more than P450SU1 where an 8-fold increase in 
glycerol concentration leads to a 57 % and 13 % improvement, respectively, in 7-
hydroxycoumarin production.  In section 5.2.2.5 it was found that product 
formation begins between the 15th and 20th hour of growth.  20 gL-1 glycerol 
resulted in the highest levels of product yet a reduction in growth can be 
observed in Figure 5.24 at this concentration.  The benefits of glycerol on the 
bioconversion could be a result of cells allocating more energy into substrate 
metabolism and less to growth, accounting for the reduction observed in biomass 
concentration from the 15th hour.  However, this effect was not observed at any 
other glycerol concentration nor when a glycerol feeding approach was used.  
This may be because continual or intermittent feeding satisfies the cells 
increasing demand for energy (Shiloach and Fass, 2005) rather than the rapid 
depletion of nutrients from the start of exponential growth.  
 
Whole cell bioconversions via P450 monooxygenases are NAD(P)H-dependant 
where NAD(P)H is generated endogenously and recycled intracellularly as 
shown in reaction scheme 5.1.  Glycerol can be utilised as a reductant and enable 
NAD(P)H to be regenerated from NAD(P)+.  In this study, conducted at different 
glycerol concentrations, whole cell bioconversion yield improved implying that 
exogenous glycerol may enhance the rate of NAD(P)H regeneration.  A similar 
result has been described by Mouri et al. (2006) where exogenous glycerol was 
found to improve the oxygenation of the substrate camphor.  Mouri et al. (2006) 
used resting whole cells of E. coli expressing P450cam and a glycerol 
dehydrogenase-mediated NADH regeneration system.  This is different from the 
present work where growing cells and no additional regeneration system were 
used, however, both display the benefits of glycerol supplementation which can 
increase the cells natural NAD(P)H regeneration ability. 
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Figure 5.25 The effect of glycerol concentration on 7-hydroxycoumarin 
production from (A) E. coli [pQR367] and (B) E. coli [pQR368]. 2.5 gL-1 (!), 5 
gL-1 ("), 10 gL-1 (!), 20 gL-1 (#), fed 10 gL-1 every 5 hours (!). Error bars 
indicate the range of measured values about the mean. 
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Figure 5.26 shows the CO difference spectra achieved at each of the conditions 
tested with glycerol for P450SU2.  The spectra for P450SU1 were found to be of 
poor quality thus have not been included in this work.  Table 5.4 shows the 
active yield of P450SU2 where both a concentration of 20 gL-1 and glycerol 
feeding method produced the highest yields of active P450.  The addition of 
glycerol to the culture is proposed to improve protein folding as previously 
reported by Kagawa and Cao (2001) and Vail et al. (2005).  As observed from 
the ALA study the level of active protein expression is responsible for the 
improvements in bioconversion observed. 
 
Table 5.4 P450 expression at varying glycerol concentrations. 
 
Glycerol Concentration* (gL-1) P450 Expression (nmolg-1) 
2.5 47 
5 47 
10 99 
20 104 
10 Feed 122 
* Concentration does not include the 4 mLL-1 glycerol in TB media formulation. 
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Figure 5.26 Representative CO difference spectra of P450SU2 expressed in E. 
coli [pQR368] cultured at varying glycerol concentrations. Samples were from 
cultures where no 7-ethoxycoumarin was added. 
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5.2.3.3 The Effect of 7-ethoxycoumarin Concentration 
 
To evaluate any substrate inhibition effects 7-ethoxycoumarin was tested at three 
initial concentrations (0.1 mM, 1 mM and 2 mM).  The concentration of product 
was found to increase with substrate concentration from 0.1 mM up to 1 mM as 
shown in Figure 5.27.  In the case of 0.1 mM substrate concentration no product 
was detected from P450SU1 bioconversion, probably due to very low product 
levels or poor substrate contact with the cell.  Doubling the substrate 
concentration from 1 mM up to 2 mM further reduced the product concentration 
by 13 % for P450SU1 and 55 % from P450SU2, indicating potential substrate 
inhibition effects.  To determine the operating substrate concentration a study 
was designed to test a range of substrate concentrations.  This study was only 
conducted with P450SU2 as although product concentrations differed a similar 
trend was achieved from P450SU2 and P450SU1 as presented in Figure 5.27.  
Additionally, product levels achieved at reduced substrate concentrations (0.1 
mM) were undetectable with P450SU1 making accurate assessment of usable 
substrate concentrations difficult.  
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Figure 5.27 The effect of substrate concentration on 7-hydroxycoumarin 
production from (A) E. coli [pQR367] expressing P450SU1 and (B) E. coli 
[pQR368] expressing P450SU2. Experiments were conducted as described in 
section 2.3.2.3. Error bars indicate the range of measured values about the mean. 
 
 
 
!"
#"
 229 
According to the results obtained the best operating concentration was likely to 
be between 0.1 mM and 1 mM therefore concentrations from 0.5 mM up to 1 
mM were tested using the automated approach shown in Figure 5.14.  It is 
important to note that no haem precursors were added in this study, cells were 
induced and substrate was added at the appropriate time points.  Figure 5.28 
shows the effects of substrate concentration on the growth of cells.  The highest 
biomass concentration was achieved at 1 mM substrate and the lowest at 0.5 mM 
substrate.  This may imply that 7-ethoxycoumarin is utilised as a carbon source.  
 
The bioconversion kinetic data is shown in Figure 5.29 where a 2-fold increase in 
substrate concentration causes over a 2-fold increase in final product 
concentration.  Studies on the effects of substrate concentration were not reported 
with P450SU1 or P450SU2 making it challenging to draw realistic and 
meaningful conclusions.  However, Yamazaki et al. (1999) found that the rate of 
O-dealkylation by human liver cytochrome P450 increases with increasing 7-
ethoxycoumarin concentration up to 1 mM, and the rate increase reduces as 
concentrations approach 1 mM.  It was thus decided that the original protocol 
using 1 mM substrate would continue to be used as it was demonstrated that this 
is below any potential substrate inhibitory limits. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 230 
 
Figure 5.28 The effect of 7-ethoxycoumarin concentration on the culture of E. 
coli [pQR368]. 0.5 mM (!), 0.6 mM (!), 0.7 mM ("), 0.8 mM (#), 1 mM 
($). Error bars indicate the range of measured values about the mean. 
 
 
Figure 5.29 The effect of substrate concentration on 7-hydroxycoumarin 
production from E. coli [pQR368]. 0.5 mM (!), 0.6 mM (!), 0.7 mM ("), 0.8 
mM (#), 1 mM ($). Error bars indicate the range of measured values about the 
mean. 
 231 
5.2.3.4 Improved Bioconversion of 7-ethoxycoumarin 
 
A number of factors were tested (haem precursors, sugars, media additions) and 
some were shown to cause an improvement in the bioconversion yield of 
P450SU1 and P450SU2.  It was then thought appropriate to run a process using 
those factors which were found to promote both biocatalyst expression and 
bioconversion product yield improvement.  This included additions of 5 mM 
ALA to prevent haem formation from becoming limiting, 20 gL-1 glycerol, which 
was found to enhance NAD(P)H regeneration and drive correct protein folding, 
and 1 mM substrate concentration which was below substrate inhibitory limits.  
The improved process was carried out alongside a control process with no factor 
addition.  The growth kinetics for both processes are shown in Figure 5.30 A.  
The addition of glycerol is presumed to be responsible for sustaining the growth 
of cells up until the 30th hour, however this result was surprising as in section 
5.2.3.2 this results was not seen when cells were grown at 20 gL-1 glycerol.  The 
onset of cell death at the 25th hour is observed in cultures where ALA and 
glycerol were absent.   
 
A comparison of the bioconversion kinetics in Figure 5.30 B shows a clear 
improvement in product formation from cultures containing both ALA and 
glycerol.  The final concentration of 7-hydroxycoumarin produced from 
P450SU1 with and without media supplementation was 4.02 ± 0.19 mgL-1 and 
0.85 ± 0.09 mgL-1 corresponding to product yields of 2.1 % and 0.4 % 
respectively.  The final concentration of 7-hydroxycoumarin produced from 
P450SU2 with and without media supplementation was 6.50 ± 0.10 mgL-1 and 
4.20 ± 0.03 mgL-1 corresponding to product yields of 3.4 % and 2.2 % 
respectively.  There is an overall 5-fold and 1.5-fold improvement from E. coli 
[pQR367] expressing P450SU1 and E. coli [pQR368] expressing P450SU2, 
respectively.  Additionally, in the case of E. coli [pQR367] where typically there 
is little increase during the last 5 hours of culture, the culture additions also 
increased the rate of product formation.  
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Figure 5.30 (A) Growth kinetics and (B) time course of 7-hydroxycoumarin 
production from E. coli [pQR367] (!) and E. coli [pQR368] (") with 20 gL-1 
glycerol, 5 mM ALA and 1 mM 7-ethoxycoumarin (closed symbols) and no 
media supplementation with 1 mM 7-ethoxycoumarin (open symbols). Error bars 
indicate the range of measured values about the mean. 
 
 
 
!"
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Finally, the media additions resulted in significant improvements to the level of 
active P450 expression shown in Figure 5.31.  The corresponding yields are 
presented in Table 5.5.  A 5-fold increase is observed from both cytochrome 
P450s.  It is interesting that, even though the yield of active P450SU1 has been 
significantly increased, the inactive P420 peak is present in the CO spectra.  The 
addition of ALA should enable an adequate supply of correctly formed haem 
prosthetic group, however, the presence of apoenzyme indicates there is still 
some variable preventing the formation of fully functioning holoenzyme.  
Potentially, even if more haem is formed, the limiting step could be when 
incorporating it into the active site as previously described by Healy et al. (2002).  
Healy et al. (2002) also refers to particular conditions which cause the transition 
of the active P450 to the P420 state, including pressure, temperature variations or 
extreme pH values.  These are not thought to be likely causes considering 
identical culture conditions for E. coli [pQR367] and E. coli [pQR368] were 
setup and no P420 was detected from E. coli [pQR368].  It therefore must be a 
factor specific to P450SU1 which makes it more susceptible to converting to the 
inactive P420 form. 
 
Table 5.5 Comparison of P450 study with media additions. 
 
* Concentration does not include the 4 mLL-1 glycerol in TB media formulation. 
 
 
[ALA] (mM) [Glycerol] (gL-1)* P450SU1  
  XFinal  
(gDCWL-1) 
PFinal  
(mgL-1) 
Expression  
(nmolg-1) 
0 0 5.44 0.85 27 
5 20 9.44 4.02 134 
  P450SU2 
  XFinal  
(gDCWL-1) 
PFinal  
(mgL-1) 
Expression  
(nmolg-1) 
0 0 7.37 4.20 57 
5 20 8.60 6.50 293 
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Figure 5.31 CO difference spectra of (A) P450SU1 expressed in E. coli 
[pQR367] and (B) P450SU2 expressed in E. coli [pQR368] with (blue line) and 
without (green line) the addition of 5 mM ALA and 20 gL-1 glycerol. Samples 
were from cultures where no 7-ethoxycoumarin was added. 
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5.3 Concluding Remarks 
 
In Chapter 4 it was found that automated approaches could be used to rapidly 
optimise the production of the oxidative biocatalyst CHMO.  Cytochrome P450s 
have versatile catalytic properties however have failed to be successfully utilised 
to their full potential at an industrial scale.  Little is known on novel P450s and 
the ability to rapidly collect process data on novel strains and biocatalysts is a 
desirable feature.  Automated approaches enable data collection during the initial 
development stage, where strains, which initially would be rejected due to poor 
yields, can be further investigated for determination of their true potential.  
Additional benefits include a greener and sustainable approach to chemical 
synthesis of target compounds without the need for dangerous or toxic reagents.  
For these reasons the initial automated approach was applied to two novel P450 
expression systems E. coli [pQR367] expressing P450SU1 and E. coli [pQR368] 
expressing P450SU2.  
 
Shake flask cultures, as described by Hussain and Ward (2003 b), were 
successfully reproduced confirming the conditions for active P450 expression 
and bioconversion.  Using these initial culture conditions the microscale 
approach was developed where 96-DSW plates enabled the collection of 
reproducible growth and bioconversion kinetics across the plate and on different 
days.  Due to the extended culture times there was an issue of evaporation, 
however, the use of a gas permeable membrane was found to adversely affect the 
oxygen transfer.  By limiting the culture to 30 hours, using a sacrificial well 
approach along with the maximum fill volume of 1000 !L liquid loss did not 
exceed more than 15 % of the well contents and was within reported ranges 
enabling valid data to still be collected.  Using the automated approach cells of E. 
coli [pQR367] and E. coli [pQR368] grew at a specific growth rate of 1.56 h-1 
and 1.84 h-1 and reached final biomass concentrations of 9.33 gDCWL-1 and 9.01 
gDCWL-1 respectively.  P450SU1 and P450SU2 were actively expressed at a yield 
of 29 nmolg-1 and 53 nmolg-1 producing 0.98 ± 0.062 mgL-1 and 3.55 ± 0.17 
mgL-1 respectively of 7-hydroxycoumarin.  This represented 7-ethoxycoumarin 
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conversions of 0.5 % and 1.9 % from P450SU1 and P450SU2, respectively and 
further studies were conducted to improve this bioconversion yield.   
 
An initial study was performed and 14 factors previously found to positively 
affect enzymatic expression, were tested.  Three of these were selected for a 
complete analysis of growth, expression and bioconversion.  The automated 
approach successfully identified limitations in haem prosthetic group formation, 
NAD(P)H regeneration and substrate inhibitory limits enabling the correct 
concentrations of the haem precursor ALA, carbon source glycerol and substrate 
7-ethoxycoumarin to be used.  By combining the best conditions found in each 
study of 5 mM ALA, 20 gL-1 glycerol and 1 mM 7-ethoxycoumarin P450SU1 
and P450SU2 were actively expressed at a yield of 134 nmolg-1 and 293 nmolg-1 
producing 4.02 ± 0.19 mgL-1 and 6.50 ± 0.10 mgL-1 respectively of 7-
hydroxycoumarin.  This represented 7-ethoxycoumarin conversions of 2.1 % and 
3.4 % from P450SU1 and P450SU2, respectively.  These results corresponded to 
a 5-fold improvement in enzymatic expression and a 5-fold and 1.5-fold increase 
in product levels from P450SU1 and P450SU2, respectively.    
 
The automated platform was demonstrated to be an effective tool to quickly test 
a range of process parameters.  It can be used in two formats as an initial screen 
for end point bioconversion performance or to gain informative data on growth, 
whole cell bioconversion and active P450 yield depending on the users 
requirements.  Information on these important steps is crucially important early 
during process design in order to determine the best culture, expression and 
bioconversion conditions for P450 biocatalysts.  The ability to improve a process 
at the microscale has been achieved with two oxidative systems, however, if this 
data is to be effectively exploited the same results need to be reproduced at larger 
scales of operation.  Due to the geometrical differences between microwells and 
stirred bioreactors the final objective of the thesis is to demonstrate predictive 
scale-up of the data collected at the microscale.  Chapter 6 presents the lab/pilot 
scale studies conducted in this work. 
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6 Establishing the Scalability of Oxidative Biocatalytic 
Microscale Processes! 
 
6.1 Introduction 
 
Automated microscale approaches have been applied for the quantitative data 
collection and rapid bioprocess evaluation of two whole cell oxidative 
biocatalysts.  Knowledge gained at the microscale can be used to effectively 
inform steps in bioprocess development.  However, in order to build confidence 
in the data collected, there needs to be a suitable scale-up methodology 
demonstrating comparable results at larger scales of operation.  Cell growth, 
maintenance and metabolite production are reliant on oxygen as a crucial 
substrate in many bacterial processes.  One approach proved to be effective for 
scale-up of aerobic microbial culture is the use of a matched gas liquid mass 
transfer coefficient (KLa) approach (Ferreira et al., 2005; Micheletti et al., 2006; 
Islam et al., 2008; Kensy et al., 2009; Marques et al., 2009; Marques et al., 2010; 
Marques et al., 2012).  During aerobic culture oxygen needs to be transported 
from the gas bubble to the medium containing cells.  The solubility of oxygen in 
water is approximately 0.272 mmolL-1 at 25 oC and 101 kPa air pressure thus 
solubility may represent a transport bottleneck (Doran, 2003).  The rate at which 
oxygen is transported OTR (mmolL-1h-1) will depend on KLa (h-1) and a driving 
force CL*- CL, where CL (mmolL-1) is the dissolved oxygen concentration in the 
bulk liquid and CL* (mmolL-1) is the liquid phase concentration which is in 
equilibrium with the gas phase (Bailey and Ollis, 1986).  This relationship is 
described by Equation 6.1: 
 
! 
OTR = KLa(CL* "CL )       (Eq. 6.1) 
 
In the case of KLa this is affected by a number of factors including culture vessel 
design (number of impellers and baffles), culture operating conditions !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
!!Some of the results presented in this chapter are included in Baboo et al (2012), ‘An automated 
microscale platform for evaluation and optimization of oxidative bioconversion processes’, 
Biotechnology Progress, 28, 392-405, DOI: 10.1002/btpr.1500. 
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(temperature and volume), culture growth and physical fluid properties such as 
viscosity and media electrolytes.  It can therefore be a challenge to keep a 
constant KLa especially in the case of growing cultures where Vashitz et al. 
(1989) found KLa to increase with oxygen uptake by the microorganism.  It may 
therefore be appropriate to consider a biological enhancement factor termed E 
which takes into account mass transfer enhancement due to oxygen uptake by the 
microorganism.  In order to establish an appropriate scale-up criteria KLa needs 
to be determined experimentally or calculated using available correlations.  In 
this study KLa was determined experimentally as described in section 2.6.1.2.  A 
number of experimental approaches are available for example it is possible to use 
growing cells to follow the depletion of oxygen (direct methods) or use cell free 
based methodologies (indirect methods). 
 
One of the methods using growing cells is the oxygen-balance method or gas 
phase analysis and it can be conducted during normal operation whilst culturing 
(Bailey and Ollis, 1986).  It involves measuring the oxygen content in the gas 
streams from the fermenter inlet and outlet.  Using steady state mass balance 
analysis and from very accurate measurements of partial pressure, temperature 
and flow rate KLa values can be determined.  It is quite a reliable method if 
compared to others, however it is very dependant on the accurate measurement 
of gas composition and considerable errors can be introduced in the absence of 
sensitive equipment available for these measurements.  
 
A common method invovles analysing the dynamic change in dissolved oxygen 
concentrations during batch cell culture to measure KLa.  Bandyopadhyay et al. 
(1966) describes a method which involves an initial de-oxygenation of the 
culture by switching the gas supply off so that the rate at which the dissolved 
oxygen concentration decreases is equivalent to the oxygen consumption of 
actively respiring cells.  The oxygen supply is then turned back on and 
continuously monitored until a steady oxygen concentration is reached.  
Measurements are carried out using an oxygen electrode where, in the case of 
high probe response times, an appropriate correction has been applied.  Similarly, 
the dynamic pressure method uses pressure to change the interfacial oxygen 
concentration (Linek et al., 1989).  Dynamic measurements are inappropriate for 
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viscous cultures as large residence times of bubbles affect the accuracy of 
measurement (Heijnen et al., 1980).  Additionally, very low oxygen 
concentrations make measurements difficult and for this reason modifications to 
the method have been proposed by Gomez et al. (2006) using pure oxygen. 
 
Indirect measurements of KLa can be carried out in the presence of metal 
catalysts, responsible for catalysing the reaction of sodium sulfite in the presence 
of dissolved oxygen to produce sulfate.  In this method KLa is determined from 
the rate of sulfite consumption.  It is relatively easy to carry out and the method 
has been used previously (Thibault et al., 1990; Yasukawa et al., 1991; Hermann 
et al., 2003; Kensy et al., 2009), however it was found to overestimate the KLa as 
differences in physicochemical properties to culture broths cause changes in the 
hydrodynamics of the solution (Garcia-Ochoa and Gomez, 2009).  A few 
alternative procedures involving chemical reactions exist.  For example, Ortiz-
Ochoa et al. (2005) used catechol-2,3-dioxygenase bio-oxidation of catechol 
yielding 2-hydroxymuconic semialdehyde to measure KLa in 4 mL cuvettes, 
Warnecke and Hubmann (1989) used hydrazine oxidation, while Duetz et al. 
(2004) used a horseradish peroxidase and glucose oxidase coupled enzyme 
reaction.  These enzymatic alternatives do have the advantage of being applicable 
to small-scales thus reducing assay times, however present difficulties when 
applied at large-scale and as this methods do not take place in actual culture 
broths may also result in overestimated KLa measurements.   
 
One final method based on the dynamic approach without the requirement for 
cells is known as dynamic gassing out.  In this method nitrogen is initially gassed 
into the vessel and once the solution has been fully de-oxygenated, the media is 
re-oxygenated under typical culture aeration techniques (agitation and airflow).  
Taking into account the probe response time and the rate of re-oxygenation, the 
KLa can be measured accurately.  While the most accurate KLa measurement 
would be achieved using the cell population of interest, this presents 
experimental challenges including inoculum preparation, contamination 
prevention and requirement for cell culture control during measurement, thus 
making the use of actively growing cells inconvenient.  Considering the issues 
reported with chemical approaches the gassing out approach was selected in this 
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work due to its simplicity and relative accuracy.  In addition recent development 
of miniature probes (John et al., 2003) allows the same approach to be used at the 
microscale.  Its application to KLa measurements leading to the successful scale-
up from microwell plate format to stirred bioreactors has also been previously 
demonstrated (Ferreira-Torres et al., 2005; Islam et al., 2008). 
 
The use of a miniature oxygen probe incorporated into a microwell plate for KLa 
measurements via the dynamic gassing out approach has been reported by Doig 
et al. (2005).  Using this methodology Ferreira-Torres et al. (2005) measured KLa 
in both microwell and bioreactor configurations and successfully scaled up 
microscale growth and bioconversion using E. coli TOP10 [pQR239] expressing 
CHMO to a 2 L stirred bioreactor.  It was found that operating under non-oxygen 
limited conditions was crucial in enabling predictive scale-up.  Moreover, Funke 
et al. (2009) has stated that oxygen unlimited cultivations are necessary to 
prevent the selection of suboptimal strains, media and culture condition.  Islam et 
al. (2008) applied scale-up on the basis of matched KLa to the culture of E. coli 
BL21 (DE3) expressing firefly luciferase where microwell cell growth, protein 
expression and substrate utilization were accurately reproduced at 7.5 L and 75 L 
stirred bioreactor scale.  The provision of adequate mixing and gas liquid 
distribution were found to be very important, as studies conducted at a relatively 
low value of KLa did not present reproducible performance between scales.  In 
this work it is hypothesized that a matched KLa approach can reliably reproduce 
microscale growth and bioconversion kinetics of the oxidative biocatalysts 
CHMO expressed in E. coli TOP10 [pQR210] and cytochrome P450SU1 and 
P450SU2 expressed in E. coli [pQR367] and E. coli [pQR368], respectively, at 
stirred tank bioreactor scale.  A discussion on alternative scale-up strategies and 
their applicability to microscale will conclude this chapter. 
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6.2 Results and Discussion 
 
6.2.1 Scale Translation at Matched KLa – Application to CHMO 
 
It was first of interest to assess if the matched KLa approach would reproduce 
data collected at the microscale in a 75 L stirred tank bioreactor.  In Chapter 3 
the similarity of the strains E. coli TOP10 [pQR239] and E. coli TOP10 
[pQR210] was confirmed.  Initial KLa measurements at varying agitation rates 
and fill volumes were conducted previously in a modified 96-DSW plate 
equipped with a fibre optic oxygen sensor using LB-glycerol medium (Ferreira-
Torres, 2008).  A KLa of 115 h-1 was measured previously at a shaker speed of 
1000 rpm and fill volume of 500 !L.  Whilst in prior work the KLa-matched 
approach was applied to the bioconversion stage, it was of interest to extend the 
study it to the whole process sequence using E. coli TOP10 [pQR210].  Islam 
(2007) obtained a correlation between KLa and agitation rate (N) in the 75 L 
stirred tank bioreactor shown in Equation 6.2 from a series of gassing-out KLa 
measurements studies.  This correlation was obtained from experiments 
conducted at a working volume of 45 L of TB medium with 0.2 mLL-1 PPG, at 
room temperature and an airflow of 1 vvm. 
 
       (Eq. 6.2) 
 
Using this correlation a KLa of 115 h-1 can be achieved in the 75 L stirred tank 
bioreactor if operated at an agitation rate of 384 rpm.  Table 6.1 contains the 
operating conditions selected for the present study at microwell and 75 L scale 
using a matched KLa approach where KLa was obtained from previous 
measurements (Islam, 2007 and Ferreira-Torres, 2008).  To ensure both 
processes were operated under identical conditions no pH control was used and 
microscale cultures were inoculated with a sample taken from the inoculated 75 
L bioreactor as described in section 2.4.1.2.  This would eliminate any 
differences arising from inoculum preparation, media sterilisation or the use of 
antifoam agents.  In this way both processes would begin under identical 
conditions and optical densities.  Samples were taken periodically during 
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microscale and pilot plant processes to monitor the growth and bioconversion 
progress and results are shown in Figure 6.1 A and B respectively. 
 
Table 6.1 Comparison of microwell and bioreactor parameters. 
 
Parameter 96-DSW Microwell 
Plate 
75 L Stirred Bioreactor 
Agitation Rate 1000 rpm 
Throw: 3 mm 
384 rpm 
Vessel Total Volume 2 mL 75 L 
Working Volume 500 !L 45 L 
KLa 115 h-1 115 h-1 
Airflow n/a 1 vvm 
Temperature 37 oC 37 oC 
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Figure 6.1 (A) Growth kinetics at a matched KLa of 115 h-1 for E. coli TOP10 
[pQR210] in a 75 L bioreactor (working volume 45 L) (!) and 96-DSW plate 
with a 500 !L fill volume (") and corresponding 75 L DOT profile (----). Error 
bars indicate the standard deviation of triplicate optical density readings for the 
75 L process and the range of measured values about the mean for the microwell 
process. (B) Bioconversion kinetics of CHMO with 0.5 gL-1 bicyclo[3.2.0]hept-
2-en-6-one (unfilled symbols) to lactone product (filled symbols) at a matched 
KLa of 115 h-1 in a 75 L bioreactor (#) and 96-DSW plate (!). Error bars 
indicate the range of measured values about the mean. 
!"
#"
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During the seven-hour culture cells grew in a similar fashion at specific growth 
rates of 0.89 h-1 and 0.77 h-1 up to final biomass concentrations of 8.8 gDCWL-1 
and 7.5 gDCWL-1 for microwell and 75 L processes respectively.  There is a 
gradual reduction in the 75 L DOT profile shown in Figure 6.1 A which precedes 
a rapid decline after 2 hours of culture where the fastest oxygen uptake rate is 
observed during exponential growth.  The DOT profile obtained in this study 
compares well to that achieved by Ferreira-Torres, (2008) in a 2 L stirred 
bioreactor where the DOT achieves maximum values at 4, 6 and 7 hours.  The 
presence of such peaks could be attributed to a depletion of primary carbon 
sources (Turner et al., 1994; Neubauer et al., 1995), to the addition of the 
bioconversion substrate which has been reported to be harmful to the cell (Shitu 
et al., 2009) and to the onset of cellular death, respectively.  In terms of the 1 
hour bioconversion similar substrate consumption and product formation profiles 
are observed in Figure 6.1 B.  Full conversion was achieved in less than 30 
minutes and a space time yield of 1.8 gL-1h-1 was calculated for the 75 L reactor.  
From initial rates of product formation specific activities of 21 UgDCW-1 and 23 
UgDCW-1 were calculated for the microwell and 75 L processes respectively.  A 
lower than expected 75 L initial substrate concentration is shown in Figure 6.1 B 
even though the same concentration was added to both cultures.  High aeration 
rates in bioreactors can contribute to increased evaporation of volatile substrates 
and may be an explanation for the results obtained in this work (Zambianchi et 
al., 2004).  The 10 % higher specific activity achieved at the 75 L scale is a result 
of the lower than expected initial substrate concentration added to the reactor.  A 
summary of the comparable data obtained at both scales is shown in Table 6.2.  
This study has established the use of matched KLa approaches to reproduce 
microscale growth and bioconversion kinetics, hence in section 6.2.2 its 
application to the optimised process described in Chapter 4 will be presented.  
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Table 6.2 Summary of growth and bioconversion kinetics achieved at a matched 
KLa of 115 h-1. 
 
Growth  
Scale ! (h-1) X Final (gDCW.L-1) 
96-DSW (500 !L) 0.89 7.5 
75 L Bioreactor (45 L) 0.77 8.8 
 Bioconversion 
 
Scale 
Initial Lactone* 
Formation rate  
(!molL-1min-1) 
Specific Activity  
(Ug-1) 
Yield  
(%) 
96-DSW (500 !L) 155 21 120 
75 L Bioreactor (45 L) 203 23 106 
* Produced from bicyclo[3.2.0]hept-2-en-6-one. 
 
6.2.2 Scale Translation at Matched KLa – Optimised Production 
of CHMO 
 
6.2.2.1 KLa Measurement Using Dynamic Gassing Out 
 
KLa values ranging from 100 – 300 h-1 in standard stirred-tank bioreactors of 
volumes between 30 – 50000 L were reported by Trilli (1986).  Previous studies 
have established that microwell plates are characterised by KLa values in the 
lower range of those achieved using stirred bioreactors as shown in Table 6.3.  
Therefore it should be possible to achieve conditions in both configurations 
where the KLa is matched.  Proof of concept was demonstrated in section 6.2.1, 
however the matched KLa was based on previous correlations and was not 
experimentally measured. 
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Table 6.3 Range of KLa values achievable in microwell formats compared to 
stirred bioreactors. 
 
Microwell Format Microwell 
KLa range 
(h-1) 
Bioreactor Bioreactor 
KLa range 
Measurement 
Method 
Ferreira-Torres, (2008) 
96-DSW plate 
 
16 – 186 *† 2 L  40 – 168 * Dynamic  
gassing out 
Islam, (2007) 
48-Rectangular flat base 
wells 
0.7 - 88.9 * 7.5 L  9.7 - 272.1 * Dynamic  
gassing out 
24-Square round base 
wells 
1.8 - 187.6 * 75 L  48.4 - 384.9 * Dynamic  
gassing out 
24-Square pyramidal 
base wells  
2.1 – 241 *   Dynamic  
gassing out 
Duetz et al., (2000) 
96-DSW plate Maximum: 
188 † 
n/a n/a Oxygen-limited 
growth of 
P.putida 
Funke et al., (2009) 
48-Well plate with square 
rounded edges 
> 600 *† n/a n/a Sulfite  
oxidation 
* Achieved at varying shaker speeds.  
† Achieved at varying fill volumes. 
 
An adapted microwell plate and incorporated optical fibre were used in this work 
for KLa measurements.  The system was designed as previously described by 
Ferreira-Torres (2008) and Islam (2007), and gassing out studies were conducted 
as described in section 2.6.11.1 using culture medium with 0.2 mLL-1 PPG in 
order to replicate at the microscale the same conditions experienced by cells at 
large-scale.  PPG is typically added to stirred bioreactors as a antifoam agent.  
Antifoam has been found to decrease the KLa at low concentrations and increase 
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it at high concentrations thus it was important to add it to the medium during 
microscale studies (Kawase and Moo-Young, 1990; Morão et al., 1999).  The 
ultimate aim was to determine the KLa at the optimised microwell operating 
conditions as determined from the results presented in Chapter 4.  However, it 
was first of interest to determine if the predicted trends described in section 4.2 
concerning the effect of microwell fill volume on KLa could also be observed 
from the experimental measurements.   
 
From DOT measurements at varying fill volumes the KLa was calculated as 
described in section 2.6.11.1.  Figure 6.2 shows KLa to increase in a linear 
fashion with decreasing fill volume as observed in a similar study carried out by 
Ferreira-Torres (2008).  This effect has been reported in other works for a 
number of microwell plate geometries (Kensy et al., 2005; Funke et al., 2009).  
John et al. (2003), reported KLa values being inversely proportional to fill 
volume in round well formats.  In Chapter 4 the same trend was predicted using 
the correlation found by Doig et al. (2005) for the prediction of KLa values in 
microwell plate format.  The authors attributed the reason for this finding to the 
fact that a decrease in fill volume increases the specific interfacial area for 
oxygen transfer, thus resulting in an improvement in growth.  Unexpectedly, the 
predicted values were significantly larger than those determined experimentally.  
Zhang et al. (2008) used the same methodology described in this work to 
measure KLa values in 96-DSW plates and reported their predicted values to be 
higher than their measured values.  This discrepancy between predicted and 
measured values was explained by Zhang et al. (2008) to be due to a combination 
of factors ie the high sensitivity of the probe to the shaking movement, probe 
location and well mixing time, all of which are likely to have an impact on 
measured KLa values when using the dynamic approach (Doig et al., 2005; 
Zhang et al., 2008).  For these reasons the experimentally determined values 
were deemed to be a more accurate representation of the system KLa values than 
the predicted ones as they were obtained using the medium, the bioreactor 
geometry and agitation system used in actual experiments.  
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Figure 6.2 Relationship between 96-DSW plate fill volume and KLa. Values 
were measured using the gassing out approach in an adapted 96-DSW as 
described in section 2.6.11.1. These experiments were conducted at 37 oC, in LB 
glycerol medium with 0.2 mLL-1 PPG and at 1000 rpm. Errors bars indicate the 
standard deviation of triplicate measurements. 
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Figure 6.3 Relationship between 75 L stirred bioreactor agitation speed and KLa. 
Values were measured using the gassing out approach as described in section 
2.6.11.3. These experiments were conducted at 37 oC, in LB glycerol medium 
with 0.2 mLL-1 PPG, at a working volume of 45 L and an aeration rate of 1 vvm. 
Errors bars indicate the standard deviation of triplicate measurements.  
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In Chapter 4 the optimised microscale process was operated at 37 oC, 1000 rpm 
and 500 !L and a KLa of 228 h-1 was measured at these conditions.  Dynamic 
gassing out was then carried out in a 75 L stirred tank bioreactor using LB-
glycerol medium with 0.2 mLL-1 PPG to determine the range of KLa values 
achievable at this scale as described in section 2.6.11.3.  Figure 6.3 shows how 
the KLa varies with agitation speed. 
 
The KLa was found to increase with increasing agitation rate from 57 h-1 up to 
415 h-1 at the conditions tested, and the values measured at the microscale fall 
within this range.  This linear relationship has been reported previously in a 
range of bioreactors (Ni et al., 1995; Islam, 2007) and miniature bioreactors (Gill 
et al., 2008).  Finn, (1954) explains that agitation improves KLa by three different 
mechanisms including increasing the interfacial area by creating small gas 
bubbles, circulating the liquid into swift eddies thus delaying the escape of gas 
bubbles, and thirdly creating turbulent shear which reduces the liquid film 
thickness.  Equation 6.3 relates agitation speed (N) to KLa and the coefficient in 
the equation was found by linear interpolation of the data presented in Figure 6.3.  
Using Equation 6.3 an agitation rate of 467 rpm was calculated to achieve a KLa 
of 228 h-1 in the 75 L bioreactor to enable scale-up of optimised microscale 
kinetics. 
 
       (Eq. 6.3) 
 
The relation achieved by Islam (2007) shown in Equation 6.2 is similar to the 
one obtained in this work.  The difference is thought to be due to the media used 
for KLa measurement in the two studies, as TB medium was used by Islam 
(2007) and LB-glycerol was used in this work.  The ion concentration in the 
medium has a significant influence on bubble size because it has been found to 
decrease bubble size by preventing bubble coalescence (Craig et al., 1993), thus 
increaseing the specific gas-liquid interfacial area and therefore KLa (Ferreira-
Torres, 2008).  LB-glycerol has a higher salt concentration than TB and this may 
explain the higher KLa values obtained in this study than those achieved by Islam 
(2007).  Furthermore, Islam (2007) also took measurements at room temperature 
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whereas studies done in this work were conducted at 37 oC which would also 
cause an increase in KLa. 
 
6.2.2.2 Scale Comparison at Matched KLa 
 
The optimised process described in Chapter 4 was scaled up to 75 L stirred 
bioreactor scale by operating at conditions to achieve a matched KLa of 228 h-1.  
A summary of the operating conditions at both scales is shown in Table 6.4.  The 
75 L was initially inoculated and the first sample used to inoculate the microwell 
process which was run in parallel as described in section 2.4.1.2.  The growth 
was run for a total of 3 hours as found to be the optimum time frame for 
production of active CHMO, cultivations exceeding three hours were found in 
Chapter 4 to cause a significant decline in biocatalyst activity.  A 1-hour 
bioconversion was then conducted at a substrate concentration of 0.5 gL-1 as this 
concentration was found to be below substrate inhibitory limits.  The growth 
kinetic data in Figure 6.4 A from microscale and pilot scale runs follow very 
similar profiles where cells grew at specific rates of 0.86 h-1 and 0.82 h-1 up to 
final biomass concentrations of 4.92 gDCWL-1 and 4.34 gDCWL-1, respectively.  
The DOT profile of the 75 L bioreactor was found to decrease rapidly after 1 
hour of growth and decreases to zero at around 3 hours.  In the initial scale-up 
study described in section 6.2.1 the same profile was obtained, however, in that 
case the growth lasted for a total of 6 hours of which 4 were conducted under 
oxygen limited conditions possibly reducing the effectiveness of the 
bioconversion.  In this case this is not considered to be an issue because the 
bioconversion only lasted for 1 hour and complete conversion of substrate to 
product was achieved in 20 minutes as shown in Figure 6.4 B.  The calculated 
CHMO specific activities for microscale and pilot scale processes were 53 
UgDCW-1 and 49 UgDCW-1 respectively.  The results of this study are summarised 
in Table 6.5.  Bioconversion completion was achieved in an approximately 
similar time scale to the experiment described in section 6.2.1 at the same 
substrate concentration.  In terms of the whole process time this was reduced by 
a total of 3 hours. 
 
 252 
Table 6.4 Comparison of microwell and bioreactor parameters. 
 
Parameter 96-DSW Microwell 
Plate 
75 L Stirred Bioreactor 
Agitation Rate 1000 rpm 
Throw: 3 mm 
467 rpm 
Vessel Total Volume 2 mL 75 L 
Working Volume 500 !L 45 L 
KLa 228 h-1 228 h-1 
Airflow n/a 1 vvm 
Temperature 37 oC 37 oC 
 
From the automated process conducted prior to the scale-up study as described in 
Chapter 4 cells were reported to grow at a slower specific rate, reached a lower 
final biomass concentration and there were also slight differences in the 
bioconversion.  These were due to differences in media sterilisation, antifoam 
addition and to a change in bioconversion temperature (30 oC was used 
previously, 37 oC was used for the present study).  Islam (2007) reported that 
differences in the temperature-time profiles achieved during standard autoclave 
sterilisation cycles and in-situ sterilisation within the 75 L bioreactor caused 
differences in the nutrient level in the medium, resulting in differences in 
performance between microscale and pilot scale processes.  This is why in the 
present study the microwell was inoculated with a sample taken from the 75 L 
bioreactor.  
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Figure 6.4 (A) Growth kinetics of E. coli TOP10 [pQR210] at a matched KLa of 
228 h-1 in a 75 L bioreactor (working volume 45 L) (!) and 96-DSW plate with 
a 500 !L fill volume (") and corresponding 75 L DOT profile (----). Error bars 
indicate the standard deviation of triplicate optical density readings for the 75 L 
process and microwell process.  (B) Bioconversion kinetics of E. coli TOP10 
[pQR210] biocatalyst with 0.5 gL-1 bicyclo[3.2.0]hept-2-en-6-one (unfilled 
symbols) to lactone product (filled symbols) at a matched KLa of 228 h-1 in a 75 
L bioreactor (!) and 96-DSW plate (#). Error bars indicate the standard 
deviation of triplicate GC samples. 
!"
"""#"
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Table 6.5 Summary of growth and bioconversion kinetics achieved at a matched 
KLa of 228 h-1. 
 
Growth  
Scale ! (h-1) X Final (gDCW.L-1) 
96-DSW (500 !L) 0.86 4.92 
75 L Bioreactor (45 L) 0.82 4.34 
 Bioconversion 
 
Scale 
Initial Lactone* 
Formation rate  
(!molL-1min-1) 
Specific Activity  
(Ug-1) 
Yield  
(%) 
96-DSW (500 !L) 174 53 94 
75 L Bioreactor (45 L) 161 49 90 
* Produced from bicyclo[3.2.0]hept-2-en-6-one. 
 
6.2.3 Scale Translation at Matched KLa – Application to 
Cytochrome P450SU1 and P450SU2 
 
6.2.3.1 KLa Measurement Using Dynamic Gassing Out 
 
In Chapter 5 a microscale approach for the production of cytochrome P450s was 
developed using specified operating conditions.  It was of interest to scale-up the 
cytochrome P450 kinetics on the basis of matched KLa as oxygen was again a 
crucial substrate in both growth and bioconversion and this approach proved to 
be successful with the CHMO enzyme.  Dynamic gassing out experiments 
conducted at the microscale in the adapted 96-DSW plate using TB medium with 
0.2 mLL-1 PPG.  Two distinct stages can be observed: a rapid growth phase and 
an expression phase during the production of cytochrome P450s.  Each phase is 
conducted at a particular agitation rate and temperature, as described in Chapter 
5, and both factors have an impact on KLa.  The growth phase was conducted at a 
1 mL fill volume, 1000 rpm and 37 oC and the expression phase at a 1 mL fill 
volume, 800 rpm and 25 oC, the measured microscale KLa values for each 
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condition were 200 h-1 and 62 h-1, respectively.  Gassing out studies using TB 
medium with 0.2 mLL-1 PPG were aimed at achieving these KLa values in a 7.5 
L stirred tank bioreactor.  Studies were conducted at varying agitation speeds at 
37 oC and 25 oC and the results are shown in Figure 6.5.  A linear trend is 
observed for the relation between agitation rate and KLa, as observed previously 
in the 75 L bioreactor, and is described by Equation 6.4 and 6.5 at 37 oC and 25 
oC, respectively.   
 
      (Eq. 6.4) 
 
       (Eq. 6.5) 
 
An agitation speed of 200 rpm was tested, however, during gassing out studies it 
was found that the rate of re-oxygenation did not settle to a constant rate at 37 oC 
and was extremely slow at 25 oC making it difficult to accurately measure the 
KLa at this agitation rate.  This is thought to be due to low turbulence levels 
resulting in a non-homogenous bioreactor mixing environment and poor gas-
liquid dispersion.  For this reason Equations 6.4 and 6.5 should only be used for 
KLa determination between agitation rates of 400 rpm and 800 rpm in this 
geometry.  Figure 6.5 shows how reducing the temperature reduces the KLa, in 
agreement with results reported previously (Finn, 1954; Aiba et al., 1984; Hichri 
et al., 1992) where changes in liquid viscosity and solute gas mass diffusivity in 
the liquid were found to be responsible for this effect (Hichri et al., 1992).  
However, as the agitation rate decreases, the effect of temperature has a reduced 
effect on KLa where at 400 rpm there is a 1.5-fold reduction in KLa between 37 
oC and 25 oC compared to over a 2-fold reduction at 800 rpm.  The gas-liquid 
dispersion becomes less effective as the agitation speed decreases and therefore 
the KLa is found to have a greater dependence on agitation compared to 
temperature at these conditions.  Using Equations 6.4 and 6.5 agitation rates of 
763 rpm at and 571 rpm were calculated to achieve a KLa of 200 h-1 at 37 oC and 
62 h-1 at 25 oC in the 7.5 L stirred bioreactor to enable scale-up of cytochrome 
P450 kinetics. 
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Figure 6.5 The effect of agitation speed and temperature (! 37 oC, ! 25 oC) on 
measured KLa values in a 7.5 L stirred bioreactor. Values were measured using 
the gassing out approach as described in section 2.6.11.2. These experiments 
were conducted in TB medium with 0.2 mLL-1 PPG, at a working volume of 5 L 
and an aeration rate of 1 vvm. Errors bars indicate the standard deviation of 
triplicate measurements. 
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6.2.3.2 Scale Comparison at Matched KLa 
 
Two 7.5 L scale processes were conducted for the 5000-fold scale translation of 
E. coli [pQR367] expressing P450SU1 and E. coli [pQR368] expressing 
P450SU2 as described in section 2.4.2.1.  Stirred tank bioreactors were first 
inoculated with 1 % v/v overnight prepared culture.  Once the cultures were well-
mixed a sample was taken and used to inoculate the microscale process which 
was run in parallel.  Both strains were grown at 37 oC at a matched KLa of 200 h-
1 in both stirred tank and microwell plates until a OD of 0.6 - 0.8 was reached.  
The temperature was then dropped to 25 oC and the agitation adjusted to achieve 
a matched KLa of 62 h-1 for the remainder of the culture.  Culture conditions at 
both configurations during the entirety of the process are shown in Table 6.6.   
 
Table 6.6 Comparison of microwell and bioreactor parameters. 
 
Parameter 96-DSW Microwell 
Plate 
7.5 L Stirred 
Bioreactor 
Growth Phase (Until OD reached ~ 0.6 - 0.8) 
Agitation Rate 1000 rpm 
Throw: 3 mm 
763 rpm 
Vessel Total Volume 2 mL 7.5 L 
Working Volume 1 mL 5 L 
KLa 200 h-1 200 h-1 
Airflow n/a 1 vvm 
Temperature 37 oC 37 oC 
Expression Phase 
Agitation Rate 800 rpm 
Throw: 3 mm 
571 
KLa 62 h-1 62 h-1 
Temperature 25 oC 25 oC 
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In Chapter 5, 5 mM ALA and 20 gL-1 glycerol were found to promote both the 
active yield of cytochrome P450 and bioconversion and thus were added to both 
cultures and incubated for 20 minutes.  Once the temperature had reached 25 oC 
enzymatic expression was induced with 1 mM IPTG and after a further 10 
minutes of incubation 1 mM 7-ethoxycoumarin added to begin bioconversion.  
Cultures were left for a total of 30 hours and samples taken periodically to 
monitor cellular growth and bioconversion.  The growth profiles and 
bioconversion kinetics at both scales are shown in Figures 6.6 A and B along 
with the respective DOT profiles from 7.5 L cultures.  CO assay analysis was not 
conducted in this study as 7-ethoxycoumarin was added to all cultures.  When 
bound, substrates have been found to cause spectral shifts and cause 
conformational changes which can affect CO binding (McLean et al., 1996) and 
interfere with the CO difference spectrum.  This has not been investigated with 
P450SU1 and P450SU2, however, previous works have conducted CO assay 
experiments using substrate-free samples (Hussain and Ward, 2003) and, as 
shown in section 2.6.9.2, no P450 peak could be obtained in the presence of 
substrate in this work. 
 
Both strains grew similarly for the first 3 hours in both the 7.5 L stirred tank 
bioreactor and the 96-DSW plate as no nutritional or oxygen limitation occurred 
during this stage.  Specific growth rates of E. coli [pQR367] and E. coli 
[pQR368] were 1.46 h-1 and 1.43 h-1 for the 7.5 L bioreactor and 1.28 h-1 and 
1.20 h-1 for the 96-DSW plate, respectively.  Once the temperature was dropped 
and the agitation reduced to promote expression, there was a significant change 
in growth rate between the two formats.  Cells in the bioreactor grew faster than 
those in the 96-DSW, final biomass concentrations of 13.39 gDCWL-1 and 13.65 
gDCWL-1 were achieved for E. coli [pQR367] and E. coli [pQR368] in the 7.5 L 
bioreactor while 7.48 gDCWL-1 and 8.50 gDCWL-1 were obtained at the microscale.  
This is quite different to what was obtained for E. coli expressing CHMO where 
matched KLa approaches resulted in the effective reproduction of growth kinetics 
at the pilot plant scale. 
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Figure 6.6 (A) Growth kinetics of E. coli [pQR367] (!) and E. coli [pQR368] 
(") at a matched KLa of 200 h-1 in a 7.5 L bioreactor (working volume 5 L) and 
96-DSW plate with a 1 mL fill volume (open symbols) for the first 3 hours of 
culture and then a matched KLa of 62 h-1 for the remaining culture time and 
corresponding 7.5 L DOT profile for E. coli [pQR367] (light grey line) and E. 
coli [pQR368] (dark grey line) cultures. Error bars indicate the standard 
deviation of triplicate optical density readings for the 7.5 L process and the range 
of measured values about the mean for the microwell process.  
 
 
 
 
 
 
 
!!!!"!
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Figure 6.6 (B) 7-hydroxycoumarin production from P450SU1 (!) and P450SU2 
(") at a matched KLa of 62 h-1 in a 7.5 L bioreactor (closed symbol) and 96-
DSW plate (open symbol). Error bars indicate the standard deviation of triplicate 
7.5 L HPLC samples and the range of measured values about the mean for 96-
DSW plate HPLC samples. 
 
 
 
 
 
 
 
 
 
 
!"
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Comparing the DOT profiles of E. coli [pQR367] and E. coli [pQR368] from the 
7.5 L bioreactors, oxygen was utilised quite differently even though similar 
biomass concentrations were reached.  Both strains readily consumed oxygen for 
the first 10 to 12 hours of culture after which DOT remained approximately 
constant up until the 23rd hour when the DOT started to rise potentially due to the 
onset of cellular death.  However, E. coli [pQR367] only depleted the oxygen to 
a point where the lowest DOT measured was 44 % whereas in the case of E. coli 
[pQR368] DOT fell to 7 %.  Oxygen utilisation includes cell maintenance, 
growth and oxidation of substrates to products.  The growth and cell maintenance 
of both strains is the same as shown by the growth profiles (Bailey and Ollis, 
1986).  This difference in oxygen utilisation could be associated with protein 
expression and product formation as P450SU1 was expressed at a lower level 
and produced less product than P450SU2 and hence probably had a lower 
oxygen requirement.  Moreover, this result may suggest that in the case of E. coli 
[pQR367] oxygen control may be required.  Previously, Zhang et al. (2010) 
found a 2-fold improvement in P450SMO production when the DO was 
maintained at a level below 10 % compared to no DO control.  In the current 
study the increased DO levels during the expression phase of E. coli [pQR367] 
could have resulted in oxidative damage and be a contributory factor to lower 
expression levels compared to P450SU2. 
 
Interestingly, even though there was a difference in growth, very similar product 
formation profiles were achieved from E. coli [pQR367] for the 7.5 L bioreactor 
and the microwell process.  Final 7-hydroxycoumarin concentrations were 2.59 
mgL-1 and 2.97 mgL-1, respectively.  However, in the case of E. coli [pQR368] 
higher product concentrations were observed from the 7.5 L bioreactor which 
produced a final 7-hydroxycoumarin concentration of 10.26 mgL-1 compared to 
7.98 mgL-1 at the microscale.  A summary of this study is shown in Table 6.7.  
The results obtained in this work at the microscale are similar to those obtained 
from the automated experiments. 
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Table 6.7 Summary of growth and bioconversion kinetics achieved at a matched 
KLa. 
 
 Growth Bioconversion 
 
Scale 
! 
(h-1) 
X Final 
(gDCW.L-1) 
Final Product 
Concentration 
(mgL-1) 
Yield  
(%) 
 E. coli [pQR367] Expressing P450SU1 
96-DSW (1 mL) 1.28 7.48 2.97 1.9 
7.5 L Bioreactor (5 L) 1.46 13.39 2.59 1.6 
 E. coli [pQR368] Expressing P450SU2 
96-DSW (1 mL) 1.20 8.50 7.98 5.0 
7.5 L Bioreactor (5 L) 1.43 13.65 10.26 6.4 
 
Islam (2007) reported that similar kinetic data at the microscale and 7.5 L scale 
could only be obtained at high KLa values of 247 h-1 whereas when a low KLa of 
55 h-1 was tested very different results were obtained.  This was attributed to 
poor gas-liquid distribution observed in the 7.5 L bioreactor at the low KLa value.  
The KLa values used in this work are of the same magnitude to those reported by 
Islam (2007).  It is noteworthy that the growth phase was conducted at the high 
KLa (200 h-1) and the expression phase conducted at the low KLa (62 h-1) and, as 
reported by Islam (2007), operation at a low KLa could explain the lack of 
reproducibility observed in the present study across the scales.  However, this 
does not fully explain the improved stirred bioreactor growth kinetics compared 
to the microscale.  It is possible that a factor associated solely with the 
microscale process is causing the observed behaviour.   
 
Marques et al. (2009) scaled up whole cell growth and bioconversion processes 
from a 24-well microtitre plate to a 5 L stirred bioreactor using a matched KLa 
approach.  The authors reported successful scale-up based on the shape of the 
growth and bioconversion profiles, however, found that the results from the 5 L 
were consistently higher than those achieved at the microscale.  Marques et al. 
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(2009) attributed the reason for this finding to differences in intrinsic 
hydrodynamic conditions at the different scales. 
 
The shaking diameter has been found to be critical in influencing the oxygen 
transfer rates in microwells where as the shaking diameter increases so to does 
the rate of oxygen transfer (Duetz et al., 2000; Hermann et al., 2003; Duetz and 
Withol, 2004; Kensy et al., 2005; Funke et al., 2009).  Therefore when working 
at low shaking diameters a higher critical shaking frequency is required to 
achieve the maximum oxygen transfer rate (Fernandes and Cabral, 2006).  In the 
present work high shaking frequencies of 1000 rpm were actually found to 
considerably reduce product formation and showed no benefit on growth.  Thus 
increasing the shaking diameter could contribute to improve the oxygen transfer 
rate whilst operating at a shaking frequency less detrimental to bioconversion.  
Marques et al. (2007) found that when a high shaking diameter (25 mm) was 
used the agitation rate had a strong influence on product formation.  It was 
explained that at low shaking diameters the flow pattern developed was unable to 
fully disperse cell clusters which were found deposited at the well bottom.  
Similarly, the same behaviour was noticed during initial microscale development 
studies as discussed in Chapter 5, however this was not observed during the 
matched KLa study.  This is probably due to low axial velocity characteristics 
present inside the well at the tested shaking diameters, which are responsible for 
poor substrate dispersion and limited substrate uptake (Marques et al., 2007).  
Furthermore, the hydrodynamics of microwell systems can be controlled by the 
shaking diameter and in particular, low shaking diameters have been associated 
with out-of-phase mixing (Büchs et al., 2001; Duetz and Witholt, 2004) where 
the liquid does not circulate in phase with the orbital motion of the shaker.  
Choice of shaking diameter may be a likely explanation for the lack of 
reproducibility observed across the scales for the cytochrome P450s.  In 
particular, the improved growth rates, biomass concentration and product yield 
reached in the stirred tank reactor highlight a better oxygen and substrate supply 
compared to the microscale process.  Alternative methods to improve oxygen 
transfer, such as varying the fill volume, were tested in this work but proved 
ineffective as discussed in Chapter 5, thus it is uncertain whether a change in 
operating conditions could improve mass transfer rates.   
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Based on the previous discussion it is quite challenging to point out a likely 
reason for the behaviour observed.  The growth of E. coli [pQR367] was 
considerably higher at the 7.5 L scale compared to the microscale, indicating that 
bioconversion was independent of growth as observed in a number of previous 
studies as discussed in Chapter 5.  The rate-limiting step in biotransformation can 
be due to the poor substrate solubility hindering mass transport rates of 
substrates/products to and from cells (Manosroi et al., 2008) and this is a 
reasonable explanation for the results observed in this work.  
 
E. coli [pQR367] expressing P450SU1 and E. coli [pQR368] expressing 
P450SU2 were grown at the 7.5 L scale and both successfully metabolised 7-
ethoxycoumarin to 7-hydroxycoumarin.  However, growth and bioconversion 
kinetics did not mimic those achieved at the microscale when a matched KLa 
approach was used.  An overview of alternative scale-up methodologies will be 
discussed in section 6.2.4.   
 
6.2.4 Alternative Scale-Up Strategies  
 
6.2.4.1 The Dynamic Measurement of KLa 
 
The dynamic measurement of KLa has already been discussed and was tested for 
the scale-up of two oxidative systems.  However, it is worth noting that the 
approach used in this work did not take into consideration the cells oxygen 
uptake rate.  It is recommended that accurate oxygen transfer rate measurements 
are carried out in the bioreactor, nutrient broth and the cell population of interest 
(Bailey and Ollis, 1986).  A number of studies have found that the oxygen 
transfer rate is enhanced when oxygen is consumed during microbial growth 
(Calik et al., 1997; Calik et al., 2004).  Vashitz et al. (1989) reported an increase 
in the oxygen liquid transfer coefficient as the oxygen uptake rate of 
Xanthomonas campestris cultures increased.  Moreover, KLa values obtained 
using inoculated culture were found to be higher than those using sterile medium 
(Djelal et al., 2006).  To consider this effect a biological enhancement factor 
termed E has been suggested.  This factor encompasses the enhancement of 
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transport due to oxygen uptake and includes the resistances caused by the 
presence of cells, surfactants or stagnant liquid films and their interaction with 
gas bubbles and the bulk liquid film.  Thus depending on biomass and media 
composition KLa can be described by Equation 6.6 (Garcia-Ochoa and Gomez, 
2009). 
 
! 
KLa = E * kLa         (Eq. 6.6) 
 
Typically E is close to 1 when the biochemical rate (rate of oxygen consumption 
due to cellular activity) is not much higher than the mass transfer rate, 
consequently when the kLa is very high the influence of oxygen uptake rate is 
insignificant and the enhancement low.  However, in cultures with a high oxygen 
uptake rate E will be greater than one, thus increasing the overall KLa.  This 
typically becomes more significant with increases in biomass concentration.  The 
oxygen uptake rate therefore should be considered when measuring KLa as 
oxygen consumption is both organism and growth condition specific and can 
enable a more accurate and realistic prediction of KLa values during culture.   
 
6.2.4.2 Volumetric Power Consumption 
 
The volumetric power consumption  is the energy input within a given 
time period required to generate fluid motion within a vessel.  Heat and mass 
transfer, mixing and circulation times are all influenced by the volumetric power 
consumption.  Volumetric power consumption is traditionally used for the 
effective scale-up of bioreactor configurations using well-known correlations and 
dimensionless analysis but, while estimations of power consumption have been 
achieved in shaken geometries (Buchs et al., 2001), no widely applicable method 
is currently available for well plate format.  This is because there is no 
measurement device sensitive enough to perform accurate torque measurements 
at the microscale.  Furthermore, as torque measurements need to be measured 
inside the liquid most devices are too large to fit inside the well and can be 
intrusive to the flow pattern.  The presence of surface tension, a crucial 
parameter in microwell hydrodynamics, is also not accounted for when using a 
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matched  approach (Hermann et al., 2003; Maier and Buchs, 2001).  
However, Zhang et al. (2008) has used computational fluid dynamics (CFD) to 
estimate power consumption in 24 – well and 96 – well microtitre plates.  It was 
found that power consumption estimations were in the range of those required for 
bacterial cultivation in large-scale stirred bioreactors.  Following on from this 
work Barret et al. (2010) reproduced growth kinetics and antibody titer of murine 
hybridoma cells in 24-well plates to 250 mL shake flasks using matched energy 
dissipation rates based on CFD predictions.   has also been tested to scale-
up mammalian culture at the microscale to 5 L stirred bioreactor scale and while 
similarities were observed there were still distinct differences between the scales 
in terms of growth rate and antibody production kinetics (Micheletti et al., 2006).  
Therefore,  may or may not be ideal as a scale-up parameter from 
microwell to stirred configurations.  It is important to conduct a more accurate 
evaluation of experimental velocity and mixing characteristics in shaken 
bioreactors to be able to compare the hydrodynamics of the two configurations 
and therefore define appropriate scale-up parameters. 
 
6.3 Concluding Remarks 
 
In Chapters 3 to 5 two fully automated microscale processes were developed for 
the quantitative analysis of CHMO and novel cytochrome P450 expressing 
systems.  A range of process parameters, culture conditions and alternative 
reactions were tested enabling optimised process conditions to be defined for 
CHMO and cytochrome P450 bioconversion improvement.  Nevertheless, this 
data can only be deemed useful in early stage bioprocess design and development 
if comparable data can be reproduced in typical stirred tank reactors, the 
configuration of choice for large-scale production.  This chapter thus focused on 
using established scale-up methodologies to reproduce the best conditions 
achieved from the various microscale studies in laboratory and pilot plant scale 
fermenters. 
 
Scale-up based on a matched KLa approach has previously proved to be suitable 
for the reproduction of microscale kinetics on growth, protein expression and 
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bioconversion for a number of microorganisms in stirred systems.  Based on 
previous findings a preliminary scale-up study using this approach was designed 
with E. coli TOP10 [pQR210] expressing CHMO.  Using pre-determined KLa 
measurements from 96-DSW plates and a 75 L stirred bioreactor, growth and 
bioconversion kinetics were found to be similar at both scales.  An adapted 96-
DSW plate with an incorporated fibre optic sensor was manufactured and used to 
enable the dynamic measurement of KLa at the microscale in a similar manner to 
a 75 L bioreactor.  KLa was found to vary linearly with microscale fill volume 
and stirred bioreactor agitation speed.  By identifying conditions which would 
enable both processes to be operated at a matched KLa, a parallel study was run 
which produced comparable results for the growth and bioconversion steps.  This 
study also highlighted the advantage of operating under non-oxygen limited 
conditions thus enabling reproducible growth from aerobic cultures.   
 
Oxygen is required for both the growth of cytochrome P450 strains and the O-
dealkylation of 7-ethoxycoumarin, thus the matched KLa approach was applied 
for the scale-up of the improved process identified from automated microscale 
studies in Chapter 5.  During the production of cytochrome P450SU1 and 
P450SU2 growth and expression phases took place at different agitation speeds 
and temperatures both of which have been found to have an impact on KLa.  KLa 
measurements carried out at different operating conditions allowed a matched 
KLa approach to be adopted to compare the microwell and 7.5 L stirred 
bioreactor processes.  Both strains grew and successfully metabolised 7-
ethoxycoumarin to 7-hydroxycoumarin.  Strains were found to grow faster in the 
stirred bioreactor where a significant increase in biomass concentration was 
observed once the expression was initiated.  While operation was conducted 
under non-oxygen limitations, as previously discussed in Chapter 5, comparison 
of the results found in this work with previous ones suggest that the use of a 
small shaking diameter may have been responsible for the lack of scalability in 
this case.  In particular the turbulence levels present in the well may have not 
been sufficient for effective dispersion of oxygen and substrate.  It was also 
important to assess the alternative scale-up strategies in order to determine 
whether different approaches could be successfully applied to scale translation 
from microwell to stirred bioreactor configuration.  In this study the impact of 
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the oxygen consumption by microorganisms was not taken into account in the 
KLa determination, however it is advisable to conduct such measurements in the 
presence of media and cells to enable accurate assessment of the variation of KLa 
during culture. 
 
Scale translation of microscale operations is necessary if they are to be 
considered a reliable tool for bioprocess development.  Accordingly, the cost and 
time benefit can only be accepted if the data collected is accurate and predicts 
trends and relationships achievable in larger scale configurations.  Using 
established methodologies successful scale-up was demonstrated under non-
oxygen limited conditions but in the case of more complex systems requiring 
specific expression conditions accurate measurement of KLa variations during 
culture are crucial and should consider the biological enhancement promoted by 
metabolic activity. 
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7 Conclusions and Future Work 
 
7.1 Concluding Remarks 
 
A major challenge of bringing biologics to market is the establishment of robust 
manufacturing processes.  In particular, the industrial exploitation of oxidative 
biocatalytic approaches has been limited by the slow implementation time due to 
the number of process variables requiring characterisation and optimisation.  The 
development of miniaturised systems which can effectively mimic the large-scale 
processes is a potential solution to reducing the costs and accelerating process 
development.  Moreover, linking multiple unit operations by means of automated 
processing to gain a better understanding of process interactions is a novel 
concept and has only be investigated to a limited extent.  For this reason this 
thesis tested the hypothesis that high-throughput automated microscale 
approaches could be used for the development and investigation of novel 
oxidative biocatalytic processes.   
 
The initial objective was to develop a generic microscale automated platform for 
bioprocess investigation.  The well-established recombinant CHMO expressing 
strain E. coli TOP10 [pQR210] was used as a model system as the focus of this 
research was on oxidative biocatalysis.  The Tecan automated robotic platform 
was used to achieve process automation, where three distinct steps in the 
production and use of CHMO were demonstrated at the microscale and linked to 
enable the investigation of process interactions.  Unit operations including 
growth, bioconversion and liquid-liquid extraction along with relevant analytic 
techniques were performed using 96-DSW plates.  Each step was found to enable 
the rapid and reproducible collection of quantitative kinetic data over multiple 
runs.  In particular up to six variables could be screened per run and up to 96 
samples processed for GC analysis.  Key achievements included a demonstration 
of robustness, increased throughput and accuracy of data collection comparable 
to manual alternatives.  Furthermore, as time-consuming cell culture and 
maintenance steps were automated, ‘walk away operation’ was achieved where 
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the majority of the process time could be utilised for data analysis, further 
experimentation and analytical operations.   
 
Once the generic microscale platform was in place it was of interest to 
demonstrate its use for whole bioprocess evaluation and optimisation.  
Considering the progress that had already been made with similar CHMO 
expressing systems oxygen transfer rate, biomass concentration and amino acid 
source were chosen to identify the effect on CHMO specific activity.  Each was 
shown to have an impact on both growth and bioconversion activities.  
Furthermore, effects of varying media composition described in this thesis have 
not been previously reported and the data collected thus contributes to improve 
current knowledge of factors which can influence CHMO activity.  The ability to 
assess the combined effect of changing variables on multiple steps enabled 
conditions maximizing CHMO specific activity and bioconversion effectiveness 
to be identified.  This study was followed by an investigation into alternative 
CHMO reactions including an assessment of substrate inhibitory effects and 
screening of Baeyer-Villiger substrates previously untested with E. coli TOP10 
[pQR210].  Substrate specificity and product selectivity were effectively 
demonstrated where two new substrates were successfully metabolised to the 
respective products.  With a view to develop an optimised process sequence and 
to improve the bioconversion of the new substrates, the best condition obtained 
from each study was selected.  Using the optimised process, an almost 2-fold 
decrease in processing time and 5-fold increase in CHMO specific activity were 
achieved.  These conditions were also found to confirm substrate mass transfer 
limitation to be the reason for the lack of conversion with unproductive 
substrates. 
 
From the literature review it was found that novel cytochrome P450 systems 
show great promise and would significantly benefit from high-throughput 
microscale approaches for rapid evaluation.  The automated approach had 
already been demonstrated for robustness and application to biocatalytic process 
evaluation and improvement.  It thus was applied to the novel self-sufficient 
cytochrome P450 systems expressed from E. coli [pQR367] and E. coli 
[pQR368].  The automated approach was adapted and a linked sequence of 
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growth, induction, expression, bioconversion and liquid-liquid extraction was 
established for the investigation of these systems.  This approach was initially 
used to screen fourteen factors for bioconversion improvement and from this 
study the best three were selected and assessed in detail for their influence on 
growth, expression and bioconversion phases.  In particular, the automated 
approach successfully identified limitations in haem prosthetic group formation, 
NAD(P)H regeneration and substrate inhibitory limits.  Previous to this work 
there have been limited reports on the positive impact of glycerol 
supplementation and inhibitory effects of 7-ethoxycoumarin thus these findings 
contribute new data to the field of cytochrome P450 biocatalysis.  When the best 
conditions from these studies were combined, a 5-fold improvement in 
enzymatic expression of both systems was achieved as well as a 5-fold and 1.5-
fold increase in product formation from P450SU1 and P450SU2 bioconversions, 
respectively.  This therefore confirmed high-throughput automated microscale 
approaches could be applied for the creation and rapid evaluation and 
optimisation of novel biocatalytic processes. 
 
Finally, in order for data collected using microscale automated approaches to be 
accepted as a tool for early stage bioprocess design and development, the data 
needs to be reproduced in typical stirred tank reactors.  To examine the potential 
for predictive scale-up, the optimised CHMO process was scaled to 75 L stirred 
bioreactor scale and both cytochrome P450 improved processes were scaled to 
7.5 L stirred bioreactor scale.  A matched KLa approach was chosen as reported 
previously to be successful for aerobic systems.  This scale-up methodology 
proved successful for the CHMO based process where near identical results to 
the microscale were reproduced at the pilot plant scale.  The approach was not 
successful, however, for the two novel cytochrome P450 systems.  While similar 
growth profiles and product formation trends were observed, the final biomass 
concentrations for both strains and also product titre from P450SU2 catalysed 
bioconversion were significantly higher in laboratory scale bioreactors than at the 
microscale.  A number of reasons for these results were discussed in Chapter 6 
including the small shaking diameter used in microscale operations potentially 
preventing effective mass and oxygen dispersion.  Published works have 
demonstrated that KLa estimation can be significantly effected by the biological 
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enhancement resulting from cellular metabolism and oxygen uptake (Calik et al., 
1997; Calik et al., 2004).  This was not considered in these studies where KLa 
measurement were carried out using cell free medium.  KLa should therefore be 
determined in the presence of both cells and medium to enable accurate 
assessment of the variation of KLa as the biomass increases during culture.  This 
may be critical for the scale translation of complex systems such as the 
cytochrome P450s. 
 
7.2 Future Work 
 
The outcome of this thesis has been the development of a generic fully 
automated microscale approach for the whole bioprocess evaluation of oxidative 
biocatalytic processes.  The next step would be to apply the microscale platform 
to a range of challenging strains and bioconversion substrates which have yet to 
be fully studied.  In particular, novel systems were shown to be rapidly evaluated 
in this work, making the technology an important tool during initial 
characterisation and developmental studies.  
 
The short-term future work stemming from the findings of this project would be 
to establish the reason for the lack of scalable data achieved with the cytochrome 
P450 systems.  This could involve initially testing a different shaking platform to 
enable a range of shaking diameters to be assessed.  Visually monitoring the fluid 
flow and mixing of the current system by means of a high-speed camera would 
also be worthwhile.  Grant et al. (2012) used this method and visually identified 
poor bioconversion performance to be due to poor mixing in microwell formats.  
In the case of the present work a transparent glass mimic could be designed for 
such investigations.  In addition, KLa measurements could be carried out during 
cell cultivations as described by Bandyopadhyay et al. (1996) in order to check if 
biological enhancement is causing a significant change to the KLa measured in 
cell free medium.  The demonstration of scalable kinetics for cytochrome P450 
systems is of crucial importance, while the data collected in the present work is 
still useful predictive scale-up would strengthen the results for early stage 
bioprocess design and development. 
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Building on the work done in this thesis there are a number of studies which 
could be done to improve the implemented sequences further.  The control of 
evaporation was found to be an issue during developmental experiments.  An 
appropriate microwell closure system which prevents evaporation but is not 
detrimental to oxygen transfer capacity could be developed.  In particular, being 
able to automate the opening and closure or using non-destructive lid piercing 
options to enable additions and sampling would be an advantage.  Such a system 
would considerably benefit those cultures requiring extended culture or 
bioconversion times and sustain higher cell densities.   
 
Incorporating control and monitoring of factors such as DO and pH at the 
microscale would contribute to better process understanding.  Development of 
smaller, more accurate and reliable sensor technology would be crucial to enable 
variations in optimum culture conditions to be readily controlled. 
 
The incorporation of Design of Experiments (DoE) for the selection of 
appropriate experiments could also improve the overall approach.  While this 
was not an objective of the present thesis, in the case of novel systems the 
number of process variables to be initially tested can be significantly reduced by 
carrying out a DoE study. 
 
Substrate inhibition was highlighted in the present work and is typically a 
limitation of many oxidative bioconversions.  Substrate feeding regimes as well 
as the use of resins for product removal have been reported (Hilker et al., 2008).  
Incorporating such methods into the current automated approach would lead to 
more productive processes.  In particular, using plates with incorporated resins 
for substrate addition and product removal represent an interesting future study.   
 
One additional improvement related to achieving better bioconversion processes 
would be the trial of two-liquid phase systems.  Some of the substrates used in 
this work were poorly water-soluble.  It has been found that using a system 
comprised of both aqueous and organic phases can aid bioconversion, especially 
when those substrates are toxic or inhibitory and in addition can simplify 
downstream processing operations.  This approach has been found effective at 
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the microscale (Marques et al., 2009; Grant et al., 2012) and may be worth 
incorporating for those substrates found to be unproductive in the present work. 
 
In order to take the present work further, incorporation of more microscale unit 
operations into the current automated sequence would be an advantage.  All the 
steps in the production and use of the biocatalyst were automated, including the 
effective extraction into organic solvent, however, small-scale purification may 
also be appropriate.  For example, in the large-scale process, steps such as silica 
gel chromatography and crystallization may be required to achieve a final 
purified product.  The impact of production steps on final purification steps could 
be modeled at small-scale to determine product processing capacity.  Moreover, 
analytic techniques such as GC, HPLC and the CO assay used to quantify active 
cytochrome P450 are currently the rate-limiting step where each sample has to be 
processed individually.  Chhatre and Titchener-Hooker (2009) state that assay 
run times ideally need to be similar to, if not shorter than, the actual experiment 
to prevent analysis becoming the process bottleneck.  In this way incorporating 
high-throughput analytics capable of working with small volume samples could 
reduce the turnaround time prior to the start of process development 
experimentation. 
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9 Appendices 
 
9.1 Appendix A – Calibration Curves  
 
A.1 Dry Cell Weight Calibration Curves 
 
 
Figure A.1 Dry cell weight calibration curve for E. coli TOP10 [pQR210] cells. 
Error bars indicate the range about the mean of duplicate optical density readings 
(x) and duplicate biomass concentration measurements (y). Measurements were 
conducted as described in section 2.6.1 and 2.6.2. 
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Figure A.2 Dry cell weight calibration curve for E. coli [pQR367] cells. Error 
bars indicate the range about the mean of duplicate optical density readings (x) 
and duplicate biomass concentration measurements (y). Measurements were 
conducted as described in section 2.6.1 and 2.6.2. 
 
Figure A.3 Dry cell weight calibration curve for E. coli [pQR368] cells. Error 
bars indicate the range about the mean of duplicate optical density readings (x) 
and duplicate biomass concentration measurements (y). Measurements were 
conducted as described in section 2.6.1 and 2.6.2. 
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A.2 Gas Chromatography Calibration Curves 
 
 
Figure A.4 Bicyclo[3.2.0]hept-2-en-6-one calibration curve. Error bars indicate 
the standard deviation of triplicate stock preparations in ethyl acetate. 
Experiments were conducted as described in section 2.6.4.2. 
 
Figure A.5 (1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one calibration curve. Error 
bars indicate the standard deviation of triplicate stock preparations in ethyl 
acetate. Experiments were conducted as described in section 2.6.4.2. 
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Figure A.6 Cyclohexanone calibration curve. Error bars indicate the standard 
deviation of triplicate stock preparations in ethyl acetate. Experiments were 
conducted as described in section 2.6.4.2. 
 
 
Figure A.7 !-caprolactone calibration curve. Error bars indicate the standard 
deviation of triplicate stock preparations in ethyl acetate. Experiments were 
conducted as described in section 2.6.4.2. 
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Figure A.8 Norcamphor calibration curve. Error bars indicate the standard 
deviation of triplicate stock preparations in ethyl acetate. Experiments were 
conducted as described in section 2.6.4.2. 
 
 
Figure A.9 2-oxabicyclo[3.2.1]octan-3-one calibration curve. Error bars indicate 
the standard deviation of triplicate stock preparations in ethyl acetate. 
Experiments were conducted as described in section 2.6.4.2. 
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Figure A.10 Cycloheptanone calibration curve. Error bars indicate the standard 
deviation of triplicate stock preparations in ethyl acetate. Experiments were 
conducted as described in section 2.6.4.2. 
 
 
Figure A.11 Oxocan-2-one calibration curve. Error bars indicate the standard 
deviation of triplicate stock preparations in ethyl acetate. Experiments were 
conducted as described in section 2.6.4.2. 
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Figure A.12 (1R)-(-)-fenchone calibration curve. Error bars indicate the standard 
deviation of triplicate stock preparations in ethyl acetate. Experiments were 
conducted as described in section 2.6.4.2. 
 
 
Figure A.13 (+)-(3R,6SR)-Dihydrocarvone calibration curve. Error bars indicate 
the standard deviation of triplicate stock preparations in ethyl acetate. 
Experiments were conducted as described in section 2.6.4.2. 
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Figure A.14 Cyclooctanone calibration curve. Error bars indicate the standard 
deviation of triplicate stock preparations in ethyl acetate. Experiments were 
conducted as described in section 2.6.4.2. 
 
 
Figure A.15 (1R)-(+)-camphor calibration curve. Error bars indicate the standard 
deviation of triplicate stock preparations in ethyl acetate. Experiments were 
conducted as described in section 2.6.4.2. 
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A.3 HPLC Calibration Curves 
 
 
Figure A.16 7-ethoxycoumarin calibration curve. Error bars indicate the 
standard deviation of triplicate stock preparations in acetonitrile. Experiments 
were conducted as described in section 2.6.5.2. 
 
Figure A.17 7-hydroxycoumarin calibration curve. Error bars indicate the 
standard deviation of triplicate stock preparations in acetonitrile. Experiments 
were conducted as described in section 2.6.5.2. 
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9.2 Appendix B – Sample Chromatograms 
 
B.1 Gas Chromatography Chromatograms 
 
B.1.1 Standards 
 
Experiments conducted as described in section 2.6.4.2. 
 
 
 
Figure B.1 Chromatogram of 1 gL-1 bicyclo[3.2.0]hept-2-en-6-one (retention 
time: 6.44 min) dissolved in ethyl acetate. Peak present at 11 minutes 
corresponds to naphthalene which was used as an internal standard and added to 
all samples.   
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Figure B.2 Chromatogram of 1 gL-1 (1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one 
(retention time: 13.53 min) dissolved in ethyl acetate. Peak present at 11 minutes 
corresponds to naphthalene which was used as an internal standard and added to 
all samples.   
 
 
 
Figure B.3 Chromatogram of 1 gL-1 cyclohexanone (retention time: 5.65 min) 
dissolved in ethyl acetate. Peak present at 11 minutes corresponds to naphthalene 
which was used as an internal standard and added to all samples. 
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Figure B.4 Chromatogram of 1 gL-1 !-caprolactone (retention time: 12.81 min) 
dissolved in ethyl acetate. 
 
 
 
Figure B.5 Chromatogram of 1 gL-1 norcamphor (retention time: 7.39 min) 
dissolved in ethyl acetate. Peak present at 11 minutes corresponds to naphthalene 
which was used as an internal standard and added to all samples. 
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Figure B.6 Chromatogram of 1 gL-1 2-oxabicyclo[3.2.1]octan-3-one (retention 
time: 14.83 min) dissolved in ethyl acetate. Peak present at 11 minutes 
corresponds to naphthalene which was used as an internal standard and added to 
all samples. 
 
 
 
Figure B.7 Chromatogram of 1 gL-1 cycloheptanone (retention time: 8.25 min) 
dissolved in ethyl acetate. Peak present at 11 minutes corresponds to naphthalene 
which was used as an internal standard and added to all samples. 
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Figure B.8 Chromatogram of 0.5 gL-1 oxocan-2-one (retention time: 10.13 min) 
dissolved in ethyl acetate. Peak present at 11 minutes corresponds to naphthalene 
which was used as an internal standard and added to all samples. 
 
 
 
Figure B.9 Chromatogram of 1 gL-1 (1R)-(-)-fenchone (retention time: 9.19 min) 
dissolved in ethyl acetate. Peak present at 11 minutes corresponds to naphthalene 
which was used as an internal standard and added to all samples. 
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Figure B.10 Chromatogram of 1 gL-1 (+)-(3R,6SR)-dihydrocarvone (isomer 1 
retention time: 11.68 min, isomer 2 retention time: 11.86 min) dissolved in ethyl 
acetate. Peak present at 11 minutes corresponds to naphthalene which was used 
as an internal standard and added to all samples. 
 
 
 
Figure B.11 Chromatogram of 1 gL-1 cyclooctanone (retention time: 10.42 min) 
dissolved in ethyl acetate. Peak present at 11 minutes corresponds to naphthalene 
which was used as an internal standard and added to all samples. 
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Figure B.12 Chromatogram of 1 gL-1 camphor (retention time: 10.81 min) 
dissolved in ethyl acetate. Peak present at 11 minutes corresponds to naphthalene 
which was used as an internal standard and added to all samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 324 
B.1.2 Bioconversions 
 
Experiments conducted as described in section 2.3.1.2 and analysed by GC as 
described in section 2.6.4.2. 
 
 
 
Figure B.13 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 bicyclo[3.2.0]hept-2-en-6-one (retention time: 6.57 min) 
to (-)-(1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one and (-)-(1R,5S)-3-
oxabicyclo[3.3.0]oct-6-en-2-one (retention times: 13.56 min and 13.67 min) at 
(A) 0 minutes and (B) 60 minutes. Peak present at 11 minutes corresponds to 
naphthalene which was used as an internal standard and added to all samples. 
Results are from microwell based bioconversions.   
!"
#"
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Figure B.14 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 cyclohexanone (retention time: 5.10 min) to !-
caprolactone (retention time: 12.77 min) at (A) 0 minutes and (B) 60 minutes. 
Peak present at 11 minutes corresponds to naphthalene which was used as an 
internal standard and added to all samples. Results are from microwell based 
bioconversions.   
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Figure B.15 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 norcamphor (retention time: 7.66 min) to 2-
oxabicyclo[3.2.1]octan-3-one (retention time: 14.79 min) at (A) 0 minutes and 
(B) 60 minutes. Peak present at 11 minutes corresponds to naphthalene which 
was used as an internal standard and added to all samples. Results are from 
microwell based bioconversions.   
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Figure B.16 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 cycloheptanone (retention time: 8.28 min) to oxocan-2-
one (retention time: 10.18 min) at (A) 0 minutes and (B) 60 minutes. Peak 
present at 11 minutes corresponds to naphthalene which was used as an internal 
standard and added to all samples. Results are from microwell based 
bioconversions.   
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Figure B.17 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 (1R)-(-)-fenchone (retention time: 9.24 min) at (A) 0 
minutes and (B) 60 minutes. Peak present at 6.34 minutes corresponds to DMSO 
used to solubilise substrate. Peak present at 11 minutes corresponds to 
naphthalene which was used as an internal standard and added to all samples. 
Results are from microwell based bioconversions.   
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Figure B.18 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 camphor (retention time: 10.82 min) at (A) 0 minutes 
and (B) 60 minutes. Peak present at 6.37 minutes corresponds to DMSO used to 
solubilise substrate. Peak present at 11 minutes corresponds to naphthalene 
which was used as an internal standard and added to all samples. Results are 
from microwell based bioconversions.   
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Figure B.19 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 cyclooctanone (retention time: 10.44 min) at (A) 0 
minutes and (B) 60 minutes. Peak present at 11 minutes corresponds to 
naphthalene which was used as an internal standard and added to all samples. 
Results are from microwell based bioconversions.   
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Figure B.20 Chromatograms displaying the E. coli TOP10 [pQR210] 
bioconversion of 1 gL-1 (+)-(3R,6SR)-dihydrocarvone (isomer 1 retention time: 
11.83 min, isomer 2 retention time: 12.02 min) at (A) 0 minutes and (B) 60 
minutes. Peak present at 6.40 minutes corresponds to DMSO used to solubilise 
substrate. Peak present at 11 minutes corresponds to naphthalene which was used 
as an internal standard and added to all samples. Results are from microwell 
based bioconversions.   
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B.2 HPLC Chromatograms 
 
B.2.1 Standards 
 
Experiments conducted as described in section 2.6.5.2. 
 
 
Figure B.21 Chromatogram of 1 gL-1 7-ethoxycoumarin (retention time: 9.7 
min) dissolved in acentonitrile.  
 
 
Figure B.22 Chromatogram of 1 gL-1 7-hydroxycoumarin (retention time: 6.26 
min) dissolved in acentonitrile.  
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B.2.2 Bioconversions 
 
Experiments conducted as described in section 2.2.2.5 and analysed by HPLC as 
described in section 2.6.5. 
 
 
 
 
 
Figure B.23 Chromatograms displaying E. coli [pQR367] bioconversion of 1 
mM 7-ethoxycoumarin (retention time: 9.73 min) to 7-hydroxycoumarin 
(retention time: 6.26 min) at (A) 0 minutes and (B) 30 hours of bioconversion. 
Results are from induced shake flask based bioconversions.   
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Figure B.24 Chromatograms displaying E. coli [pQR368] bioconversion of 1 
mM 7-ethoxycoumarin (retention time: 9.73 min) to 7-hydroxycoumarin 
(retention time: 6.26 min) at (A) 0 minutes and (B) 30 hours of bioconversion. 
Results are from induced shake flask based bioconversions.   
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9.3 Appendix C – Assays  
 
C.1 NADPH Assay – Sample Calculation 
 
The activity of the sample was expressed in Units (U) where one unit is 
equivalent to the number of µmoles of NADPH consumed per minute.  The 
concentration of NADPH in the microwell was calculated using the Beer 
Lambert Law shown in Equation C1. 
 
        (Eq. C1) 
 
= Absorbance at 340 nm 
 = Extinction coefficient (mLµmol-1cm-1), for NADPH ! = 6.22 
c = NADPH concentration (µmolmL-1) 
 = Light path length (cm) 
The sample and background activity in units can therefore be obtained using 
Equation C2. 
 
       (Eq. C2) 
 
In Figure C.1 the initial linear rate of absorbance change after substrate addition 
is 0.0427 "A340min-1 and the background rate is 0.0131 "A340min-1.  Subtraction 
of the background rate from the initial linear rate gives 0.0296 "A340min-1. Using 
equation C2 a ! = 6.22 mLµmol-1cm-1 and a path length of 0.55 cm in a 
microplate well the number of units in the sample is 8.66 UL-1.  Taking into 
account the dilution of 3.3 and the biomass concentration is 1.3 gL-1 the sample 
has a CHMO activity of 21.98 Ug-1. 
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Figure C.1 The background absorbance change with time and the absorbance 
change with time after addition of the cyclohexanone substrate for a typical 
spectrophotometric assay for CHMO activity.  Assay performed as described in 
section 2.6.8. 
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C.2 CO Assay Development 
 
 
Figure C.2 CO difference spectrums showing the effect of sample incubation 
time with carbon monoxide prior to wavelength scan. 
 
 
Figure C.3 The effect of substrate addition on CO difference spectrum. 
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C.3 CO Assay - Sample Calculation 
 
A sample prepared as described in section 2.6.9.1 and reduced with 25 mM 
sodium hydrosulphite is first scanned on a UV-Vis spectrophometer between 400 
and 500 nm giving the green spectrum in Figure C.4.  CO is then bubbled 
through the sample and the sample scanned between 400 and 500 nm giving the 
dark blue spectrum in Figure C.4. 
 
Subtraction of the reduced spectrum from that complexed with CO produces the 
spectrum in Figure C.5. 
 
Using the values from the CO difference spectrum in Figure C.5 the active P450 
content can be calculated using Equation C3: 
 
! 
P450Content(nmolg"1) =
A# 450nm " A# 490nm( ) ÷ $ cytP 450( )
TProteinconc
% 
& 
' 
' 
( 
) 
* 
* 
*1000 (Eq. C3) 
 
!cytP450 = Extinction Coefficient  0.091 "M-1cm-1 
 
TProteinconc = Total Protein Concentration = 1.6 gL-1 
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Figure C.4 Spectrums of sample reduced with sodium hydrosulphite and the 
same sample which has been bubbled with CO. 
 
 
Figure C.5 CO difference spectrum. 
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9.4 Appendix D – NMR, MS and IR Data  
 
D.1 2-Oxa-bicyclo[3.2.1]octan-3-one Data 
Figure D.1 Representative Proton NMR of purified norcamphor products 2-oxabicyclo[3.2.1]octan-3-one and 3-oxabicyclo[3.2.1]octan-
2-one. 
Ha 
Hd 
Hb Hc Normal Lactone 
Abnormal Lactone 
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Figure D.2 Representative C-13 NMR of purified norcamphor product 2-oxabicyclo[3.2.1]octan-3-one. 
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Figure D.3 Representative mass spectrum of purified norcamphor product 2-
oxabicyclo[3.2.1]octan-3-one.   
 
 
Instrument Resolution: 6659 
Mass Calculated for: C7H10O2 
Theoretical Mass: 126.06753 
Measured Mass: 126.06814 
Error: 4.68 ppm 
MOLECULAR ION PEAK (parent ion peak), 
10 % relative abundance. 
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Figure D.4 Representative infra red spectrum of purified norcamphor product 2-oxabicyclo[3.2.1]octan-3-one. Trough at 1730.1 cm-1 
indicates a carbonyl group (C=O) and a trough at 2949.5 cm-1 indicates a C-H group. 
 
C-H 
C=O 
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D.2 Oxocan-2-one Data 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure D.5 Representative Proton NMR of chemically synthesised oxocan-2-one from cycloheptanone. 
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 Ha 
Hb 
Hb 
Ha 
Hb 
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Figure D.6 Representative mass spectrum of chemically synthesised oxocan-2-
one from cycloheptanone. 
Instrument Resolution: 6664 
Mass Calculated for: C7H13O2 
Theoretical Mass: 129.09155 
Measured Mass: 129.09101 
Error: 4.18 ppm !
MOLECULAR ION PEAK 
(parent ion peak), 100 % 
relative abundance. 
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Figure D.7 Representative Proton NMR of purified oxocan-2-one from CHMO catalysed cycloheptanone. 
Ha 
 Ha 
Ha 
Hb 
Hb 
 Hb 
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Figure D.8 Representative C-13 NMR of purified oxocan-2-one from CHMO catalysed cycloheptanone. 
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Figure D.9 Representative mass spectrum of purified oxocan-2-one from CHMO 
catalysed cycloheptanone. 
 
 
Instrument Resolution: 7142 
Mass Calculated for: C7H13O2 
Theoretical Mass: 129.09155 
Measured Mass: 129.09101 
Error: 4.18 ppm !
MOLECULAR ION PEAK 
(parent ion peak), 100 % 
relative abundance. 
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Figure D.10 Representative infra red spectrum of purified oxocan-2-one from CHMO catalysed cycloheptanone. Trough at 1724.9 cm-1 
indicates a carbonyl group (C=O) and a trough at 2930.6 cm-1 indicates a C-H group. 
C-H 
C=O 
